Me yasa wadannan alamun ke faruwa na wani lokaci?
Kuma duk ciwon kirji dole ne a bi da shi ta wannan hanyar, musamman ma a shekarun ku.
Kuma tãre da zazzabi.
Hakanan za a gwada karfin jini da kuma cholesterol.
Kuma kuna da ciwon kirji a yanzu?
Kuma kuna da wannan ciwon kirji a yanzu?
Kuma a gefe guda, kuna da matsalar numfashi?
Kuma za ku iya gaya mani, waɗanne alamun cutar da kuke da su?
Kuma yawan zafin jikinka?
Kuma ina tari.
Kuma ina da ɗan tari da tari.
Kuma a yau ina da ciwo mai tsanani a kirji.
Kuma shin lokaci ne mai kyau don rashin lafiyar ku?
Kuma ta yi ɓarna a cikin ƙirjinsu.
Kuma ina ganin ina da zazzabi.
Kuma ina so ku bayyana yanayin ciwon kirji.
Kuma suna da zazzabi kaɗan.
kuma idan kana da ciwon sukari
Kuma kun sani, ina jin kamar kirji na ya fara zubewa.
Ka sani fa, mutane suna ta yi mini baƙar magana kullum.
Kuma ƙirjinka yana ciwo.
Kuma kun ce, 'Wannan nauyi ne a kanku.'
wani a cikin iyali yana da cututtukan zuciya, cututtukan zuciya, ciwon zuciya, babban cholesterol, hawan jini;
Waɗanne alamomi ko matsaloli kuke lura da su tare da ciwon tsoka?
Shin akwai wasu mutane a gida da ke fama da irin wannan cutar?
Shin kuna da wasu alamun cutar?
Kuna da ƙarancin numfashi?
Shin har yanzu kuna da ciwon nono?
Domin yanzu ne lokacin mura.
Shin bai kamata mu manta da ciwon kirji ba daga asalin zuciyarmu?
Amma mafi muhimmanci yanzu shine ciwon kirji.
Amma ina da matsalar numfashi.
Amma na san cewa mutane da yawa za su gane ni.
Amma dole ne mu ɗauki ciwon kirji da muhimmanci.
Amma yanzu yana numfashi sosai, ko ba haka ba?
Na manta da shi gaba ɗaya saboda ciwon kirji.
Kuna jin wani yana matsawa a kan kirjinku.
Har yanzu kuna jin numfashi a cikin ku.
Shin suna fama da irin wannan cutar da alamomi?
Shin kuna da wata cuta mai tsanani kamar hawan jini ko kuma irin wannan cuta?
Kuna da wata cuta ko wata cuta ta kullum kamar ciwon sukari?
Shin kuna da ciwon kirji tare da numfashi mai wahala?
Kuna da hawan jini?
Shin kun yi ƙunci da numfashi?
Shin kun san abin da ya faru da ita?
Kuna ganin hoton?
Sha ruwa mai yawa yau.
Duk da haka, ina yin gwajin ciwon sukari.
Duk da haka, yana da alamun da suka yi kama da nawa.
Yaya yawan zafin jikinka yake?
Yaya karfin jini naka yake?
Idan har yanzu kuna da zazzabi mai yawa
Idan zazzabinka ya ɗara ɗari biyu ko fiye,
Idan kana ganin alamun cututtuka ko matsaloli na bukatar ƙarin bincike
Na yi zazzabi a jiya.
Ina da zazzabi mai tsanani.
Na yi zazzabi a jiya.
Ina da ciwo mai tsanani a cikin kirji.
Ina da matsalar numfashi.
Zan aiko muku da hoto.
Ina jin ciwo a cikin kirji a yau.
Ina da ciwon kai da zazzabi a yau.
Ina tsammanin mura ce.
Ina ganin wannan cutar mura ce mai laushi.
Shin kamar mutum mai nauyi ne yake zaune a kan wuyanka?
Ya fara da ciwon kai da zazzabi kusan lokaci guda.
Yana daidai a tsakiyar kirjina.
Matsin lamba kamar ciwon kirji ne
Ina jin ciwon kai.
Yana tsakiyar kirji na.
Yana tsakiyar kirji na.
Ƙarƙashin ƙugu na ciwo
Ina damuwa sosai game da ciwon kirji.
Ina so ku gaya mani yadda kuke kwatanta wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
Yana daidai a tsakiyar kirjina.
Yanzu zaka iya shan takapirina don zazzabin sukari.
To, Mary, kuna da alamun cututtuka na kwanaki da yawa.
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina fama da ciwon kirji.
To, kuna da wasu alamun ban da ciwo?
Ko kuwa akwai wanda yake zaune a kan ku?
Zazzabi, tari, ciwon kai, ciwon tsoka, duk kusan iri ɗaya ne.
Yana daidai a tsakiyar kirjina.
A cikin wannan hoton, nuna mani inda kake jin zafi.
Domin kuna da zazzabi.
Shin kuna ganin wasu daga cikin waɗannan alamun zasu iya zama masu alaƙa da ciki?
Shin yaranku suna da wasu daga cikin waɗannan alamun?
Ku gaya mani game da ciwon kirji.
Zazzabi yakan tashi da dare.
Na yi ciwon zazzabi na kwana biyu.
Ta yi zazzabi sosai a daren jiya.
Wannan shi ne Dr. Porter a cikin ɗakin gaggawa na farko.
To, za ka iya gaya mana kadan game da ciwon kirjinka?
Ina jin zafi a gaban jikina a cikin kirji.
Na jima ina fama da ciwon kirji mai tsanani.
To, idan na ji ciwon kai a cikin kirji,
Wane irin ciwo ne kuke da shi a cikin kirjin ku?
Yaushe ne wannan ciwon kirji ya fara?
A wane ɓangaren kirjinka kake jin zafi?
A ina kuke jin wannan ciwon kirji?
Kuna jin tsananin damuwa a kan kirji.
Kamar yadda kuka sani, ina da ciwon sukari da wasu matsaloli.
Kun ce kuna da ciwon kirji.
Cutar cutar coronavirus (COVID-19) ta haɓaka cikin sauri a cikin EU / Yankin Tattalin Arzikin Turai da Ingila, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
An samu ci gaba mai kama da na cutar coronavirus (COVID-19) a cikin ƙasashen EU / EEA da Ingila, wanda ke nuna cewa ko da yake cutar ta ɓarke a matakai daban-daban a cikin ƙasashe daban-daban, cutar ta COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Dangane da kwarewar da aka samu daga cutar a Italiya, ƙasashe, asibitoci da sassan kulawa na musamman dole ne su haɓaka shirye-shiryen su don babban tasirin marasa lafiya da ke fama da COVID-19 waɗanda ke buƙatar kulawa da kulawa ta musamman.
A ranar 31 ga watan Disamba, 2020, an samu rahoton wani rukunin marasa lafiya da ke fama da cutar huhu da ba a san dalilin da ya sa ba a Wuhan, lardin Hubei na kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin ta ba da rahoton cewa cutar ta samo asali ne daga wani sabon kwayar cutar coronavirus, wanda yanzu ake kira SARS-CoV-2.
Tun daga wannan lokacin, rashin lafiyar da ke haifar da kamuwa da SARS-CoV-2 an kira cutar coronavirus (COVID-19).
Bayanan da ake da su a halin yanzu sun nuna cewa kusan kashi 80% na mutanen da ke fama da cutar COVID-19 suna fama da cutar ta hanyar kamuwa da cutar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan suna murmurewa.
A cikin kusan kashi 14 cikin ɗari, COVID-19 ya zama mafi tsanani wanda ya sa ya zama dole a kwantar da marasa lafiya a asibiti, yayin da sauran kashi 6 cikin ɗari suka kamu da rashin lafiya mai tsanani kuma aka sanya su cikin kulawar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke cikin asibiti saboda COVID-19 ya kusan 4%.
A cikin wannan binciken, mun kimanta yanayin yanayin cutar COVID-19 a kowace ƙasa ta EU / EEA da Ingila kuma mun kwatanta yanayin da lardin Hubei na China.
Mun kuma kwatanta yawan mutanen da ke fama da cutar COVID-19 a cikin EU / EEA da Ingila da adadin masu kamuwa da cutar a Italiya a lokacin Janairu 31 zuwa Maris 15, 2020.
Cutar COVID-19 a cikin EU / EEA da Ingila.
Bayan haka, COVID-19 ya bazu zuwa wasu yankuna a China, kuma yanayin cutar COVID-19 a sauran sassan duniya yanzu yana bin irin wannan yanayin a cikin ƙasar.
A ranar 11 ga watan Maris, Sakatare Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana cutar ta COVID-19.
A cikin fitowar da aka buga a ranar 5 ga Maris a cikin mujallar Eurosurveillance 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon tabbataccen mara lafiyar Turai na coronavirus bisa ga ma'anar Hukumar Lafiya ta Duniya.
A cikin EU/AEA, an fara tabbatar da cutar a ranar 24 ga Janairun 2020 a Faransa tsakanin matafiya da suka dawo daga Wuhan, lardin Hubei na China.
A ranar 15 ga Maris, 2020, an gano mutane 39,768 da suka kamu da cutar a cikin dukkan ƙasashen EU / Yankin Tattalin Arzikin Turai 30 da Ingila (UK), tare da mutuwar mutane 1,770 da mutuwar mutane 1,441 a Italiya kawai.
Samun ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ba da rahoton adadin mutanen da aka tabbatar da cutar COVID-19 a kowace ƙasa a duniya a kowace rana daga kafofin hukuma kamar ma'aikatar lafiya, hukumomin kiwon lafiya na ƙasa da na yanki a waɗannan ƙasashe da Hukumar Lafiya ta Duniya da karfe 8:00 na safe.
An yi amfani da bayanan ne don kimanta yanayin COVID-19 a cikin EU / EEA da Ingila da kwatanta su da Italiya.
A matsayin tushen don ƙayyade yaduwar COVID-19 masu aiki, mun lissafa gajeren lokacin haɗuwa na kwanaki 14 don marasa lafiya na COVID-19, don haka an yi la'akari da lokacin al'ada na COVID-19 a kowace ƙasa memba ta EU / EEA da Ingila, a cikin lokacin daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Hakanan an kwatanta yawan adadin masu cutar a kowace ƙasa a karfe 8:00 na safe 15 ga Maris, 2020 tare da adadin a cikin Janairu 31 zuwa Maris 15, 2020.
Yanayin kamuwa da COVID-19 a cikin EU / EEA da Ingila.
Hanyoyin da aka lura a cikin raguwar kwanaki 14 na haɗuwa da cututtukan COVID-19 a cikin EU / EEA da Ingila gabaɗaya sun dace da abubuwan da aka ambata a lardin Hubei (China) (Hoto na 1).
Gabaɗaya, a cikin EU / EEA da Ingila, ɓarkewar COVID-19 ya fara ne a ranar 21 ga Fabrairu, sannan ya haɓaka cikin sauri a ranar 28 ga Fabrairu, 2020.
Wannan ya fi yawa saboda saurin karuwar adadin wadanda aka ruwaito daga Italiya, amma duk sauran membobin EU / EEA da Ingila sun nuna irin wannan yanayin karuwa a cikin cutar COVID-19 (mai neman da aka makala).
Hoto na 2 ya nuna kwatancen yawan mutanen da ke dauke da COVID-19 a cikin EU / EEA da Ingila tare da adadin masu kamuwa da cutar a Italiya a lokacin Janairu 31 zuwa Maris 15, 2020.
Ya bayyana cewa a karfe 8:00 na safiyar ranar 15 ga Maris, wasu kasashe 15 na EU / EEA da Ingila sun ba da rahoton adadin masu kamuwa da cutar, wanda ya yi daidai da na Italiya a makonni 3 da suka gabata ko ƙasa da haka.
Sakamakonmu ya nuna cewa yawan adadin masu cutar COVID-19 a cikin EU / EEA da Ingila suna ƙaruwa cikin sauri.
Hanyoyin da aka lura a cikin ɓarkewar COVID-19 sun nuna cewa annobar tana yaduwa a cikin dukkan ƙasashe a irin wannan saurin.
Duk da cewa kasashe suna fuskantar matakai daban-daban na barkewar cutar, akwai bambance-bambance a yadda hukumomin kiwon lafiya na ƙasa ke amsawa, kuma ana amfani da ƙa'idodi daban-daban a cikin ƙasashe daban-daban don mutanen da ke buƙatar yin gwajin tabbatarwa ko ƙarin gwajin COVID-19.
A farkon watan Maris na 2020, likitoci a yankunan da ke fama da cutar a Italiya sun ba da rahoton cewa kusan kashi 10% na marasa lafiya da ke fama da COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa an riga an cika iyakar ƙarfin asibitoci da sassan kulawa mai tsanani a waɗannan yankuna.
A halin yanzu, a cikin EU / EEA, kawai a cikin kashi 6% da 1% na ƙasashe, ana samun bayanai game da asibiti da / ko kulawar ICU na marasa lafiya na COVID-19.
Koyaya, dole ne a tattara su cikin tsari don amfani da su azaman kari ga bayanan sa ido na yanzu kuma a mai da hankali kan wasu ɓangarorin da aka ruwaito da ɓangarorin mutuwa.
Wani bincike da aka gudanar a tsakanin 2010 zuwa 2011 ya nuna bambance-bambance masu yawa game da samun damar gado na kulawa mai mahimmanci da matsakaiciyar kulawa a Turai, daga gado 29.2 a Jamus zuwa gada 4.2 a Portugal a kowane mutum 100,000.
Wannan yana nufin cewa waɗannan ƙasashe suna da albarkatu fiye da Italiya ko ƙasa da haka (a matsakaita, gadaje masu kulawa ta musamman 12.5 ga kowane mutum 100,000 a cikin 11-2010).
An gabatar da yanayin samfurin da ya danganci yawan lafiyar da kuma maganin tare da kimantawa ga kowace EU / EEA da UK don yawan marasa lafiya na COVID-19 da aka kwantar da su tare da haɗarin > 90% na wucewa fiye da ƙarfin gadaje na ICU a cikin tsarin ECDC na shida na kimanta haɗarin haɗari mai sauri don COVID-19.
Saboda an lura da cutar a cikin rukuni a wasu yankuna a cikin EU / EEA da Ingila, kuma asibitoci da wuraren kula da marasa lafiya na musamman galibi suna ba da sabis ga al'ummomin yanki, ya kamata a fi son samar da bayanai game da cutar da gadajen kula da marasa lafiya bisa ga tsarin yanki na matakin kididdiga na 2 (NUTS-2).
Kwarewar cutar a Italiya da abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin EU / EEA da Ingila.
Don haka, ƙasashe, asibitoci da sassan kulawa na musamman dole ne su shirya kansu don yanayin ci gaba da yaduwar SARS-CoV-2 da samar da kayan aiki don karɓar marasa lafiya da ke da cutar COVID-19, musamman a cikin sassan kulawa na musamman, kamar yadda ya faru a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon kimantawa na haɗarin ECDC, yana da mahimmanci don jinkirta yaduwar SARS-CoV-2 zuwa hanzari, mai saurin yaduwa da kuma cikakkiyar hanyar da ta dace tare da sauya ra'ayi daga ƙuntatawa zuwa rage saurin annobar, saboda idan ba a ɗauki matakan da suka dace ba, saurin karuwar yawan masu kamuwa da cutar na iya ba da damar isa ga masu yanke shawara da asibitoci don ganowa, karɓa da aiwatar da martani mai dacewa.
Binciken haɗarin gaggawa yana kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Kasashe suna da ɗan gajeren lokaci don ƙarfafa ƙoƙarin sarrafawa da rage saurin yaduwar SARS-CoV-2 don haka rage matsin lamba akan tsarin kiwon lafiya.
Idan ba a yi hakan ba, tsarin kiwon lafiya na sauran ƙasashen EU / EEA na iya fuskantar babban ɗimbin marasa lafiya da ke buƙatar kulawa mai mahimmanci a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19), wacce cutar SARS-CoV-2 ke haifarwa, ta yi sanadiyar mutuwar mutane sama da 3,000 da kamuwa da cutar sama da 80,000 a China da sauran sassan duniya, don haka ta zama bala'i ga dan adam.
Hakanan, SARS-CoV-2 na iya zama kama da SARS-CoV wanda ya haifar da SARS a cikin dubban mutane a cikin 2003, wanda ya kamu da cutar ta hanyar bat, yana haifar da alamun bayyanar cututtuka ta hanyar irin wannan tsarin.
Koyaya, COVID-19 ba shi da tsanani da kisa kamar SARS, amma yana da saurin yaduwa kuma yana kamuwa da tsofaffi da maza fiye da matasa da mata.
Dangane da karuwar adadin wallafe-wallafen da aka yi game da wannan cutar mai tasowa, wannan gwagwarmaya tana ƙoƙari don samar da cikakken bayani game da wannan batun bincike mai mahimmanci.
Za mu samar da bayanan asali game da ilimin annoba, ilimin halittu, ilimin ƙwayoyin cuta, ganewar asali, magani, tsinkaya da rigakafin cutar.
Kodayake har yanzu akwai tambayoyi da yawa da ba a amsa ba, ana fatan wannan binciken bita zai taimaka wajen gano wannan cuta mai haɗari da kawar da ita.
Bikin bazara a ranar 25 ga Janairun 2020 ya zama abin tunawa ga dukkan Sinawa waɗanda aka nemi su zauna a gida duk lokacin hutu da kuma makonni da yawa bayan barkewar sabuwar cutar.
Kwayar cutar tana da hawan jini tare da kwayar cutar coronavirus (CoV) wanda ya haifar da barkewar cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Cutar ta fara ne a Wuhan na kasar Sin kuma ta bazu cikin sauri a duk fadin kasar da wasu kasashe 5 a duniya.
Tun daga ranar 2 ga Maris, 2020, cutar ta haifar da kamuwa da cutar ta tabbata ga mutane sama da 80,000, tare da adadin marasa lafiya da aka sallama sun wuce 40,000 kuma sama da 3,000 sun mutu.
"WHO ta yi gargadin cewa COVID-19 shine ""maƙiyi na 1 na jama'a"" kuma yana iya zama mafi ƙarfi fiye da ta'addanci. "
A cewar bayanan PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga sama da takardu 200 na kimiyya game da COVID-19, waɗanda suka haɗa da ilimin ƙwayoyin cuta, ilimin annoba, ilimin asibiti, ganewar asali da magani tun lokacin da aka ba da rahoton labarin farko a ranar 7 ga Janairu, 2020 game da ƙididdigar tsarin kwayoyin halittar kwayar cutar da aka samo daga marasa lafiya da yawa.
Wannan nazarin bita yana nufin taƙaita ci gaban bincike a cikin sababbin fannoni da ke cikin hankali.
A wasu wurare, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da wata cuta ta coronavirus da ake kira Ciwon Numfashi na Gabas ta Tsakiya (MERS, wanda ya zama sananne a cikin 2012).
Za mu tattauna abin da muka koya game da rigakafi da kuma bayyanar cututtuka har zuwa yanzu, da kuma wasu tambayoyi masu muhimmanci da suka rage.
Kwayoyin cutar corona sun kasance masu cutarwa waɗanda ba su da haɗari ga ɗan adam kuma suna haifar da kusan kashi 15% na cututtukan sanyi.
Koyaya, a cikin wannan karni, mun sami sau biyu da aka yi da cutar coronavirus mai saurin kamuwa da cutar mutum, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar a cikin 2003 a China da 2012 a Saudiyya, bi da bi, kuma ba da daɗewa ba suka bazu zuwa wasu ƙasashe, suna haifar da mummunan kamuwa da cuta da mutuwa.
Don haka, COVID-19 na yanzu shine barkewar cutar coronavirus ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1, an fara bayar da rahoton tarin fuka-fukan da ba a san asalin su ba a ranar 31 ga Disamba, 2019 daga Wuhan zuwa Hukumar Lafiya ta Kasa ta kasar Sin.
Kwana bakwai bayan haka, an fara yaduwar wannan kwayar cutar.
A ranar 15 ga Janairun 2020, an bayar da rahoton farkon cutar a Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka da su, da sauran larduna da ƙasashe.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da ma'aikatan kiwon lafiya, wanda ya nuna yiwuwar yaduwar mutum zuwa mutum.
A ranar 23 ga Janairu, an kammala keɓewar Wuhan kuma an dakatar da zirga-zirgar jama'a gaba ɗaya.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 40 da aka tabbatar, 21 ne kawai ke da alaƙa kai tsaye da kasuwar abincin teku ta Wuhan, inda aka fara cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka wallafa wannan rahoton, cutar ta bazu a duk faɗin China da kuma wasu ƙasashe kusan 50 a duniya.
Saboda yanayin yana canzawa cikin sauri, dole ne a tantance yadda yaduwar cutar ta kasance da kuma tsananin cutar.
A ranar 11 ga Fabrairu, 2020, wani bincike na cibiyoyi da yawa akan marasa lafiya 8,866 na COVID-19, gami da masu haƙuri 4,021 na COVID-19, ya ba da ƙarin bayyanar cutar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Kwayar cutar SARS-CoV-2 ta kamu da mutane a kowane zamani, amma galibi ta kamu da mutane masu shekaru 65-30.
Kusan rabin (47.7%) na mutanen da ke fama da cutar sun haura shekaru 50, kaɗan ne a ƙarƙashin shekaru 20, kuma mutane 14 ne kawai ke da cutar da ke ƙasa da shekaru 10.
Kwayar cutar SARS-CoV-2 tana kamuwa da maza (0.31 cikin 100,000) fiye da mata (0.27 cikin 100,000).
COVID-19 ya bazu a cikin ƙwayoyin cuta a cikin Hubei da kewayenta.
Gano COVID-19 ya ɗauki matsakaicin kwanaki 5 (kwana 9-2) daga lokacin da ya fara.
Matsakaicin lokacin al'ada (7.2-3.0) shine kwanaki 4.8.
Matsakaicin lokacin daga farkon cutar zuwa mutuwa (13-4.8) ya kasance kwanaki 9.5.
Matsakaicin ƙimar ƙimar (R<sub>0</sub>) ya kasance 3.77 (tare da kusan tabbacin: 4.05-3.51) kuma R<sub>0</sub> da aka daidaita ya kasance 4.82-2.23.
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairun 2020, daidai da lokacin da yawan tafiye-tafiye ya karu kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar sun kasance 1.44% (tare da kusan tabbacin 95%: 1.86-1.10) da kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (tare da kusan tabbacin 95%: 4.59-2.02).
Manyan abubuwan haɗari guda uku don COVID-19, jinsi (maza), shekaru (shekaru 60 ko sama da haka) da kuma ciwon huhu mai tsanani.
Coronaviruses ƙananan ƙananan ƙwayoyin cuta ne masu girma, masu ɗauke da ƙwayoyin RNA guda ɗaya.
An rarraba su zuwa jinsuna huɗu, wato, alpha, beta, gamma da delta, daga cikinsu akwai waɗanda ke kamuwa da cutar HCoVs na alpha da beta.
Glycoprotein (S) spike na murfin SARS-CoV da MERS-CoV yana haɗuwa da masu karɓar ƙwayoyin cuta na sel da ake kira enzyme mai canzawa na angiotensin 2 (ACE2) da dipeptidyl peptidase 4 (DPP4), bi da bi, kuma yana haɗuwa da membrane na tantanin halitta.
Ana sakin kwayoyin RNA na kwayar cutar a cikin cytoplasm; bayan kwayar cutar ta ninka, RNA na kwayar halitta tare da murfin glycoproteins da nucleopeptide sun hada da vesicles dauke da virion, wanda daga bisani ya haɗu da membrane plasma, yana haifar da sakin sabon kwayar cutar.
An fara rahoton jerin kwayoyin halittar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Binciken ya nuna cewa SARS-CoV-2 wani sabon nau'in kwayar cutar beta ne wanda samfurori 10 da aka gano daga asalin cutar a kasuwar abincin teku ta Hunan da ke Wuhan suna da kamanceceniya da kashi 99.98%.
Kwayar cutar SARS-CoV-2 ta fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar binciken microscope na lantarki, an gano ƙwayoyin SARS-CoV-2 a cikin ƙananan ƙananan epithelium na hanyar numfashi na mutum.
ACE2 na mutum an san shi da mai karɓar kwayar cutar SARS-CoV-2 da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da rauni a haɗuwa da mai karɓar ACE2 na ɗan adam fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma yana samar da sabon ɗan gajeren furotin wanda aka tsara ta hanyar orf3b da furotin mai ɓoyewa wanda aka tsara ta hanyar orf8.
Furotin orf3b na SARS-CoV-2 yana da tasiri a cikin yanayin cutar ta cutar kuma yana hana bayyanar IFNβ (interferon beta); duk da haka, orf8 ba ya ƙunshe da wani abu na biyu ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun ba da rahoton tsarin microscopy na lantarki na mutum na ACE2 mai karɓar ƙarfin hali na 2.9 ingstrom a cikin hadaddun tare da mai ɗaukar amino acid mai suna B0AT1.
Sun gano cewa hadaddun da ke sama, wanda ke da buɗewa da rufewa, ana haɗa shi a cikin dimer kuma hadaddun ACE2-B0AT1 na iya haɗawa da sunadarai biyu na S waɗanda za a iya amfani da su azaman ma'auni don ganowa da kamuwa da cutar coronavirus.
B0AT1 na iya zama maƙasudin magani don tantance magunguna don magance kamuwa da cutar SARS-CoV-2.
Tushen da kuma mai watsa shiri na tsakiya
An gano cewa ƙwayoyin cuta na SARS-CoV da MERS-CoV duka sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar San Zhabad cat da raƙumi, bi da bi.
Ta hanyar kwatanta kwayoyin halittar SARS-CoV-2 da sauran coronaviruses, an gano cewa jemage ne babban mai karɓar SARS-CoV-2, saboda sabon kwayar cutar yana da kamanceceniya da kashi 96% na SARS-like coronaviruses biyu daga jemage, bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, har yanzu ba a san ko wane mai watsa shiri ne ya taimaka wa kwayar cutar ta ƙetare iyakokin nau'in kuma ta kamu da mutane ba, kuma hanyar watsawa har yanzu ba a bayyana ba.
Jay da abokan aikinsa sun ba da shawarar cewa macizai sun kasance masu ɗaukar kwayar cutar daga jemage zuwa mutane ta hanyar ba da izinin kwayar halitta ta S.
A cewar wani bincike, masu bincike a Guangzhou na kasar Sin sun ba da shawarar cewa pangolins - dabbobi masu shayarwa masu dogon ƙaho , waɗanda ake amfani da su a cikin maganin gargajiya na kasar Sin, bisa ga kamannin kwayoyin halitta tare da kwayar cutar coronavirus da aka gano a cikin pangolins da kuma SARS-CoV-2, na iya zama mai watsa shiri na SARS-CoV-2.
Duk da haka, bambancin 1% tsakanin kwayoyin halitta biyu har yanzu babban bambanci ne; saboda haka, ana sa ran samar da sakamako mai mahimmanci don tabbatar da hujja (Fig. 3).
Ba a san ainihin yanayin jiki da sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin yanayin in-vitro na tsawon awanni 48 a cikin yanayin bushewa, har zuwa kwanaki 5 a yanayin zafi ƙasa da digiri 20 Celsius da zafi 50%-40%.
Kwayar cutar SARS-CoV-2 na iya samun irin wannan halaye.
An ba da rahoton cewa SARS-CoV-2 yana da ƙwarewa ga waɗannan abubuwan da za su iya kashe kwayar cutar yadda ya kamata: hasken ultraviolet da kuma kasancewa a cikin zafin jiki na 56 ° C na minti 30; ether, 75% ethanol, maganin kashe ƙwayoyin cuta wanda ya ƙunshi chlorine, prasectic acid, chloroform da sauran magudanar mai, amma chlorhexidine ba shi da irin wannan damar.
Gabaɗaya, duk mutanen da ke cikin duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, ba a ba da rahoton amsawar rigakafi ga SARS-CoV-2 a cikin kowane binciken ba.
Don haka, zamu iya komawa ne kawai ga binciken da aka yi a baya akan sauran coronaviruses, musamman SARS-CoV da MERS-CoV (Figure 4).
Ana gano kwayar cutar gabaɗaya ta hanyar tsarin rigakafin jiki na mai masaukin baki ta hanyar masu karɓar alamun ganowa (PRRs) waɗanda suka haɗa da masu karɓar nau'in -C na lectin, mai karɓar hanyar wucewa (TLR), mai karɓar NOD (NLR), da mai karɓar RIG-I (RLR).
Kwayar cutar tana haifar da ayyuka ta hanyoyi daban-daban kamar bayyana abubuwan ƙonewa, balaga na dendritic da kuma samar da nau'ikan I-type interferons (IFNs) waɗanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na ƙwayoyin cuta na kwayar cuta ta hanyar macrophages.
Koyaya, furotin N na SARS-CoV na iya taimakawa wajen ceton kwayar cutar daga martani na tsarin garkuwar jiki.
Amsar rigakafin daidaitawa za ta fara aiki nan ba da jimawa ba don magance kwayar cutar.
T lymphocytes, wanda ya ƙunshi CD4+ da CD8+ T-cell, suna taka muhimmiyar rawa a cikin kariya.
Kwayoyin T na CD4+ suna motsa ƙwayoyin B don motsa ƙwayoyin rigakafi na musamman ga kwayar cutar, kuma ƙwayoyin T na CD8+ suna kashe ƙwayoyin cutar kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu kumburi don taimakawa kwayoyin da ke karewa.
Koyaya, COVID-19 na iya hana ayyukan T-cell ta hanyar haifar da apoptosis.
Kwayar cutar ta ƙunshi wasu abubuwa kamar C3a da C5a, kuma ƙwayoyin cuta suna taka rawa wajen magance kamuwa da kwayar cuta.
Misali, ƙwayoyin cuta da aka ware daga mai haƙuri mai warkewa sun kawar da MERS-CoV.
A gefe guda kuma, rashin karfin jiki yana haifar da yawan adadin radicals na gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, a cikin mafi munin yanayin, rashin aiki da yawa ko ma mutuwa.
Haɗarin kamuwa da SARS-CoV-2, wanda ke nuna yaduwar kwayar cuta, ya fi girma a cikin mutanen da ke da cututtukan da ke tattare da su da kuma mata masu ciki.
A dabi'ance, mutane da ke fama da yawan kamuwa da cutar ko kuma waɗanda ke da lahani a cikin aikin rigakafi suna da damar kamuwa da cutar fiye da sauran mutane.
Matsakaicin matsakaicin matsakaicin matsakaicin matsakaici na SARS-CoV-2 shine kwanaki 1 zuwa 14, tare da nazarin marasa lafiya 425 na farko a Wuhan wanda ya nuna cewa yawanci kwanaki 3 zuwa 7.
Koyaya, binciken da aka yi akan marasa lafiya 1,099 ya nuna cewa tsawon lokacin cutar ta kasance kwanaki 3 a matsakaita kuma ya bambanta daga kwanaki 0 zuwa 24.
Wani sabon binciken da aka ambata a sama ya ba da labarin tsawon lokacin cutar ta 4.8 (7.2-3.0) kwanakin, dangane da nazarin alƙaluma na marasa lafiya 8,866.
Yana da mahimmanci ga hukumomin kiwon lafiya su aiwatar da lokacin keɓewa mai tasiri bisa ga mafi kyawun yanayin al'ada don hana watsa kwayar cutar ga wasu ta hanyar marasa lafiya marasa alamun cutar.
A matsayin wata al'ada, mutanen da ke dauke da cutar ko kuma waɗanda ke da cutar za su kasance cikin keɓewa na kwanaki 14.
Shin ya kamata a kara wa'adin keɓewa zuwa kwanaki 24?
Sau da yawa zazzabi shine farkon alamun COVID-19, wanda zai iya faruwa shi kaɗai ko tare da wasu alamun kamar bushewar tari, numfashi mai ƙanƙanta, ciwon tsoka, ciwon kai, ciwon kai, ciwon makogwaro, zubar ruwa, ciwon kirji, gudawa, tashin zuciya da amai.
Wasu marasa lafiya sun sami wahalar numfashi da / ko rage iskar oxygen a cikin nama mako guda bayan farawar cutar.
A cikin mummunan ciwon baya, an lura da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ya kamata a gwada marasa lafiya da zazzabi da / ko cututtukan numfashi da zazzabi mai tsanani, koda kuwa ba su da wani abu mai ban mamaki a cikin hotunan ƙwayar cuta, don saurin ganewa game da kamuwa da cutar.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin ɗari na alamun da aka lura a cikin marasa lafiya sun kasance: zazzabi, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na numfashi da kashi 3 cikin ɗari na zawo; kashi 8 cikin ɗari na marasa lafiya suna buƙatar taimakon iska.
An bayar da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan a cikin rukunin iyali da kuma rukunin da aka kafa ta hanyar watsawa ta hanyar mutane marasa alamomi.
A matsayin kwatancen, binciken alƙaluma a cikin 2012 ya nuna cewa marasa lafiya na MERS-CoV suna da zazzabi (98%), tari mai bushe (47%) da ƙarancin numfashi (55%) a matsayin manyan alamun cutar.
Koyaya, kashi 80% daga cikinsu suna buƙatar taimakon numfashi, wanda ya fi na marasa lafiyar COVID-19 yawa kuma ya dace da ƙimar mutuwa mafi girma a cikin MERS idan aka kwatanta da COVID-19.
An kuma lura da gudawa (26%), da ciwon makogwaro (21%), a cikin marasa lafiya da ke fama da MERS.
A cikin marasa lafiya da ke fama da SARS, an gano cewa manyan alamun cutar sun haɗa da zazzabi (99% zuwa 100%), tari mai bushewa (29% zuwa 75%), numfashi mai ƙanƙanta (40% zuwa 42%), gudawa (20% zuwa 25%) da ciwon makogwaro (13% zuwa 25%), kuma kusan 14% zuwa 20% na marasa lafiya suna buƙatar taimakon numfashi.
Zuwa 14 ga Fabrairu, lokacin da aka tabbatar da adadin mutane 66,576 a duk duniya, yawan mutuwar COVID-19 a duk duniya ya kai kashi 2%.
Don kwatanta, yawan mutuwar SARS zuwa Nuwamba 2002 ya kai 10% na 8,096 da aka tabbatar.
Dangane da MERS, bisa ga binciken alƙaluma na Yuni 2012, yawan mutuwar ya kai kashi 37 cikin ɗari na 2,494 marasa lafiya.
Wani binciken da aka yi a baya ya ba da rahoton cewa <i>R</i><i>0</i></i> na SARS-CoV-2 yana da tsayi da yawa, daidai da 6.47 tare da tazarar tabbaci (CI) daidai da 7.23-5.71, yayin da <i>R0</i> na SARS-CoV kawai 2 zuwa 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomi, mutuwa da <i>R</i><i><sub>0</i></sub> an gabatar da su a cikin Tebur na 1.
Lambobin da ke sama suna nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma yawan mutuwar ya fi ƙasa da waɗannan biyu.
Saboda haka, sarrafa cutar SARS-CoV-2 ta fi ƙalubale fiye da MERS-CoV da SARS-CoV.
Sau da yawa ƙungiyoyi suna farawa daga cikin iyali ko al'umma ko kuma daga cikin abin hawa guda ɗaya kamar jirgin ruwa.
Sau da yawa marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu wurare masu cutar ko kuma sun kasance a cikin hulɗa da mutane masu cutar ko marasa lafiya a cikin makonni biyu kafin cutar ta fara.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da nuna alamun cutar ba, kuma yana yiwuwa marasa lafiya da suka warke da aka sallama daga asibiti suna da kwayar cutar a cikin jiki, wanda ya haifar da faɗakarwa don ƙara tsawon lokacin keɓewa.
A farkon mataki, adadin ƙwayoyin farin jini na yanayi (musamman ƙwayoyin lymphocytes) a cikin marasa lafiya na al'ada ne ko kuma an rage su.
Misali, an lura da cutar lymphopenia tare da ƙididdigar ƙwayoyin farin jini ƙasa da 10<sup>9</sup>×4 ƙwayoyin cuta a kowace lita, gami da ƙididdigar ƙwayoyin cuta ƙasa da 10<sup>9</sup>×1 ƙwayoyin cuta a kowace lita, da ƙaruwa a cikin aspartate aminotransferase da viremia (ƙididdigar kwayar cutar a cikin jini) a cikin marasa lafiya 1,099.
An sami matakan enzymes na hanta da tsoka da myoglobin a cikin jinin wasu marasa lafiya, kuma sun karu da furotin C mai amsawa da kuma lalatawar erythrocytes a cikin jini na yawancin marasa lafiya.
A cikin masu cutar da ke fama da cutar, matakin D-dimer, wanda shine samfurin lalacewar fibrin a cikin jini, ya karu kuma yawan ƙwayoyin lymphocytes ya ragu.
Ana samun rashin daidaito a cikin radiography na kirji na yawancin marasa lafiya na COVID-19 kuma sun haɗa da inuwa mai kama da siffar simintin gyare-gyare ko ƙirar gilashi a cikin huhu.
Marasa lafiya galibi suna kamuwa da ciwon huhu mara kyau, mummunan rauni na huhu da kuma ciwon ƙwayar cuta mai tsanani (ARDS).
Lokacin da ciwon ciwon ƙwayar cuta na numfashi ya faru, ƙwayoyin cuta ba su da iko, ƙwayoyin cuta da fibrosis na ci gaba, suna da matukar damuwa da musayar gas.
Rashin aiki na numocytes na huhu na nau'i daya da biyu yana rage yawan surfactant kuma, sakamakon haka, yana kara girman shimfidawa wanda ke rage ikon huhu don fadadawa kuma yana kara hadarin fashewar huhu.
Don haka, mafi munin binciken radiography na kirji ya dace da mafi munin yanayin cutar.
A ranar 18 ga Fabrairun 2020, bincike na farko na cutar COVID-19 ya nuna alamun bayyanar cututtuka: shanyewar kwayoyin huhu, samar da membrane mai haske, ɓarkewar ƙwayoyin lymphocytes na intracranial da kuma ganin ƙwayoyin sinus cialis masu yawa a cikin huhu na marasa lafiya da suka mutu daga cutar; alamun da suka dace da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
An gano RNA na SARS-CoV-2 ta hanyar juyawa na juyawa na juyawa (RT-PCR) azaman babban ma'auni don gano COVID-19.
Koyaya, saboda yawan ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Haka kuma an samu a lokacin da aka gano SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da binciken radiology suna da mahimmanci don ganewar asali.
A ranar 14 ga Fabrairun 2020, ƙungiyar Feng Zhang ta gabatar da yarjejeniya ta amfani da fasahar CRISPR-based SHERLOCK don gano SARS-CoV-2, wanda a ciki ake gano ɓangarorin RNA na SARS-CoV-2 a cikin girma daga <18->10 × 20 moles a kowace lita zuwa <18-</sup>10 × 200 moles a kowace lita (100-10 kwafi a kowane microliter na shigarwa) ta hanyar sanda a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu rikitarwa ba.
Ana fatan cewa sabon fasahar zai iya inganta ƙwarewa da kwanciyar hankali idan an tabbatar da shi a cikin gwajin asibiti.
Saboda rashin gogewa game da sabon coronavirus, likitoci galibi suna ba da kulawa ta tallafi ga marasa lafiyar COVID-19, yayin da suke ƙoƙarin amfani da matakan magani daban-daban waɗanda aka yi amfani da su ko aka ba da shawarar don magance ɓarkewar cutar coronavirus da ta gabata, gami da SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table 2).
Wadannan magungunan sun hada da maganin psychoactive da yiwuwar maganin antiviral, masu hana rigakafi, steroids, plasma na marasa lafiya da suka warke, maganin kasar Sin da kuma goyon bayan tunani.
Har ma an ba da shawarar yin amfani da plasma na marasa lafiya da suka warke don magance sababbin marasa lafiya.
Kamfanonin harhada magunguna suna gasa don samar da kwayoyin rigakafi da allurar rigakafi akan kwayar cutar.
SARS-CoV-2 yana fara kai hari ga huhu da kuma yiwuwar wasu gabobin da ke bayyana mai karɓar ACE2, kamar tsarin narkewa da ƙwayoyin cuta.
Duk da haka, rashin lafiya da rashin ƙarfi na numfashi shine babban barazana ga marasa lafiya kuma shine babban dalilin mutuwa.
Don haka, hanyoyin taimakawa numfashi suna da mahimmanci don sauƙaƙe alamun cututtuka da ceton rayukan marasa lafiya kuma sun haɗa da maganin oxygen na yau da kullun, yawan zagayawar oxygen, iska mai ƙarancin iska da iska mai ƙarfi dangane da tsananin cutar.
Marasa lafiya da ke fama da mummunan cututtukan numfashi dole ne a sanya su a ƙarƙashin ECMO, fasaha mai amfani da zuciya ta hanyar zuciya da aka yi amfani da ita don magance rashin ƙarfi na zuciya ko cututtukan numfashi.
Bugu da ƙari, kiyaye daidaiton electrolytes, rigakafi da maganin kamuwa da cuta na biyu da harin kamuwa da cuta da kare ayyukan gabobin jiki suna da mahimmanci ga marasa lafiya da ke fama da cutar SARS-CoV-2.
An tabbatar da cewa guguwar cytokine a cikin marasa lafiya da ke fama da SARS da MERS ta haifar da tsananin amsawar tsarin garkuwar jiki.
Cytokine cystine wani nau'i ne na halayen kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan cytokines suna motsa kwayoyin jikin mutum don sakin yawancin radicals kyauta wanda shine babban dalilin ARDS da rashin aiki na gabobin jiki.
Tsananta tsarin garkuwar jiki yana da mahimmanci a maganin guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tuclizumab, wanda shine kwayar cutar monoclonal anti-IL6, don magance guguwar cytokine.
Sauran hanyoyin magance rigakafin rigakafin rigakafin cutar ta cytokine sun haɗa da: daidaitawar amsawar rigakafi ta hanyar T-cell; toshe aikin IFN-γ, IL-1 da TNF; hana JAK; Blenatumum; hana siginar cytokine 4; da masu hana HDAC.
Ana amfani da steroids a matsayin magungunan rigakafi don magance SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a cikin babban allurai ba su da amfani wajen warkar da mummunan lalacewar ƙwayoyin cuta a cikin marasa lafiya na COVID-19 da SARS.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman ƙwayoyin ƙwayoyin ƙwayoyin cuta wanda ke haifar da cutar anemia wanda ke shafar cutar sosai.
Koyaya, an ba da shawarar yin amfani da taka tsantsan a cikin gajeren lokacin magani tare da ƙananan allurai zuwa matsakaici na corticosteroids don magance marasa lafiya na COVID-19 da ke cikin mawuyacin hali.
A lokacin da aka rubuta wannan labarin, ba a tabbatar da maganin rigakafin cutar ba.
Koyaya, allurar cikin jijiya ta Remdesivir, wanda shine analog na nucleotide, ya kasance mai tasiri a cikin wani mai cutar Amurka da ke da COVID-19.
RedSever wani sabon magani ne na rigakafin cutar da Gilead ta samar, wanda aka fara amfani da shi don magance cututtukan da ke haifar da cutar Ebola da Marburg.
Daga baya, an gano cewa RedSevir na iya hana wasu ƙwayoyin cuta na RNA guda ɗaya, gami da MERS da SARS.
A sakamakon haka, Gilead ta ba da wannan fili ga China don gwaji biyu na asibiti a kan masu cutar da cutar SARS-CoV-2, sakamakon ya kasance daidai da yadda ake tsammani.
Bugu da ƙari, baricetinb, interferon alfa, lupinavir / ritonavir da ribavirin an kuma yi amfani da su azaman magunguna masu yuwuwa don magance marasa lafiya da ke fama da cututtukan numfashi.
Ciwon zawo, tashin zuciya, amai, lalacewar hanta da sauran halayen da ba su dace ba na iya faruwa bayan maganin haɗin gwiwa tare da lopinavir / ritonavir.
Dole ne a yi la'akari da hulɗar da ke tsakanin wannan magani da sauran magungunan da mai haƙuri ke amfani da su.
Plasma daga marasa lafiya sun warke kuma samar da ƙwayoyin cuta.
Tarin jini daga marasa lafiya da suka warke daga cutar mai saurin kamuwa da cuta, don magance wasu marasa lafiya da ke fama da cutar ko kare mutane masu lafiya daga kamuwa da cutar mai saurin kamuwa da cuta, yana da tarihi mai girma.
A zahiri, marasa lafiya da suka warke galibi suna da matakan ƙwayoyin cuta masu yawa don magance cutar a cikin jinin su.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin B ke samarwa don yaƙi da kwayoyin cuta da sauran ƙwayoyin waje waɗanda ke gano kwayoyin halitta na musamman a cikin kwayoyin cuta kuma kai tsaye suna kawar da su.
A sakamakon haka, an tattara plasma daga ƙungiyar marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar rigakafi ga marasa lafiya 10 masu tsanani.
Alamun sun inganta cikin awanni 24, tare da rage ƙonewa, rage nauyin kwayar cutar da ingantaccen ƙoshin oxygen a cikin jinin su.
Koyaya, ba da shawarar wannan hanyar don amfani da ita a cikin manyan sikelin yana buƙatar ƙarin yarda da nuna gaskiya kafin a gabatar da takamaiman hanyoyin magani.
Bugu da ƙari, ban da tasirin magani, dole ne a yi la'akari da rashin lafiyar da ke tattare da maganin plasma.
Misali, ƙwayoyin cuta na iya haifar da halayen rigakafi da ke haifar da cutar ƙwayar cuta wanda zai iya haifar da guba mai guba.
Yawan ƙwayar ƙwayoyin cuta a cikin jini yawanci yana da ƙasa, kuma ana buƙatar plasma mai yawa don magance mutanen da ke da mummunan cuta.
Ci gaba da samar da takamaiman ƙwayoyin cuta a cikin lokaci mai sauri don magance cututtukan duniya yana da wahala.
Don haka, ware kwayoyin B daga marasa lafiya da suka warke da kuma gano kwafin kwayoyin halitta wanda ke tsara kwayar cutar ko kuma tantancewa don kwayar cutar da ke da tasiri a kan sunadarai masu tasiri na kwayar cutar yana da mahimmanci da amfani.
Wannan hanya tana da sauƙi don haɓaka samar da ƙwayoyin cuta.
An yi amfani da maganin gargajiya na gargajiya a kasar Sin don magance cututtuka da dama na dubban shekaru.
Koyaya, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin tsari ɗaya wanda ya dogara da ganewar asali bisa ga ka'idodin maganin gargajiya na kasar Sin.
Yawancin abubuwan da ke aiki ba a san su ba ko kuma ba su da tabbas saboda yana da wuya a cire su da kuma tabbatar da waɗannan abubuwa ko kuma mafi kyawun haɗin su.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM (maganin gargajiya na kasar Sin) ana ɗaukarsa a matsayin ɗayan manyan magunguna masu madadin marasa lafiya tare da alamun bayyanar cututtuka masu sauƙi da matsakaici ko marasa lafiya waɗanda suka warke daga mawuyacin yanayi.
Misali, an lura cewa capsules Shu Feng Jie Du da Lian Hua Qing Wen suna da tasiri wajen magance COVID-19.
An lura da mafi yawan adadin warkewar marasa lafiya na COVID-19 a larduna da dama na kasar Sin inda aka yi amfani da maganin gargajiya na kasar Sin don kashi 87% na marasa lafiya, gami da Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da lardin Hubei, inda aka yi amfani da maganin gargajiya na kasar Sin don kusan 30% na marasa lafiya na COVID-19, yana da mafi ƙarancin adadin murmurewa (13%).
Koyaya, wannan kwatancen yana da matukar wahala, saboda yawancin sauran abubuwan da ke tasiri kamar yawan marasa lafiya da tsananin cutar dole ne a yi la'akari da su a cikin kimantawa.
A ranar 18 ga Fabrairun 2020, Boley Zhang da abokan aikinsa sun wallafa wani bincike wanda ya kwatanta maganin Yammacin Turai (WM) da magani na gargajiya na Yammacin Turai da na gargajiya na kasar Sin.
Sun gano cewa lokacin da ake buƙata don dawo da zafin jiki zuwa mafi kyawun yanayin, kawar da bayyanar cututtuka da kuma kwantar da hankali a cikin ƙungiyar magungunan Yammacin Turai + Magungunan gargajiya na kasar Sin ya kasance ƙasa da ƙasa da ƙungiyar magungunan Yammacin Turai kawai.
Abin sha'awa, yawan ciwo tare da bayyanar cututtuka (daga mai laushi zuwa mai tsanani) ga ƙungiyar WM + TCM (Traditional Chinese Medicine + Western Medicine) ya kasance ƙasa da ƙasa da ƙungiyar kawai ta Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Yammacin Y
Koyaya, inganci da amincin maganin gargajiya na kasar Sin har yanzu ana buƙatar kimanta su ta hanyar gwaji mai sarrafawa a cikin manyan sikelin da cibiyoyi.
Yin ƙoƙarin gano tsarin aiki da kuma gano abubuwan da ke da tasiri a cikin maganin gargajiya na kasar Sin ko kuma idan ya yiwu, haɗuwa da su yana da ban sha'awa da jaraba.
Marasa lafiya da ake zargi ko tabbatar da cutar COVID-19 galibi suna fuskantar tsoro da yawa game da wannan cuta mai saurin yaduwa da kisa, yayin da waɗanda aka keɓe ke fama da gajiya, kaɗaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta sun haɗa da zazzabi, rashin isashshen oxygen da tari, da kuma sakamako masu illa na hanyoyin magani, ciki har da rashin barci na corticosteroids, damuwa da rashin jin daɗi.
A farkon lokacin barkewar cutar SARS, an ba da rahoton wasu cututtukan psychotic da suka haɗa da ci gaba da baƙin ciki, damuwa, fargaba, tashin hankali, halayen halayen motsi, alamun cutar, rikicewar tunani, har ma da tunanin kashe kansa.
Binciken tuntuɓar mutum da keɓewa na tilas, a matsayin ɓangare na amsar lafiyar jama'a ga ɓarkewar COVID-19, na iya haifar da damuwa da jin laifi a cikin waɗanda ke fama da cutar dangane da tasirin kamuwa da cuta, keɓewa da kuma matsalar matsayi ga iyalai da abokai.
Don haka, ya kamata a samar da kulawar lafiyar kwakwalwa ga marasa lafiyar COVID-19, mutanen da ake zargi da cutar da kuma mutanen da suka taɓa hulɗa da su, da kuma jama'a waɗanda ke buƙatar waɗannan sabis ɗin.
Tallafin ilimin halayyar dan adam ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar kwakwalwa tare da ƙwarewa da yawa, bayyananniyar sanarwa tare da daidaitaccen bayani game da barkewar SARS-CoV-2 da shirye-shiryen magani tare da amfani da na'urorin lantarki da aikace-aikacen magana don hana kusanci da wasu.
Alluran rigakafi masu tasiri suna da mahimmanci don yanke sarkar watsawa daga wuraren adana dabbobi da ƙwayoyin cuta na mutum zuwa masu karɓar marasa lafiya kuma galibi ana amfani da su don haɓaka maganin rigakafin cutar a cikin kula da annoba ta sabbin ƙwayoyin cuta.
An yi ƙoƙari don haɓaka alluran rigakafi na S-protein don samar da ƙwayoyin cuta masu aiki na dogon lokaci da ƙarancin ƙarfi da / ko rigakafin kariya ga SARS-CoV.
An gwada alluran rigakafin rayuwa da aka narkar da su a cikin samfurin dabbobi don SARS.
Koyaya, kafin a fara binciken asibiti, ya kamata a ƙayyade ingancin in-vivo na waɗannan takarar allurar rigakafi a cikin ƙwayoyin cuta da ƙwayoyin da ke mutuwa da kuma kare su daga kamuwa da cutar kwayar cutar.
Wannan na iya zama saboda SARS ya ƙare shekaru 17 da suka gabata kuma babu wani sabon abin da aka ruwaito tun daga lokacin.
Sabanin haka, ana samun ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
An haɓaka dabarun allurar rigakafi ta amfani da ƙwayoyin cuta marasa aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta na kusan-kwayar cuta da ƙwayoyin ƙwayoyin cuta na MERS kuma an gwada su a kan wasu ƙirar dabbobi.
Samar da ingantaccen allurar rigakafi mai lafiya da inganci ga SARS-CoV-2 ga mutanen da ke da rauni a cikin rigakafi yana da gaggawa kuma yana da mahimmanci don sarrafa ci gaban cutar.
Koyaya, magance wannan matsala yana da ƙalubale saboda tsayin lokaci mai tsawo da ake buƙata don tsarawa da samar da allurar rigakafi (a matsakaita watanni 18) da canjin canjin coronavirus.
A matsayin sabon cuta, COVID-19 ya fara fara sake zagayowar asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya suna samun sauƙi a hankali kuma ba tare da wani ciwo ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da rashin lafiya da mutuwa a cikin waɗanda ke fama da cutar mai tsanani.
Saboda haka, tsara samfurin gargadi na cutar yana da mahimmanci ga ƙungiyoyin kula da lafiya don ba da fifiko ga ayyukansu, musamman a yankunan da ke da iyakance albarkatu.
Dangane da nazarin asibiti da aka yi zuwa yanzu, abubuwan da ke ƙasa na iya tasiri ko alaƙa da ganewar asali na marasa lafiya na COVID-19 (Table 3):
Shekaru: Shekaru sune mafi mahimmancin abin da ke haifar da cutar SARS, kamar yadda yake tare da COVID-19.
COVID-19 galibi yana faruwa ne tsakanin shekaru 65-30, kamar yadda kashi 47.7 cikin ɗari na masu tsayi sama da shekaru 50 suka kamu da cutar a cikin binciken da aka yi da marasa lafiya 8,866 da aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa ta musamman sun fi sha wahala daga cututtukan cututtuka da rikice-rikice na asali kuma sun fi tsufa fiye da marasa lafiya waɗanda ba sa buƙatar kulawa ta musamman (tare da matsakaicin shekaru 66 da 51), wanda ke ba da shawarar cewa ana iya ɗaukar shekaru a matsayin mai nuna alama ga sakamakon marasa lafiya da ke da COVID-19.
Jima'i: Kamar yadda aka ambata a sama, SARS-CoV-2 ya kamu da maza fiye da mata (0.31 cikin 100,000 idan aka kwatanta da 0.27 cikin 100,000).
Cutar cututtuka da rikice-rikice: Marasa lafiya da ke da COVID-19 waɗanda ke buƙatar kulawa ta musamman suna iya samun rauni mai tsanani ko arrhythmias.
Cutar zuciya ita ce kuma babbar hanyar mutuwa a cikin marasa lafiya da ke fama da cutar SARS.
An kuma bayar da rahoton cewa kwayar cutar SARS-CoV-2 na iya haɗuwa da kwayar cutar ta ACE2-positive, wanda zai iya haifar da lalacewar hanta a cikin marasa lafiya na COVID-19.
Yana da mahimmanci a lura cewa shekaru da cututtukan cututtuka suna da dangantaka mai karfi kuma suna iya yin tasiri tare.
Binciken gwaje-gwaje na yau da kullun: Matsayin furotin mai amsawa na C a cikin jini yana nuna tsananin kumburi ko lalacewar nama kuma an ba da shawarar a matsayin mai yuwuwar gano cutar, amsawa ga magani da kuma murmurewa.
An ba da shawarar cewa akwai alaƙa tsakanin matakan CRP da tsananin cutar da cutar COVID-19.
Bugu da ƙari, ƙaruwa a cikin matakan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana a cikin yawancin kyallen takarda, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar kyallen takarda.
Saboda haka, suna da alamun gargajiya don gano cututtukan zuciya ko hanta.
Babban alamun asibiti: don hango abubuwan da ke faruwa da kuma rikice-rikice na COVID-19, radiography na kirji da ci gaban lokaci na alamun asibiti dole ne a yi la'akari da su tare da sauran batutuwan da suka shafi.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune masu hana tsarin rigakafi wanda galibi ana amfani dasu azaman ƙarin magani don rage tsananin lalacewar kumburi a cikin yaƙi da cututtukan cututtuka.
Saboda ana amfani da allurai masu yawa na corticosteroids a cikin marasa lafiya masu fama da cutar SARS, yawancin waɗanda suka tsira daga cutar anemia sun sha wahala daga cutar ƙashin ƙashi tare da nakasa na dogon lokaci da ƙarancin rayuwa.
Don haka, idan ya zama dole, ya kamata a yi amfani da steroids a ƙananan allurai da gajeren lokaci ga marasa lafiya na COVID-19.
Matsin lamba: Kamar yadda aka bayyana a sama, yawancin marasa lafiya sun sami damuwa sosai yayin barkewar COVID-19 saboda yawanci ana tilasta su yin keɓewa na dogon lokaci, suna da shakku da shakku game da abin da ke faruwa, kuma suna ganin mutuwar danginsu ko abokai na kusa.
Bayar da shawarwari na ilimin halayyar dan adam da tallafi na dogon lokaci yana da mahimmanci don taimakawa waɗannan marasa lafiya su kawar da damuwa da komawa rayuwa ta al'ada.
Dangane da nazarin alƙaluma da aka yi zuwa yanzu, COVID-19 yana da halaye na annoba daban-daban idan aka kwatanta da SARS.
Kwayar cutar SARS-CoV-2 tana iya yin yawa a cikin ƙananan iska, kamar sauran COVID-19 na yau da kullun, a cikin ƙananan iska, yana nuna alamun rashin bayyanar cutar ko kuma ba tare da alamun cutar ba.
Saboda haka, marasa lafiya masu kamuwa da cutar a farkon lokaci ko lokacin da suka kamu da cutar za su iya samar da kwayar cutar da yawa a yayin ayyukan yau da kullun, wanda ke haifar da matsaloli da yawa don sarrafa cutar.
Koyaya, binciken ya nuna cewa SARS-CoV yana yaduwa yayin da marasa lafiya ke cikin mawuyacin hali, don haka yawancin lokuta ba sa yaduwa a farkon lokacin.
Don haka, cutar ta COVID-19 ta yanzu ta fi hatsari da wahala fiye da cutar SARS.
Ana yin ƙoƙari sosai a China, gami da cikakken sarrafawa da fita daga Wuhan da biranen da ke kewaye da shi da kuma keɓewar kusan dukkanin jama'a a cikin fatan dakatar da sarkar watsa SARS-CoV-2.
Duk da cewa waɗannan matakan sun yi mummunan lahani ga tattalin arziki da sauran sassan ƙasar, yawan sabbin masu cutar yana raguwa, wanda ke nuna cewa annobar ta ragu.
Hasashen mafi kyawun hasashe shine cewa barkewar cutar za ta ƙare a watan Maris, kuma za a ɗauki watanni 3 zuwa 4 don ci gaba da nazarin.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun kiyasta cewa annobar COVID-19, wacce ta fi cutar SARS saurin kamuwa da cuta, ba za ta ƙare a cikin 2020 ba.
Ira Langini da abokan aikinsa sun tsara samfurin don hango sakamakon annobar, suna ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin duka jerin samfuran swabs na hanci da makogwaro a cikin marasa lafiya da suka warke waɗanda aka sallama daga asibiti makonni biyu da suka gabata.
Koyaya, akwai kyakkyawan fata a China dangane da raguwar sabbin cututtukan da ke nuna yiwuwar nasarar dabarun yanzu.
Da farko an yi hasashen cewa cutar Ebola za ta kamu da mutane miliyan daya kuma ta kashe mutane miliyan biyar.
Duk da haka, ta hanyar keɓewa da keɓewa mai ƙarfi, cutar ta ƙarshe ta kasance ƙarƙashin iko.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni a hankali kuma daga ƙarshe ya ɓace ko ya canza zuwa kwayar cuta mai ƙarancin cututtuka wanda ke zaune tare da mutane.
Kwatanta cutar ta COVID-19 da SARS da MERS an nuna su a ƙasa (Figure 5).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko hancinsa kuma yana iya yaduwa ta hanyar hulɗa kai tsaye da abubuwan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin kayan da ke cikin jijiyoyin jiki, wanda ke haifar da yiwuwar sabon kamuwa da cutar ta hanyar jijiyoyin jiki.
Wani binciken da aka yi kwanan nan akan marasa lafiya 138 ya ba da rahoton cewa kusan kashi 41 cikin ɗari na waɗanda suka kamu da cutar ta hanyar kamuwa da cuta ta asibiti, gami da marasa lafiya 17 da ke fama da wasu cututtuka da ma'aikatan kiwon lafiya 40.
Don haka, dole ne a yi taka tsantsan don kare mutane musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangin, abokan aiki har ma da waɗanda ke ziyartar marasa lafiya ko mutanen da ke da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cutar shine sanya abin rufe fuska; amfani da masks na tiyata da masks na numfashi na N95 (jerin 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana watsawa daga iska daga digo na ruwan numfashi daga kashin baya mai yuwuwar kamuwa da cutar zuwa wasu ko mannewa ga kayan abu sannan kuma bayan an watsa su zuwa wasu.
Koyaya, kawai masks na N95 (lambar jerin 1860s) na iya kare ku daga numfashin kwayoyin cutar da ke da girman 10 zuwa 80 nm, wanda kashi 5% na kwayoyin cutar ke iya shiga.
Saboda ana iya yin amfani da ƙananan abubuwa a tsakanin masks biyar na tiyata, masu ba da kiwon lafiya masu kula da lafiyar da ke hulɗa da marasa lafiya kai tsaye dole ne su yi amfani da masks na N95 (jerin 1860s) kuma su guji saka masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sanya rigunan keɓewa waɗanda ke rufe su gaba ɗaya don rage haɗarin haɗuwa da cutar.
Kwayoyin cutar na iya kamuwa da mutum ta hanyar ido.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95; mai yiwuwa ya shiga cikin jikinsa ta hanyar idanunsa masu kumburi.
Don haka, masu ba da sabis na kiwon lafiya masu kulawa dole ne su yi amfani da garkuwar fuska ko tabarau yayin kula da marasa lafiya.
Don kiyaye lafiyar jama'a a yankunan da ke dauke da cutar ko kuma masu yuwuwar kamuwa da cutar, ana ba da shawarar sosai cewa mutane su wanke hannayensu da sabulu mai kashe kwayoyin cuta fiye da yadda suka saba, su shiga keɓewa da zama a gida, da kuma iyakance hulɗa da mutanen da ke da yiwuwar kamuwa da cutar.
Matsakaicin da ya kamata tsakanin mutum da mai ciwo ya zama ƙafa uku.
Ana ganin waɗannan matakan sune ingantattun hanyoyi don ragewa da kuma hana yaduwar kwayar cutar.
Kodayake an san SARS-CoV-2 a matsayin sabon kwayar cutar ga ɗan adam, babban kamannin da yake da shi da SARS-CoV wanda aka ruwaito a ranar 7 ga Janairu, 2020 ya zama babban gargaɗi ga China, yana tunatar da mu game da barkewar cutar SARS a 2003.
Koyaya, ba a yi ƙoƙari don tabbatar da kwanciyar hankali ba har zuwa 19 ga Janairun 2020, ranar da shugaban Cibiyar Kula da Cututtuka ta Wuhan ya ba da sanarwar cewa sabon kwayar cutar tana da ƙarancin kamuwa da cuta da iyakantaccen tasirin watsawa daga mutum zuwa mutum kuma ana iya hanawa da sarrafa cutar.
Wannan sakon ya sa ba a ɗauki gargadin jama'a da mahimmanci ba, musamman a lokacin da ƙasar ke shirin bikin Sabuwar Shekarar bazara, don haka an rasa babbar dama don hana yaduwar cutar a Wuhan.
Hukumomin kula da cututtuka a kasar Sin na iya koyon darasi daga wannan mummunan darasi kuma su yi wasu manyan ci gaba ga matakan da za a dauka nan gaba.
Misali, waɗannan ƙungiyoyin suna buƙatar (1) zama masu hankali yayin sanar da jama'a saboda duk wani abu da suka gabatar zai iya jan hankalin jama'a kuma ya canza ra'ayoyinsu da yanke shawara; (2) zama masu saurin amsawa ga bayanan da ba na al'ada ba daga wuraren asibiti, maimakon jiran rahotanni na hukuma daga likitoci ko hukumomin da ke da alhakin; (3) zama masu tsauraran matakai don hana yiwuwar barkewar cutar a farkon matakan maimakon kiran jama'a zuwa nutsuwa; (4) samar da ci gaba, ingantaccen bayani mai tasiri ga jama'a don haɓaka wayar da kan jama'a game da cutar ta annoba da kuma gwadawa da inganta tsarin amsawar al'umma a kai a kai.
Cutar COVID-19, wacce sabon kwayar cutar SARS-CoV-2 ke haifarwa, ta fara a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, cutar ta bazu ko'ina cikin China kuma a lokacin da ake rubuta wannan labarin, ta bazu zuwa wasu ƙasashe 50 a duniya.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS sun yi kama, barkewar COVID-19 ya haifar da tunanin cewa SARS ya dawo.
Koyaya, akwai wasu bambance-bambance da yawa tsakanin COVID-19 da SARS waɗanda ke da mahimmanci don hana yaduwar cutar da kula da marasa lafiya.
COVID-19 yana shafar tsofaffi da maza fiye da matasa da mata, kuma yana da tsananin rauni da yawan mutuwa a cikin tsofaffi fiye da matasa.
Yawan mutuwar SARS ya fi na COVID-19 girma (10.91% vs. 1.44%).
Marasa lafiya da COVID-19 suna watsa cutar koda kuwa basu da alamomi, yayin da marasa lafiya na SARS galibi suna watsawa yayin da cutar ta yi tsanani, saboda haka hana yaduwar COVID-19 ya fi wahala idan aka kwatanta da SARS.
Wannan ya bayyana wani ɓangare dalilin da yasa kwayar SARS-CoV-2 ke yaduwa da sauri kuma a kan sikelin da ya fi na SARS-CoV.
A wasu marasa lafiya na COVID-19, gwajin RNA na yau da kullun don gano SARS-CoV-2 na iya haifar da sakamako mara kyau.
A gefe guda kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Wadannan binciken sun kara hadarin yaduwar kwayar cutar sosai.
Ganin irin wannan saurin ci gaban da aka samu a binciken COVID-19, har yanzu akwai wasu mahimman batutuwan da ba a warware su ba, gami da:
Daga ina ne kwayar cutar SARS-CoV-2 ta samo asali?
Kodayake an sami kashi 96% na jini tsakanin kwayar cutar SARS-CoV-2 da kuma kwayar cutar SARS-CoV-2 ta bat, har yanzu ba za mu iya yanke shawarar cewa asalin SARS-CoV-2 daga bat ba.
Wane dabba ne ya kasance matsakaici don watsa kwayar cutar daga babban mai masaukin sa, jemage zuwa mutane?
Ba tare da sanin amsoshin tambayoyi 1 da 2 ba, ba za mu iya yanke sarkar watsawa yadda ya kamata ba, kuma ana iya sake barkewar cutar a kowane lokaci.
Kodayake ƙirar kwayoyin halitta da kimantawa na ilimin halittu sun nuna cewa SARS-CoV-2 ya haɗu da mai karɓar ACE2, ta yaya ainihin kwayar cutar ta shiga cikin ƙwayoyin hanyar iska kuma ta haifar da sauye-sauyen cututtuka?
Shin kwayar cutar tana haɗuwa da ƙwayoyin bayyana ACE2 a wasu gabobin jiki?
Har sai an amsa waɗannan tambayoyin a fili, ba za mu iya samun ingantaccen maganin cutar ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke jujjuyawa ta hanyar kwayoyin halitta yayin watsawa tsakanin mutane?
Shin zai zama annoba ta duniya, ya ɓace kamar SARS, ko kuma ya sake ɓarkewa kamar mura?
Samun amsar wannan tambaya da sauran tambayoyi da yawa yana da mahimmanci amma yana iya ɗaukar lokaci.
Koyaya, ba tare da la'akari da kuɗin da ake buƙata ba, kawai zaɓinmu na gaba shine dakatar da annobar da wuri-wuri da kuma dawo da rayuwa zuwa al'ada.
Asalin dabbobi na HCoVs
A cikin dubunnan shekaru, maye gurbi da daidaitawa sun taimaka wajen haɓaka lokaci ɗaya na coronaviruses (CoVs) da masu karɓar su, gami da mutane.
Kafin 2003, an san cewa kwayar cutar HCoV guda biyu tana haifar da cututtuka masu sauƙi, kamar su cutar sankarar bargo.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Bayyanuwar SARS-CoV-2 a tsakiyar China a ƙarshen 2019, ya sake mayar da hankali ga coronavirus kuma ya ba mu mamaki da tsawon lokacin watsawa, amma rashin cutarwa idan aka kwatanta da ɗan'uwansa SARS-CoV.
Kamuwa da cutar HCoV na dabbobi ne (zoonosis), kuma sanin asalin dabbobi na HCoVs na iya taimaka mana sosai.
Yawancin kwayar cutar HCoV ta mutum tana farawa ne daga jemage, waɗanda ba su da cutar.
Hakanan an san wasu masu watsa shirye-shiryen tushen tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tashar tash
Gano dabbobi masu karɓar baƙi yana taimakawa kai tsaye wajen hana cututtukan ɗan adam.
Bincike kan hulɗar COVID-19 a cikin dabbobi na iya ba mu mahimman bayanai game da cutar a cikin mutane.
A cikin wannan binciken bita, muna ba da bayyani game da bayanan da ke akwai game da kwayar cutar HCoV guda bakwai da ke akwai, tare da mai da hankali kan tarihin gano su da asalin dabbobi da kuma watsawa tsakanin jinsuna.
Mafi mahimmanci, muna kwatanta da kuma magance HCoVs daban-daban daga yanayin juyin halitta na kwayar cutar da kuma ba da izinin tsarin kwayoyin halitta.
Ana tattauna cutar coronavirus ta 2019 (COVID-19) a cikin wannan mahallin.
Bugu da ƙari, yanayin da ake buƙata don samun nasarar motsi tsakanin masu karɓar baƙi da kuma alamun ci gaban kwayar cutar a cikin yanayin cutar sun zama abin da aka fi mayar da hankali.
Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin RNA masu ɗaure-ɗaure-da-ƙasa.
"Wadannan ƙwayoyin cuta, waɗanda ke da mafi girman kwayoyin halitta na 26-32 kilobes a cikin ƙwayoyin cuta na RNA, an kira su ""CoVs (coronavirus) "" ko ƙwayoyin cuta masu ɗauke da kambi saboda siffar su kamar kambi a ƙarƙashin microscope na lantarki. "
A matsayin tsari, coronaviruses suna da kwayoyin halittar guda daya wanda ke da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta sun hada da sassan karatu guda biyu (ORF1a da ORF1b) waɗanda ke fassara a matsayin polyprotein pp1a da pp1ab.
Ana sarrafa polyproteins don samar da sunadarai 16 marasa tsari waɗanda ake kira nsp1 zuwa 16.
Kwayar cuta ta genome ta ƙunshi ORFs don gina jiki, ciki har da spike (S), murfin kwayar cutar (E), membrane (M) da nucleoprotein (N).
Yawancin ƙwayoyin cuta na musamman na asali suna ƙunshe da nau'ikan coronavirus daban-daban.
Dangane da bambancin tsari na furotin, ana rarraba CoVs zuwa jinsuna huɗu (COV alpha, beta, gamma, da delta) kuma a cikinsu, jinsin beta na CoV ya ƙunshi yawancin HCoVs kuma an raba shi zuwa ƙananan layi huɗu (A, B, C, da D).
Shaidar phylogenetic ta nuna cewa jemage da rodents suna aiki a matsayin tushen kwayoyin halitta na yawancin alpha da beta coronaviruses, yayin da tsuntsaye sune babban ma'ajiyar gamma da delta coronaviruses.
A cikin dubban shekaru, coronaviruses sun ci gaba da ƙetare shingen tsakanin jinsuna, wasu daga cikinsu sun zama manyan cututtukan mutum.
Zuwa yau, an gano nau'ikan HCoV guda bakwai.
Daga cikin su akwai HCoV-229E da HCoV-NL63, waɗanda ke cikin alpha-CoVs.
Sauran nau'ikan beta guda biyar na COVID-19 sun haɗa da HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV, da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun bayyanar cututtuka kamar su zubar da jini da / ko zawo.
Sabanin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da cutar cuta sosai kuma suna haifar da kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututut
An ware HCoV-229E na farko, B814, daga mucous na hanci na marasa lafiya da suka kamu da cutar a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar yin nazarin HCoV-229E da HCoV-OC43, waɗanda duka biyu ke haifar da alamun ƙuntatawa.
A zahiri, kafin barkewar SARS, an yarda da cewa kamuwa da cutar ta HCoV gabaɗaya ba ta da lahani.
Cutar SARS ta 2003 tana daya daga cikin cututtuka mafi muni a zamaninmu, inda mutane fiye da 8,000 suka kamu da cutar kuma yawan mutuwar ya kai kusan 10%.
Shekaru goma bayan haka, barkewar cutar murar tsakiya ta Gabas ta Tsakiya (MERS) ta haifar da barkewar cutar a cikin yankin Larabawa, kuma wasu ƙananan lokuta sun bazu zuwa sauran sassan duniya.
Sabuwar kwayar cutar coronavirus ta mutum ta 2019 (2019-nCoV), wanda daga baya aka canza masa suna zuwa SARS-CoV-2, shine sanadin barkewar cutar coronavirus ta 2019 (COVID-19), wanda ya kashe mutane 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
An yi kararrawar gargadi kuma dole ne duniya ta shirya don cutar ta SARS-CoV-2.
Duk nau'ikan HCoV guda bakwai suna da asalin dabbobi daga jemage, beraye da dabbobin gida.
Akwai shaidu da yawa da ke tabbatar da cewa asalin juyin halitta na dukkan HCoVs ya kasance daga bat, inda ƙwayoyin cuta ke da dacewa sosai amma ba su da cututtuka kuma suna da bambancin kwayoyin halitta.
Cutar COVID-19 ta haifar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin dabbobi na HCoVs yana ba da tsarin don fahimtar tarihin halitta, abubuwan motsawa da abubuwan da ke iyakance canjin yanayi.
Hakanan yana iya sauƙaƙe ko jagorantar bincike game da dabbobi masu tanki, masu matsakaici da masu haɓaka SARS-CoV-2 kuma ana amfani da su don hana faruwar irin wannan a nan gaba.
A cikin wannan binciken bita, mun ba da cikakken bayyani game da asalin dabbobi, watsawa tsakanin jinsuna da kuma aikin cututtukan mutum na HCoVs.
Musamman, mun haskaka kuma tattauna al'adar cewa iyaye na HCoVs ba su da cutar a cikin masu karɓar bakunan ajiyar su, amma sun zama masu cutar bayan watsawa tsakanin jinsuna zuwa sabon mai karɓar baƙi.
Muna ci gaba da nazarin yanayin juyin halitta na HCoVs, inda yawanci haɓakar watsawa ke haifar da raguwar aikin cutar.
Hakanan an tattauna sakamakon ci gaba da yaduwar SARS-CoV-2 a cikin wannan mahallin.
An san da CAVs na dabbobi tun daga ƙarshen 1930s.
Kafin a fara ware HCoV-229E mai suna B814, an gano nau'ikan CoV daban-daban daga dabbobi daban-daban masu kamuwa da cutar daga mucous na hanci na marasa lafiya da suka kamu da cutar, gami da turke, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano mutane bakwai da ke dauke da cutar HCoV.
Takaitaccen tarihin gano kwayar cutar HCoV a cikin jerin lokutan (Table 1) na iya zama mai fa'ida da amfani.
An samo asalin HCoV-229E na farko a cikin 1966 daga hanyoyin numfashi na marasa lafiya da ke fama da cutar ta sama, sannan kuma ya dace da ci gaban kwayoyin cuta na WI-38.
Marasa lafiya da ke dauke da HCoV-229E sun nuna alamun bayyanar cututtuka na yau da kullun, gami da ciwon kai, atishawa, rashin lafiya da ciwon makogwaro, tare da zazzabi da tari a cikin kashi 10 zuwa 20 cikin ɗari.
Daga baya a cikin 1967, HCoV-OC43 ya rabu da shi daga ƙwayar ƙwayar cuta da kuma hanyar da ta biyo baya a cikin kwakwalwar yara.
An gano cewa halayen asibiti na kamuwa da cutar HCoV-OC43 suna kama da waɗanda HCoV-229E ya haifar, waɗanda ke da alamun cututtuka daidai da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
HCoV-229E da HCoV-OC43 duka sun bazu a duniya kuma galibi ana watsa su a lokacin hunturu da kuma a cikin yanayin zafi.
Gabaɗaya, lokacin ɓoyewar waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba kuma ana iya gano cutar na tsawon makonni 2.
Dangane da binciken ɗan adam akan masu sa kai, mutane masu lafiya waɗanda ke da cutar HCoV-229E sun sami rauni mai sauƙi.
Sai dai wasu marasa lafiya da ke da raunin rigakafi sun kamu da mummunan kamuwa da cuta a cikin ƙananan numfashi.
" SARS, wanda aka fi sani da ""atypical pneumonia"", shine farkon labarin da aka rubuta game da cutar da aka samu daga kwayar cutar COVID-19 a tarihin ɗan adam, kuma an gano asalin sa SARS-CoV, wanda shine kwayar cutar COVID-19 ta uku da aka gano. "
Ana iya gano farkon cutar SARS a lardin Guangdong na kasar Sin a ƙarshen 2002.
Cutar ta SARS ta haifar da kamuwa da cutar 8,096 tare da mutuwar 774 kuma ta bazu zuwa ƙasashe da nahiyoyi da yawa.
Baya ga abubuwan da suka faru na yaduwar jama'a, an kiyasta cewa kowane abu na iya haifar da kusan kamuwa da cuta biyu na biyu, tare da tsawon lokaci na kwanaki 4 zuwa 7 da kuma ƙaruwa na kwayar cutar da ke bayyana a rana ta goma ta cutar.
Marasa lafiya da suka kamu da SARS-CoV sun fara nuna alamun bayyanar cututtuka kamar ciwon tsoka, ciwon kai, zazzabi, rauni da rawar jiki, sannan kuma suna fuskantar numfashi, tari da matsalar numfashi a matakai na ƙarshe.
Lymphopenia, ƙididdigar da ke waje da gwajin aikin hanta da kuma matakan creatine kinase masu yawa sune abubuwan da suka saba da sakamakon gwaje-gwaje na SARS.
A cikin marasa lafiya da ke fama da SARS, an kuma lura da lalacewar alveolar, ƙwayoyin epithelial da ƙaruwa na macrophages.
Kimanin kashi 20 zuwa 30 cikin dari na marasa lafiya suna buƙatar kulawa mai tsanani da iska mai iska.
Baya ga tsarin numfashi na ƙasa, gabobin da yawa ciki har da tsarin narkewa, hanta da ƙwayoyin cuta na iya kamuwa da cutar a cikin waɗannan lokuta masu tsanani; yanayin yawanci yana tare da guguwar cytokine kuma yana iya zama mai haɗari musamman a cikin marasa lafiya da ke da raunin rigakafi.
An fara ware kwayar cutar ne daga wani mutum mai dauke da cutar a cikin wani dangi da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai don bincika kwayar cutar HCoV.
An ware HCoV-NL63 daga jariri ɗan wata 7 a cikin Netherlands a ƙarshen 2004.
Da farko an lura da shi a cikin yara, masu shanyewar jiki da marasa lafiya da ke da rauni na rigakafi ko cututtukan numfashi.
Rashin jijiyoyi, kumburi, zazzabi da kuma bronchiolitis suna da yawa a cikin cutar da HCoV-NL63 ke haifarwa.
Wani bincike mai zaman kansa ya bayyana ware irin wannan kwayar cutar daga samfurin mucous na hanci na jariri mai wata 8 wanda ke da cutar kirji a Netherlands.
Kodayake an gano wannan a cikin Netherlands, amma a zahiri an yada shi a duk duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
HCoV-NL63 kuma yana da alaƙa da cutar laryngitis obstructive, wanda aka fi sani da cututtukan larynx.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti a Hong Kong saboda ciwon kirji da bronchiolitis.
Baya ga cutar sankarar bargo da kuma bronchiolitis tare da yaduwar jama'a, an kuma bayar da rahoton alaƙar HCoV-HKU1 tare da tsananin asma.
An gano HCoV-HKU1 a duk duniya a matsayin mai haifar da cututtukan numfashi masu sauƙi, kamar yadda HCoV-NL63, HCoV-229E da HCoV-OC43.
Dukkanin waɗannan HCoVs huɗu sun dace da mutane tare da yaduwar jama'a kuma gabaɗaya suna da ƙarancin yuwuwar maye gurbi don haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Gabaɗaya, lokacin da waɗannan HCoVs suka sami damar watsawa da ci gaba da kasancewa cikin mutane, haɗarin su ko cutarwar su ta ragu.
An fara ware MERS-CoV a shekarar 2012 a Saudi Arabia daga huhu na wani mai shekaru 60 da haihuwa wanda ke fama da ciwon kirji da rashin ƙarfi.
Kodayake yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun fara ne daga Gabas ta Tsakiya, an lura da wasu ƙananan shigo da cutar ta biyu ta hanyar kusanci a cikin ƙasashen Turai da Tunisia.
A shekarar 2015, an samu barkewar cutar a Koriya ta Kudu inda aka tabbatar da mutane 186.
Alamar asibiti ta MERS tana kama da SARS, wanda ke nuna ci gaba mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da MERS suna fama da rashin isasshen ƙwayar pollen, wanda shine keɓaɓɓen MERS a cikin cututtukan da ke haifar da cutar HCoV.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan ciki kamar zawo da amai.
Har zuwa 14 ga Fabrairu, 2020, an ba da rahoton sama da lokuta 2,500 da aka tabbatar da su a cikin dakin gwaje-gwaje tare da yawan mace-mace da yawa na 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta masu cutarwa da aka sani ga ɗan adam.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano wasu ƙwayoyin cututtukan kirji da ƙugu a Wuhan, lardin Hubei, China, waɗanda yanzu an gano sun kasance masu haɗuwa da kamuwa da cutar SARS-CoV-2.
Hukumar Lafiya ta Duniya ta bayyana yaduwar kamuwa da cutar ta hanyar numfashi ta hanyar SARS-CoV-2 a matsayin gaggawa na kiwon lafiyar jama'a a duniya, ta sanya wa cutar suna COVID-19.
Zuwa 3 ga Maris, 2020, an tabbatar da adadin mutane 90,053 a duk duniya, kuma yawan mace-mace ya kai kusan 3.4%.
Ya kamata a lura cewa, yawan mace-mace a Hubei, China ya kai kashi 4.2%, yayin da a kasashen waje ya kai kashi 1.2%.
SARS-CoV-2, kamar SARS-CoV da SARS-CoV, suna haifar da mummunan kamuwa da cuta na numfashi wanda ke nuna zazzabi, tari da ƙarancin numfashi.
An kuma lura da gudawa a wasu marasa lafiya.
Ciki da ƙugu suna ɗaya daga cikin alamun bayyanar cututtuka mafi tsanani kuma suna iya zama cikin hanzari cikin ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda kashi 82% na dogon lokaci na nucleotide homology, suna cikin nau'ikan bishiyoyi daban-daban.
SARS-CoV-2 yana da ƙananan cututtuka idan aka kwatanta da SARS-CoV da MERS-CoV, amma yana iya zama mai yaduwa.
An bayar da rahoton wasu mutane marasa alamun kamuwa da cutar SARS-CoV-2 kuma suna iya taimakawa hanzarta yaduwar ta a duk duniya.
Kwatanta da kuma gano bambance-bambance tsakanin SARS-CoV-2 da sauran kwayar cutar HCoV guda shida sun nuna cewa akwai kamanceceniya da bambance-bambance da yawa.
Na farko, lokacin ɓoyewa da lokacin cutar kwayar cutar COVID-19 suna da kamanceceniya sosai.
A wannan yanayin, SARS-CoV-2 yana nuna yanayin gaba ɗaya na sauran ƙwayoyin cuta guda shida na HCoV.
Na biyu, tsananin alamun COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu masu yaduwar jama'a (gami da HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana nuna halaye waɗanda galibi ake gani yayin kamuwa da cutar ta hanyar ɓarkewar kwayar cutar HCoV, gami da bayyanar da alamun bayyanar cututtuka, mai sauƙi ko ma babu alamun bayyanar cututtuka.
A gefe guda, ƙananan ƙananan ƙananan lokuta na COVID-19 masu tsanani za a iya la'akari da su a matsayin samfurin SARS-CoV, kodayake ƙananan ƙananan.
Na uku, watsawar SARS-CoV-2 ya ci gaba da nuna halaye masu ban sha'awa waɗanda ke nunawa ga duka HCoVs da SARS-CoV.
A gefe guda, SARS-CoV-2 yana da sauƙin watsawa aƙalla kamar sauran HCoVs masu yaduwar jama'a.
A gefe guda, dole ne a gano ko yiwuwar watsa SARS-CoV-2 zuwa mutane daban-daban ya ragu bayan kamuwa da cutar, kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 kamar sauran HCoVs a cikin samfuran da aka ɗauka.
Har yanzu ba a san ko SARS-CoV-2 yana da mahimmancin aiki kamar SARS-CoV ba, aƙalla a wasu yanayi.
Har ila yau, yana da ban sha'awa don ganin ko SARS-CoV-2 yana nuna yanayi kamar yadda yake a cikin mutane masu cutar COVID-19 tare da yaduwar jama'a.
Koyaya, halaye na SARS-CoV-2, gami da watsawa, cututtukan cututtuka da ci gaba da yaduwa bayan watsawa daga ɗan adam, zasu tasiri ƙarshen ƙarshen barkewar COVID-19.
Dukkanin HCoVs guda huɗu da ke haifar da alamun rashin lafiya mai sauƙi sun dace da mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya zama waɗanda suka tsira daga tsofaffin cututtukan cutar coronavirus.
An cire HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutanen da suka kamu da cututtukan HCoVs masu tsanani daga binciken.
Don yin wannan, HCoVs dole ne su ninka a cikin mutane don ba da damar tarin maye gurbin da ke kawar da abubuwan da ke iyakance mai masaukin.
A wannan yanayin, yayin da yaduwar SARS-CoV-2 ke ci gaba da ɗorewa kuma yawancin mutane ke kamuwa da cutar, kwayar cutar tana da damar haɓaka da dacewa da mutane.
Idan kwayar cutar ta daidaita sosai, zai yi wuya a hana watsawa ta hanyar keɓewa ko wasu hanyoyin sarrafa kamuwa da cuta.
A cikin shekaru masu yawa, an sami CAV huɗu da ke yawo a cikin jama'a, suna haifar da cututtukan cututtukan jiki a cikin mutanen da ke da tsarin rigakafi na al'ada.
Wadannan ƙwayoyin cuta ba sa buƙatar tanki na dabba.
Sabanin haka, ƙwayoyin cuta masu cutarwa masu yawa SARS-CoV da MERS-CoV ba su dace da mutane sosai ba kuma ba za su iya zama masu ɗorewa ba.
Dole ne su ci gaba da haifuwa a cikin ɗakunan dabbobi, yawanci ta hanyar ɗaya ko fiye da masu watsawa, suna neman damar da za su iya kaiwa ga mutane masu mahimmanci.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da kuma HCoVs guda huɗu na jama'a.
Kamar yadda yake tare da CAVs na ɗan adam tare da yaduwar jama'a, aƙalla a yanzu, yana da babban watsawa.
Koyaya, yana da ƙwayoyin cuta fiye da CAV, amma yana da ƙarancin cututtuka idan aka kwatanta da SARS-CoV ko MERS-CoV.
Ko zai iya dacewa da mutane sosai kuma ya motsa tsakanin mutane ba tare da buƙatar tanki ko mai watsa shiri na dabba ba, za a gani a nan gaba.
Kafin tattauna asalin dabbobi na HCoVs, zai fi kyau muyi magana game da ma'anoni da halaye na masu karɓar masu juyin halitta, na halitta, masu adanawa, masu shiga tsakani da masu haɓaka HCoVs.
Dabba tana zama mai karɓar kwayar cutar HCoV idan ta kasance daga wani magabata na kusa kuma tana da babban daidaituwa a matakin jerin nucleotide.
Kwayar cutar ta asali yawanci tana da kyau tare da mai masaukin kuma ba ta da cutar.
Hakanan, mai masaukin ajiya yana riƙe da kwayar cutar ta HCoV a cikin dogon lokaci.
A kowane hali, masu karɓar baƙi suna kamuwa da cutar ta halitta kuma suna aiki a matsayin masu karɓar baƙi na HCoV ko kwayar cutar mahaifa.
A gefe guda, idan kwayar cutar HCoV ta kamu da cutar a cikin kwanan nan, kafin ko kusan a daidai lokacin da aka gabatar da ita ga ɗan adam, ba za ta dace da sabon mai masaukin ba kuma galibi yana da cutar.
Mai watsa shiri na tsakiya na iya zama tushen dabba don kamuwa da cutar ɗan adam kuma yana aiki a matsayin mai karɓar kwayar cutar wanda ke ba da damar kwayar cutar ta ninka na ɗan lokaci sannan kuma ta wuce zuwa mutane don haɓaka sikelin kamuwa da cutar a cikin ɗan adam.
Kwayar cutar COVID-19 ta mutum tana ƙare a matsayin kamuwa da cuta idan ba ta iya ci gaba da watsawa a cikin mai watsa shiri ba.
Akasin haka, HCoVs na iya daidaitawa da mai watsa shiri na matsakaici har ma da haifar da cutar ta asali na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Binciken bayanan cututtukan cututtuka ya nuna cewa mai cutar SARS yana da tarihin hulɗa da dabbobi da aka farauta.
Binciken da aka yi a baya game da cutar kanjamau ya nuna cewa cutar immunoglobulin G da ke hana SARS-CoV ta fi yawa a cikin masu sayar da dabbobi fiye da sauran jama'a.
An gano larvae na masked palm (Paguma larvata) da kuma kare raccoon a kasuwannin dabbobi masu rai a karon farko a matsayin masu dauke da kwayar cutar da ta yi kama da SARS-CoV, wanda kusan iri daya ne da SARS-CoV.
An tabbatar da wannan a kaikaice ta hanyar gaskiyar cewa ba a sake samun rahoton wani sabon SARS ba bayan an kashe dukkan 'yan kasuwa a kasuwa.
Koyaya, an ba da rahoton cewa civets na dabino masu rufe fuska a cikin daji ko gonaki waɗanda ba su da alaƙa da kasuwannin dabbobi masu rai, gabaɗaya ba su da kyau ga SARS-CoV, a wasu kalmomin, ana iya yanke shawarar cewa civets na dabino masu rufe fuska na iya zama kawai matsakaiciyar mai karɓar kwayar cutar, ba ma'aunin SARS-CoV na halitta ba.
Abin lura, tunda kashi 80 cikin ɗari na dabbobi daban-daban a kasuwannin Guangzhou suna da ƙwayoyin cuta na SARS-CoV, ba za a iya watsi da yiwuwar cewa yawancin ƙananan dabbobi masu shayarwa suna aiki a matsayin masu watsa shirye-shiryen watsa shirye-shiryen SARS-CoV ba.
Da alama duk waɗannan sune masu karɓar SARS-CoV na ƙarshe.
Binciken don gano mai karɓar SARS-CoV na dabba ya haifar da gano wani COVID-19 na bat wanda ya yi kusa da shi, wanda ake kira HKU3-related bat coronavirus Rhinolophus (SARSr-Rh-BatCoV HKU3), wanda ke cikin barbashi na kudan zuma na kasar Sin.
Gwajin gwajin rigakafin SARS-CoV da jerin kwayoyin halittar SARSr-Rh-BatCoV HKU3 sun kasance masu kyau a cikin waɗannan jemage.
Wannan da sauran bat-CoVs suna da kashi 88-92% na daidaituwa na nucleotide tare da SARS-CoV.
Wadannan nazarin sun kafa sabon ra'ayi, wanda ke nufin cewa jemage suna karɓar bakuncin cututtukan mutum.
An gano wasu SARS-like coronaviruses (SL-CoVs) da yawa daga jemage, amma babu ɗayansu da za a iya ware shi azaman kwayar cuta mai rai, ban da kwayar cutar da ake kira WIV1.
An san enzyme mai canzawa na mutum na 2 (ACE2) a matsayin mai karɓar SARS-CoV.
An gano cewa WIV1 da aka samo daga samfurin kwayoyin halitta na bat, ACE2 yana amfani da bat, bat, da mutum a matsayin mai karɓa don shiga cikin tantanin halitta.
Abin sha'awa, ƙwayar cutar SARS mai warkewa ta iya hana WIV1.
Ya zuwa yanzu, WIV1 ya nuna magabatan SARS-CoV mafi kusa a cikin jemage, suna da kashi 95% na haɗin gwiwar nucleotide.
Duk da irin wannan kamannin da ke tsakanin ƙwayoyin cuta biyu, an yarda cewa WIV1 ba kwayar cutar mahaifa ce ta SARS-CoV ba kuma cewa jemage ba shine farkon mai karɓar SARS-CoV ba.
Binciken kwayoyin halitta ya rarraba MERS-CoV a cikin rukuni guda na CoV-HKU4 na Batman da CoV-HKU5 na Batman.
Kowace CoV-HKU4 na Batman da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar.
Tsarin RNA na RNA-daidaitaccen RNA na MERS-CoV yana da kusancin kwayoyin halitta ga nau'ikan beta-bat coronaviruses da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin barbashi na daji ba.
MERS-CoV da danginsa na kusa CoV-HKU25 suna da kashi 87% na daidaiton jerin nucleotide.
Don haka, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
A gefe guda, nazarin da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman dromedary, musamman ƙwayoyin cuta masu hana ƙwayar cuta na MERS-CoV, sun kasance masu kyau, kamar raƙuman da ke Gabas ta Tsakiya waɗanda ke cikin ƙasashen Afirka da yawa.
An samo MERS-CoV mai rai mai kama da wanda aka samo a cikin mutane daga samfurin hancin raƙumi mai hawa, wanda ke nuna cewa raƙuma suna aiki a matsayin mai karɓar bakuncin ainihin MERS-CoV.
Yana da mahimmanci a lura cewa a cikin raƙuma da aka kamu da cutar MERS-CoV a cikin gwaji, ana samun alamun cutar mai laushi amma mai tsanani.
Yana da mahimmanci a lura cewa raƙuma masu kamuwa da cutar ba kawai suna watsa kwayar cutar ta hanyar numfashi ba amma har ma ta hanyar hanci-hanci, wanda shine babban hanyar watsa kwayar cutar a cikin jemage.
Koyaya, har yanzu akwai tambayoyi, saboda yawancin masu kamuwa da cutar MERS ba su da tarihin haɗuwa da raƙuma kafin bayyanar cututtuka, saboda haka ana iya yanke hukuncin cewa cutar ta kamu da mutum zuwa mutum ko ta hanyar hanyoyin da ba a sani ba da kuma nau'in dabbobi waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 yana nuna haemology na nucleotide kamar yadda kashi 96.2% tare da bat RaTG13 CoV wanda aka ware daga bat Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin jerin tsakanin SARS-CoV-2 da RaTG13 ya fi yadda za a iya ɗauka dangantakar iyaye.
A wasu kalmomin, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Wataƙila, magungunan dabbobi masu tsaka-tsakin SARS-CoV-2 dole ne su kasance daga cikin nau'ikan namun daji da aka yi wa ado da kashewa a kasuwar babban abincin teku ta Hunan, wanda yawancin farkon COVID-19 ke da alaƙa da su, yana nuna yiwuwar yiwuwar watsawa daga dabba zuwa mutum.
Yawancin sabbin nazarin da aka yi dangane da jerin metagenomic sun nuna cewa rukunin ƙananan dabbobi masu shayarwa masu haɗari da ake kira pangolins (Manis javanica) na iya zama asalin asalin SARS-CoV-2 mai alaƙa da beta-CoV.
Sabbin kwayoyin halittar CAVs na pangolin suna da kashi 85-92% na daidaituwa na jerin nucleotide tare da SARS-CoV-2.
Duk da haka, suna da kusan kusan kusan kashi 90 cikin dari na kama da RaTG13 a matakin jerin nucleotide.
Suna zama ƙananan ƙwayoyin cuta guda biyu na ƙwayoyin cuta masu kama da SARS-CoV a cikin itacen phylogenetic na rukuni, suna da kamanceceniya da yankin haɗin mai karɓar mai karɓa (RBD) tare da SARS-CoV-2 kuma suna da daidaiton amino acid 97.4%.
Sabanin haka, SARS-CoV-2 da RaTG13 RBDs sun fi bambanta, kodayake suna da ƙarin daidaito a cikin tsarin kwayoyin halitta.
Wani binciken da aka yi a baya a kan pangolins masu rashin lafiya ya kuma ba da rahoton gano ƙwayoyin cuta daga samfurori na huhu waɗanda aka gano suna da alaƙa da SARS-CoV-2.
A cikin binciken, an yi amfani da hanyoyi daban-daban na tattarawa da zaɓin hannu don ƙirƙirar jerin ƙananan kwayoyin halittar da ke ɗaukar kusan 86.3% na tsawon cikakkiyar kwayar cutar.
Ba za a iya watsi da yiwuwar cewa pangolin yana ɗaya daga cikin masu karɓar bakuncin dabbobi na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja game da asalin kai tsaye na SARS-CoV-2 a cikin pangolin saboda bambancin tsari tsakanin SARS-CoV-2 da SARS-CoV-2 mai alaƙa da beta-CoV.
Bugu da ƙari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi tazara tsakanin SARS-CoV-2 da SARS-CoV-2 masu alaƙa da beta-CoVs a cikin pangolin.
Dole ne a gano hanyar juyin halitta na SARS-CoV-2 a cikin barbashi, pangolins da sauran dabbobi masu shayarwa.
Yayinda aka sami daidaituwa mafi girma a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2, SARS-CoV-2 da RaTG13 masu alaƙa da beta-CoVs suna da mafi girman daidaituwa a cikin jerin abubuwan homology a matakin kwayoyin halitta.
Ana tsammanin cewa babban kamanceceniya tsakanin RBDs na SARS-CoV-2 beta-CoVs a cikin pangolins da SARS-CoV-2 ya samo asali ne ta hanyar juyin halitta tare da matsakaiciyar zaɓi.
Wani shawarwari na gaba ɗaya don amfani da ba da izini tsakanin beta-panculin coronavirus mai alaƙa da SARS-CoV-2 da RaTG13 a cikin nau'in dabba na uku.
Ana gabatar da nutritional a matsayin mai haɓaka juyin halitta tsakanin beta-CoVs.
A halin yanzu ana ci gaba da bincike kan asalin SARS-CoV-2 na dabbobi kuma ba za a iya yin magana da tabbaci ba.
Baya ga HCoVs masu cutar cuta, asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 suma an yi nazarin su.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga bat-CoV, yayin da aka sami kwayoyin cutar iyaye HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ba da rahoton cewa kwayar cutar COVID-19 ta bat da aka gano a cikin barkonon dabbobi na Arewacin Amurka, mai suna ARCoV.2 (Appalachian Ridge CoV), tana da alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da wani kwayar cutar bat bat, Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da raƙuma ake tsammanin sune masu watsawa.
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin dabbobi na sanannun HCoVs a cikin Hoto 1 da Tebur 2.
Binciken phylogenetic ya ba da hujja game da abubuwan da suka faru na watsawa tsakanin jinsunan HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya sami hanyar watsawa tsakanin jinsuna daga dabbobi zuwa mutane a cikin 1890, an yi rikodin cutar ta hanyar numfashi.
Ba a san tarihin watsawar HCoV-229E tsakanin jinsuna ba.
An gano cewa kwayar cutar alpha-CoVs ta dan adam tana da alaƙa da SARS-CoV-2.
Daga cikin su akwai alpaca alpha coronavirus.
Akwai shaidu da yawa da ke tallafawa mahimmancin watsa kwayar cutar kai tsaye daga jemage zuwa ɗan adam.
Na farko, mutane na iya tuntuɓar bat, ba alpacas ba, saboda kasancewar su a cikin yanayin muhalli na yau da kullun.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E-related bat-alpha CoVs sun bambanta kuma ba su da cutar a cikin bat, yayin da Alpha Alpaca CoV ya haifar da cutar numfashi a cikin dabbobi masu kamuwa da cuta.
A ƙarshe, babu wani alpaca alfaCoV da aka lura a cikin dabbobin daji.
Don haka, ba za a iya watsi da yiwuwar alpacas suna ɗaukar HCoV-229E-related alpha coronavirus daga mutane ba.
A zahiri, jemage sune tushen kai tsaye na ƙwayoyin cuta na mutum, gami da cutar hayaki, cutar Ebola, cutar Nipah da cutar Hendra.
Saboda haka, ba abin mamaki bane cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
A gefe guda, kodayake kwayar cutar ta alpha-CoV ta zama mai riƙe da kwayoyin HCoV-229E, alpacas da raƙuma na iya zama masu watsawa na matsakaici don watsa ƙwayoyin cuta ga mutane, kamar yadda ya faru da MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar jinsuna daga jemage zuwa raƙuma na dutse kuma daga baya daga raƙuma na dutse zuwa mutane.
A farkon gano MERS-CoV, an gano cewa jemage ne tushen asalin cutar, kuma binciken da aka yi daga baya ya tabbatar da hakan.
A bayyane yake cewa jemage suna da wadataccen tushen nau'in ƙwayoyin cuta don musayar kwayoyin halitta tsakanin nau'in halitta da watsawa tsakanin nau'in halitta.
"Doguwar rayuwa, yawancin yankuna, hulɗar zamantakewar jama'a da ƙarfi da ikon tashi, duk suna da kyakkyawan yanayi ga jemage a matsayin ""mai watsa kwayar cuta"" mai kyau. "
A gefe guda, MERS-CoV ya kasance a cikin raƙuma shekaru da yawa.
Kwayar cutar ta dace da waɗannan raƙuman da kyau, ta zama mai watsa shiri na tsakiya zuwa mai riƙewa na yau da kullun.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma ƙimar maye gurbinsa a cikin waɗannan dabbobin ba ta da yawa.
Yaduwar watsawa ga mutane ba ta da daidaituwa, kuma mutane suna karɓar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsawa tsakanin mutane ba.
Idan aka kwatanta da rawar raƙuma a cikin watsa MERS-CoV, rawar pangolins - idan akwai wani aiki - a cikin watsa SARS-CoV-2 ya bambanta.
Musamman, beta-CoVs na pangolin suna da matukar cutarwa a cikin pangolins.
Suna iya zama masu karɓar bakuncin SARS-CoV-2 alpha-CoVs, kamar yadda SARS-CoVs ke da alaƙa da spores.
Yawancin yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane dole ne a tabbatar ko ƙaryata su a cikin karatun gaba.
Na farko, jemage na iya zama mai karɓar bakuncin kwayar cutar da ke da alaƙa da SARS-CoV-2 wanda yayi kama da SARS-CoV-2.
Mutane na iya samun haɗin gwiwar muhalli tare da bat ta hanyar aiki a cikin butchery ko ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin masu karɓar bakuncin masu haɓaka matsakaici waɗanda cutar da ke da alaƙa da SARS-CoV-2 ta shigo kwanan nan.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman farauta.
Yawancin dabbobi masu shayarwa, gami da dabbobin gida da na gida, na iya kamuwa da SARS-CoV-2.
Ana buƙatar bincike akan dabbobi da dabbobi don bincika ƙwayoyin cuta.
Na uku, kamar yadda aka ambata a sama, ba za a iya samun nau'in SARS-CoV-2 da kuma daidaitawa a cikin nau'in na uku ba, wanda ya kasance a cikin lamba tare da bat da pangolins.
Ana ci gaba da bincike kan asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'ikan nau'ikan dabbobi daban-daban, akwai manyan abubuwa guda uku na kwayar cutar da ke sauƙaƙe ƙetare shingen tsakanin jinsuna don COVID-19.
Da farko dai, suna da yawan canjin kwayoyin halitta a lokacin kwafin RNA.
"Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, dangane da lokacin daidaitawar kwayar cutar zuwa sababbin masu karɓar baƙi, ƙididdigar canjin canji ga kwayar cutar ta COVID-19 bisa matsakaicin canjin canji na kusan 10  4 sauyawa a kowace shekara a wuri na 2, ana iya ɗaukarsa ""matsakaici"" zuwa ""mai girma"". "
COVID-19 yana da exoribonuclease wanda ba za a iya karantawa ba, kuma cire shi yana haifar da canji mai yawa da lalacewa ko ma ya ɓace.
Abin sha'awa, analogue na nucleotide da ake kira Remdesivir an san shi don hana aiwatar da kwayar cutar COVID-19 ta hanyar hana wannan exoribonuclease da RNA-daidaitaccen RNA polymerase.
Redsevir yana daya daga cikin mafi kyawun magunguna don magance SARS-CoV-2 wanda ya kamata a gwada shi a asibiti.
Koyaya, yawan canjin kwayar cutar coronavirus ya kusan sau miliyan fiye da na masu karɓar su.
Bugu da ƙari, yawan canjin jini yawanci yana da yawa idan kwayar cutar ba ta dace da mai watsa shiri ba.
Idan aka kwatanta da yawan canjin yanayi a cikin SARS-CoV, yawan canjin yanayi na SARS-CoV-2 ya ragu sosai, yana nuna mafi girman daidaitawa ga mutane.
Wataƙila ya riga ya daidaita zuwa wani mai masaukin da ke da alaƙa da ɗan adam.
Baya ga SARS-CoV-2, wannan gaskiya ne ga MERS-CoV wanda ya dace da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
A ka'idar, ba zai yiwu ba cewa maye gurbin kwayoyin zai iya kawar da alluran rigakafi da maganin SARS-CoV-2 da sauri.
Na biyu, babban RNA genome a cikin coronaviruses yana ba da ƙarin sassauci a cikin gyaran kwayoyin halitta don maye gurbi ko nutricides, wanda ke haifar da yiwuwar haɓaka juyin halitta tsakanin jinsuna, wanda ke taimakawa wajen fitowar sabon coronaviruses lokacin da yanayi ya shirya.
Wannan yana tallafawa ta hanyar buɗewa da yawa na musamman da kuma ayyukan furotin da aka tsara zuwa ƙarshen 3′ na kwayoyin halitta.
"Na uku, coronaviruses suna canza samfuran bazuwar da sau da yawa yayin RNA ta hanyar hanyar ""zaɓar kwafi"" ".
A cikin mai karɓar baƙi wanda ke aiki a matsayin mai haɗawa, sauyawar zaren yana faruwa sau da yawa yayin rubutun RNA na COVID.
RNAs masu tsayi da tsayi na haemologues da kuma ƙarin ƙwayoyin cuta na ƙwayoyin cuta na iya haɗuwa don samar da sabon CoVs.
An gano shaidar fitowar kwayoyin halitta na halitta, duka a cikin HCoV-HKU1 da HCoV-OC43, da kuma a cikin COVID-19 na dabbobi kamar SL-CoV na Batman da CoV-HKU9 na Batman.
Hadin kai tsakanin mai watsa shiri da kwayar cutar dangane da watsawa.
Baya ga abubuwan ƙwayoyin cuta guda uku da aka ambata a sama, hulɗar ƙwayoyin cuta tare da mai karɓar mai karɓar ɗayan mahimman abubuwan da ke tasiri ga watsawar jinsuna.
An yi amfani da SARS-CoV a matsayin misali mai kyau na rashin daidaituwa kuma ya nuna shaidar zabin mai kyau a lokacin abubuwan da ke faruwa a cikin jinsuna.
Dangane da nazarin kwatancen tsakanin keɓaɓɓun SARS-CoV na ɗan adam da na dabbobi, an gano cewa SARS-CoV yana daidaitawa da sauri tare da baƙi daban-daban, musamman ta hanyar maye gurbi a cikin RBD da furotin S.
Gabaɗaya, RBD a cikin furotin S na kwayar cutar ta COV yana hulɗa tare da mai karɓar ƙwayoyin cuta kuma yana da zaɓi sosai ta hanyar amsawar ƙwayoyin cuta na mai karɓa.
RBD a cikin SARS-CoV yana cikin amino acid 318-510 akan S1 yanki wanda ke haifar da haɗin ACE2 na ɗan adam da kuma masu karɓar ra'ayi don shiga kwayar.
Yankin haɗin mai karɓar SARS-CoV yana iya gane masu karɓar ACE2 na dabbobi daban-daban ciki har da bargo, baboon, beraye da raccoons na kare, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura cewa ragowar amino acid 6 ne kawai RBD ya bambanta tsakanin ƙwayoyin cuta da aka ware daga mutane da dabbobi, kuma 4 daga cikinsu suna cikin yanayin haɗin mai karɓar don aiki tare da masu karɓar ACE2.
SARS-CoV Zbad yana da maye gurbi biyu K479N da S487T a cikin RBD wanda zai iya haifar da haɓaka dogaro da hulɗar furotin spike tare da masu karɓar ACE2 na ɗan adam.
A wasu kalmomin, waɗannan maye gurbin amino acid guda biyu na iya taka muhimmiyar rawa wajen daidaita kwayar cutar zuwa mutane.
Yana da mahimmanci a lura cewa mai karɓar ƙwayar SARS-CoV-2 iri ɗaya ne da SARS-CoV.
Bambanci na kashi 30 tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nuna cewa yiwuwar haɗuwa da S-protein zuwa ACE2 na mutum ya canza.
A zahiri, binciken cryo-EM ya nuna alaƙar da ta ninka ta 10-20 fiye da alaƙar da ke tsakanin furotin ACE2 da furotin S na SARS-CoV.
Hakanan zai zama mai ban sha'awa don ƙayyade ko waɗanne masu karɓar tallafi ne ake buƙata don watsawa idan aka kwatanta da ƙimar canjin yanayi a cikin SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana ɗaure da enzyme mai canzawa na angiotensin 2 (ACE2), amma tare da wani ɓangare na S.
Akwai sauran masu karɓar kwayar cutar HCoV da yawa, gami da aminopeptidase N don HCoV-229E da 9-O-acetyl sialic acid don HCoV-OC43.
Wannan na iya zama dalilin nasarar gano waɗannan CoVs a cikin mutane bayan watsawa tsakanin jinsuna daga dabba mai masauki.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon watsawar kwayar cutar HCoV tsakanin jinsuna yana ƙarƙashin tasirin sauran abubuwan dogara da mai masauki da abubuwan iyakancewa.
Bambancin waɗannan sunadarai masu karɓar bakuncin tsakanin mutane da kuma masu karɓar bakuncin ajiyar halitta na HCoVs kamar su bat, raƙuma, da rodents na iya zama shinge don watsawa tsakanin jinsuna.
Don samun nasarar watsawa tsakanin jinsuna, HCoVs dole ne su ɗauki abubuwan dogaro da mai masaukin baki kuma su kawar da abubuwan da ke iyakance mai masaukin baki.
A wannan yanayin, dole ne a gano da kuma ƙayyade abubuwan ƙayyade kwayoyin halitta a cikin wannan muhimmin yanayin hulɗar kwayar cutar-mai watsa shiri.
Binciken da ba shi da son kai a cikin kwayoyin halitta don dogara da mai masauki da kuma abubuwan da ke iyakance ga SARS-CoV-2, ta amfani da fasahar CRISPR mai tasowa, na iya zama mai amfani.
Fitowar sabbin kwayar cutar HCoV: Komawa zuwa ma'anar sifili
Bambancin bat-CoVs yana ba da dama mai yawa don fitowar sabon HCoVs.
Dangane da wannan, bat-CoVs suna aiki a matsayin tushen kwayoyin halittar mutum na HCoVs.
Bugu da ƙari, canji mai sauri da kuma ba da labarin halittar jini suna haifar da tsarin juyin halitta na HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, samun ko rasa sabbin kwayoyin halittar gina jiki na iya canza yanayin kwayar cutar sosai.
Daga cikin sunadarai masu illa ga SARS-CoV, ORF8 ya bayyana yana da mahimmanci wajen daidaitawa da mutane, saboda an ware ƙwayoyin cuta na SARS-CoV, amma an gano cewa sunadarai na ORF8 suna ɓoye vagra.
An gano wata alama ta kawar da 29-nucleotide na SARS-CoVs a cikin jinsunan da aka ware a farkon cutar ɗan adam.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b kuma wani nau'i ne na maye gurbin da ke taimakawa wajen sauyawa tsakanin masu karɓar.
Bugu da ƙari, SARS-CoV na iya samun tarihin ba da labari tsakanin layin alpha da gamma na coronavirus, wanda ya nuna cewa an gano yawancin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan RNA a cikin RNA polymerase.
An kuma gano wuraren nutrikeb a cikin nsp9, babban ɓangaren nsp10, da kuma sassan nsp14.
Hakanan, an gano cewa a cikin annobar MERS-CoV, an lura da wasu lokuta na haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
Baya ga SARS-CoV da MERS-CoV, an lura da abubuwan da suka faru na neutrecyclic a cikin sauran HCoVs inda HCoVs ke haifar da neutrecyclic tare da sauran HCoVs na dabbobi a cikin kwayoyin halittar su.
Hakanan ya kamata a yi gargadin cewa zabin wucin gadi na iya haifar da canje-canje da ba a so a cikin kwayoyin halittar kwayar cutar, wanda zai iya haifar da ƙarancin ƙwayoyin cuta daga matsin lamba na zaɓaɓɓu, misali ta tsarin garkuwar jiki na mai masauki.
Misali na wannan tasirin shine asarar cikakken tsawon ORF4 a cikin layin HCoV-229E wanda ya faru saboda cire nucleotides biyu.
Kodayake ana iya ganin ORF4 mai lafiya a cikin ƙwayoyin cuta na bat da raƙumi da ke da alaƙa da HCoV-229E, alpha-alpaca CoV yana da jerin nucleotide guda ɗaya wanda ke haifar da maye gurbin jujjuyawar tsarin karatu.
A kwanan nan, juyin halitta na sabon HCoVs yana ci gaba da matsa lamba na zaɓi a cikin masu karɓar ajiyar su.
Lokacin da bat bat an kamu da cutar, an gano marasa alamun ko marasa alamun cutar, wanda ke nuna daidaituwa tsakanin COVID-19 da bat.
Wannan ya nuna cewa jemage sun dace da cutar COVID-19 a cikin tsarin jiki da kuma ilimin lissafi.
Misali, rashin aiki a cikin amsawar kumburi na farko a cikin jemage yana rage tasirin cututtukan da aka kunna ta hanyar COV.
Bugu da ƙari, aikin kwayar halitta na halitta a cikin bat, saboda karuwar samar da mai karɓar ƙwayar halitta na halitta wanda ke hana NKG2/CD94 da kuma ƙananan maganganun kwayoyin halitta na babban ƙwayar halitta na aji na 1.
Bugu da ƙari, babban matakin mahaɗan da ke ƙunshe da oxygen mai aiki (ROS) wanda ke haifar da aiki mai yawa na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na iya hana kwayar cutar ta CoV ta hanyar aiki tare da tasirin exoribonuclease a kan samfurin da aka karanta, sakamakon haka, zabin zabin don samar da ƙwayoyin cuta wanda ke da sakamako mai tsanani lokacin da suka shiga sabon mai masauki.
Hanyoyin kwayar cutar COVID-19 tare da halayen cutar da suka fi girma suna haɓaka ta hanyar haɓaka, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don dacewa da mai masaukin.
Don haka, ba daidaituwa ba ne cewa sabbin kwayar cutar HCoV guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
Coronaviruses ba su da cututtuka ko kuma suna haifar da alamun rashin lafiya a cikin masu kula da su kamar su bat da raƙuma.
Suna ninkawa sosai ba tare da haifar da amsawar rigakafi mai karfi daga mai watsa shiri ba.
Akwai wasu asirin da ba a san dalilin da yasa masu dauke da cutar ba su da alamun cutar da kuma abin da ke haifar da mummunan cututtuka a cikin mutum.
Babban bayyanar cututtuka yawanci saboda yawan aiki da tsarin rigakafi da kuma hadarin cytokine, inda mafi ƙarfin amsawar rigakafi, lalacewar huhu zai zama mafi tsanani.
A akasin wannan, a cikin masu ɗaukar hoto ba tare da alamomi ba, amsar rigakafi ta rabu da haɓaka kwayar cutar coronavirus.
Wannan dabarar don ware amsar rigakafi na iya samun sakamako mai kyau a cikin maganin SARS-CoV-2.
Amsar interferon a cikin bat tana da ƙarfi sosai.
Don haka, amfani da maganin cutar ta Interferon na I ya kamata ya kasance da amfani aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, kunnawa na NLRP3 na ƙwayoyin cuta a cikin bat.
Tare da wannan ma'anar, hana NLRP3 ƙonewa tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Fitowar SARS-CoV-2 ta bi tsari iri ɗaya da SARS-CoV da MERS-CoV.
Kodayake COVID-19 beta yana da kashi 95% na nucleotide tare da SARS-CoV, akwai COVID-19 na bat wanda ke da kashi 96% na nucleotide tare da SARS-CoV-2.
Duk da yake an san cewa dabbobi masu rarrafe da sauran dabbobi a kasuwa suna karɓar bakuncin ƙwayoyin cuta masu kama da SARS-CoV, ba a san mai karɓar bakuncin SARS-CoV-2 na farko ba.
Beta-panclinal CoVs da aka gano waɗanda ke da alaƙa da SARS-CoV-2 sun nuna cewa yana yiwuwa cewa pangolins sun yi aiki a matsayin ɗaya daga cikin masu karɓar bakuncin matsakaici ko kuma mai yiwuwa beta-panclinal CoVs ya kasance cikin abubuwan da suka haifar da kwayar halittar SARS-CoV-2.
Kodayake wannan tambayar ta kasance, babu wata hujja da ke nuna cewa SARS-CoV-2 an ƙirƙira shi ne da gangan ko kuma ba da gangan ba.
Cutar coronavirus ta sake zama abin lura saboda barkewar cutar SARS-CoV-2 a kwanan nan.
Nazarin CoVs a cikin jemage da sauran dabbobi ya canza fahimtarmu game da mahimmancin asalin dabbobi da dabbobi masu ajiyar kwayar cutar HCoVs a cikin watsawa ga mutane.
Shaida mai ƙarfi ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar masu watsawa.
Ganin cewa kamuwa da cutar SARS-CoV ya samo asali ne daga hulɗar mutane da katantanwa a kasuwa, rufe kasuwannin kasuwanci da kashe katantanwa na iya kawo ƙarshen annobar SARS yadda ya kamata.
A wannan yanayin, saboda gano cewa yawancin layin beta-pangolin CoVs suna da alaƙa da SARS-CoV-2, ya kamata a tattara pangolins daga kasuwannin kasuwanci don hana watsa dabbobi.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane ta hanyar pangolins da sauran dabbobi da kuma yadda ake yaduwa, za a bayyana a cikin binciken gaba.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman dutse na dogon lokaci.
Rakuma suna da mahimmanci a matsayin hanyar sufuri da kuma babban tushen nama, madara, fata da kayan ulu ga mazauna yankin.
An yada su sosai a Gabas ta Tsakiya da Afirka.
Don haka, ba zai yiwu a kashe dukan raƙuma don magance MERS ba, kamar yadda ya faru don magance barkewar SARS-CoV da SARS-CoV-2 a cikin dabbobin daji na kasuwar China.
Don dakatar da sake barkewar MERS, dole ne a bi da tsarin da ya dace don samar da alluran rigakafi masu tasiri don magance MERS-CoV a cikin raƙuma, tare da la'akari da duk matakan da ake buƙata don sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sabon nau'in kwayoyin halitta na iya bayyana kuma ya haifar da yaduwar cutar.
Akwai nau'ikan nau'ikan HCoVs da yawa a cikin namun daji.
Musamman, bat-CoVs suna da bambancin gaske tare da yiwuwar watsawa daga dabba zuwa mutum.
Akwai dama da yawa cewa waɗannan COVID-19 na dabbobi zasu iya haɓaka ko haɓaka, wanda zai haifar da fitowar sabbin COVID-19 waɗanda zasu iya zama masu saurin yaduwa da / ko kisa ga mutane a nan gaba.
Dole ne a daina cin abincin namun daji a wasu yankuna na kasar Sin don rage yawan hulɗar da ba dole ba tsakanin mutane da dabbobi.
Dangane da masifu da SARS, MERS da COVID-19 suka haifar, ya kamata a tsara shirin shiri da amsawa mafi kyau.
A gaskiya ma, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Suna zama a cikin wuraren ajiyar su na halitta don samun damar yaduwa.
Kodayake jemage suna da halaye da yawa waɗanda ke taimakawa wajen yada ƙwayoyin cuta, idan mutane sun sami horo mai kyau don nisanta kansu daga waɗannan dabbobin, ana iya rage yiwuwar haɗuwa da ɗan adam tare da jemage da sauran nau'ikan daji.
Kulawa na yau da kullun a cikin dabbobi masu shayarwa yana da mahimmanci don fahimtar yanayin halittu na CAV da kuma masu karɓar su na halitta, wanda zai taimaka wajen hana su kamuwa da cutar daga dabba zuwa mutum da kuma yaduwar su a nan gaba.
A ƙarshe, hanya mafi inganci don hana yaduwar cutar daga dabba zuwa mutum shine a nisantar da mutane daga wuraren da ke da alamun ajiyar ƙwayoyin cuta daga dabba zuwa mutum.
Akwai abubuwa da yawa da suka ɓace a cikin asirin asalin SARS-CoV-2 a cikin dabbobi.
Da farko, idan jemage suna watsa kwayar cutar SARS-CoV-2 zuwa pangolins, zai zama mai ban sha'awa don ganin a wane yanayi jemage da pangolins zasu iya raba wuri ɗaya na muhalli.
Na biyu, idan jemage suna taka rawa kai tsaye wajen watsawa ga mutane, dole ne a gano yadda mutane ke hulɗa da jemage.
Na uku, idan dabba ta uku ta zama mai watsa shiri na gaskiya, dole ne a bayyana yadda za ta yi hulɗa da nau'o'in daban-daban ciki har da mutane, bats da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa, gami da dabbobin gida, na iya kamuwa da SARS-CoV-2, dole ne a sanya ido da kuma gano kamuwa da cuta ta gwaji.
Ko dai a cikin jemage, pangolin ko wasu dabbobi masu shayarwa, ana sa ran SARS-CoV-2 ko kuma kwayoyin cutar da suka yi kama da juna za a iya samun su a cikin mai watsa shiri na halitta a nan gaba.
Bincike mai gudana a wannan fannin zai ba da haske game da hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai game da rigakafi da sarrafa COVID-19 a cikin mutane.
" Yana da mahimmanci a sabunta ka'idodin gano COVID-19 "" yanayin da ake zargi "" da "" yanayin da aka tabbatar "" ".
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa don ganowa da magance cutar ta 2019 (2019-nCoV) ta sabon coronavirus, wanda ke ba da kwarewarmu da kuma kyakkyawan tushe don yaƙar cutar a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma iliminmu yana ƙaruwa a hankali bisa ga binciken da ake ci gaba da samu da kuma ƙwarewar aikin asibiti. Saboda haka, ana ci gaba da sabunta dabarun bincike da magani.
A cikin wannan wasikar, mun amsa ga wani bayani game da jagorarmu kuma mun gabatar da sabbin ka'idojin bincike na cutar da aka tabbatar da su bisa ga sabon jagorar ganowa da maganin COVID-19 (Fitowar bakwai) da Kwamitin Kiwon Lafiyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da barkewar cutar da ake kira cutar coronavirus ta 2019 (COVID-19) da kuma cutar coronavirus mai saurin kamuwa da cutar numfashi.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin cutar da ke yaduwa.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara jagorar shawarwari mai sauri wanda aka buga akan layi a cikin binciken likitancin soja (Military Medical Research) a ranar 6 ga Fabrairu, 2020.
Wannan ya jawo hankali sosai tun lokacin da aka buga shi.
Ka lura cewa COVID-19 sabuwar cuta ce, kuma a hankali muna ƙara wayewar kanmu da iliminmu bisa ga binciken da ake ci gaba da yi da kuma ƙwarewar asibiti. Saboda haka, ana ci gaba da sabunta dabarun bincike da magani.
Misali, an fitar da ka'idojin ganewar asali da maganin COVID-19 da Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, a cikin jimlar juzu'i bakwai, wanda wasu daga cikin ka'idodin sun canza.
Yanzu da muka sami ra'ayoyi daga Xu da abokan aiki, jagorarmu ta ba da shawara mai sauƙi don yin ƙimar bisa ga kwarewar asibiti.
Ayyukan su sun ƙara sabon shaida ga jagorarmu kuma suna ci gaba da ba da mahimman bayanai game da cutar a duk duniya.
Muna yaba musu da kuma yaba musu saboda irin kokarin da suka yi.
Koyaya, bisa ga sabbin hanyoyin ganowa da maganin COVID-19 (Fitarwa ta bakwai) da kuma binciken kwanan nan, aikin su ma yana buƙatar sabuntawa.
A cikin gyara ta bakwai (3 ga Maris 2020), don tabbatar da yanayin da ake zargi, kowane ɗayan abubuwan da ke cikin tarihin annobar ya kamata a haɗa su tare da alamun alamun asibiti guda biyu don yin cikakken bincike, ko kuma idan babu tarihin cutar, ya kamata a sami alamun asibiti guda uku:
Tarihin cututtukan cututtuka: (1) Tarihin tafiya ko zama a Wuhan da kewayenta ko wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin hulɗa da mutanen da ke da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) Tarihin hulɗa da marasa lafiya da zazzabi ko cututtukan numfashi daga Wuhan da kewayenta ko wasu al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin hulɗa tare da rukunin tabbatar da cutar (casual 2 na zazzabi da / ko cututtukan numfashi sun faru a cikin mako guda a cikin ƙananan yankuna kamar gida, wurin aiki, aji, makaranta, da sauransu).
Alamun asibiti: (1) zazzabi da / ko bayyanar cututtuka na numfashi. (2) suna da siffofin hoto na kamuwa da cutar COVID-19; (3) yawan adadin farin jini, a farkon farawa a cikin nau'ikan ƙididdigar al'ada, ko rage ƙwayoyin lymphocytes.
Tabbatar da ganewar asali dole ne ya dogara ne akan yanayin da ake zargi da cutar ko cutar ta cutar kamar haka: (1) gwajin PCR na lokaci-lokaci don SARS-CoV-2 yana da kyau; (2) jerin kwayoyin halittar kwayar cutar gaba ɗaya wanda ke nuna babban haɗin kai tare da sabon COVID; (3) sakamako mai kyau ga takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko sauyawar IgG antibody na SARS-CoV-2 daga mara kyau zuwa tabbatacce ko haɓaka tetra 4 ko fiye a lokacin farfadowa fiye da wannan a cikin lokacin matsananci.
Za mu iya ganin cewa an ƙara gwajin PCR na lokaci-lokaci, don nucleic acid a cikin tsarin numfashi ko samfurin jini a cikin bugu na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An ƙara gano cututtukan cututtukan jini a cikin bugu na huɗu (Janairu 27, 2020) da na biyar (Fabrairu 8, 2020); sannan an ƙara shaidar serology a cikin bugu na bakwai.
Waɗannan gyare-gyare sun dogara ne akan ci gaba da ƙoƙarin masu bincike don nemo ingantaccen kayan aikin gano nucleic acid don saurin ganewa, gami da samfuran tsarin numfashi, gami da ɗaukar jini, wanda ya haifar da ƙididdigar tabbatarwa tare da haɓaka wadatar samfuran daban-daban da ƙarin tallafi don dogaro da sakamako mai kyau na ƙwayoyin cuta.
Bugu da ƙari, akwai ƙarin shaidu da ke ƙarfafa mu mu kula da marasa lafiya da ke da alamun rashin lafiya ko marasa alamun cutar.
Saboda haka, dole ne a sabunta jadawalin kwararar Zhou da abokan aiki, saboda sun rarraba mutum ba tare da alamun asibiti a cikin ƙananan haɗari ba.
Hakanan dole ne a tabbatar da tsarin maki a cikin ƙarin ayyuka da nazarin asibiti.
A ƙarshe, muna fatan samun ƙarin shaidu kai tsaye kuma muna kira ga masu karatu su ba da ra'ayoyinsu.
Don gano yanayin da ake zargi da wanda aka tabbatar, muna ba da shawarar bin sabbin jagororin ƙasashensu.
Ƙungiyarmu za ta ci gaba da samar da jagororin don samar da taimako a kan lokaci.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, mafi girma a rana ɗaya.
A jiya, Bangladesh ta sanar da rashin ruwa mai tsawo na ƙafa biyar a rana ɗaya sakamakon COVID-19.
Wannan shi ne adadin mutuwar da cutar ta yi a rana guda.
A jiya, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton mutane 114 da suka kamu da cutar da kuma 33 da suka warke a gida.
An samu mutuwar mutane 17 baki daya.
A cikin wani rahoto na labarai na kan layi, Daraktan IEDCR, Dokta Mirjad Sabrina Flora, ya ce mutanen da suka mutu maza hudu ne da mace daya.
A cewar Dakta Mirjaddi, mutane biyu sun haura shekaru 60, biyu tsakanin shekaru 51 zuwa 60, kuma daya daga cikin wadanda suka kamu da cutar yana tsakanin shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda aka kashe 'yan asalin Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin cutar da ke yaduwa a duniya.
Wani jami'in asibitin ya shaida wa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda aka kama shine Jalal Sifoor Rahman, shugaban hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda aka kula da shi a asibitin Maitreya na Kuwait.
A ranar Asabar, ministan sufuri da gadoji na Bangladesh, Ubayd al-Qadir, ya ce a cikin sanarwar bidiyo ta yanar gizo cewa za a dakatar da zirga-zirgar jama'a fiye da yadda aka tsara a farko, wato har zuwa Asabar mai zuwa.
Shirin dakatar da zirga-zirgar jama'a ya fara daga 26 ga Maris kuma ya kamata ya ƙare a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu mahimmanci - magani, mai da abinci.
An fara samun mutum na farko da ya kamu da cutar a Bangladesh a ranar 8 ga watan Maris, wanda ya shafi mutane biyu da suka dawo daga Italiya, kuma matar daya daga cikinsu ta kamu da cutar.
A ranar 19 ga watan Maris, uku daga cikin mutanen sun warke.
Cutar SARS-CoV-2 ta wuce mutane miliyan ɗaya a duk duniya.
A ranar Alhamis, yawan masu cutar SARS-CoV-2 a duniya ya zarce miliyan daya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutuwar 52,000 sun kasance masu alaƙa da COVID-19, cutar da ke haifar da coronavirus.
Wannan muhimmin abu ya faru ne a ranar da Malawi ta sanar da cutar ta farko ta coronavirus kuma Zambia ta ba da rahoton mutuwar farko ta cutar.
Koriya ta Arewa a ranar Alhamis ta yi ikirarin cewa tana ɗaya daga cikin ƙasashe kalilan da ba su da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 105,1635 da aka tabbatar da su, gami da mutane 79,332 a cikin awanni 24 kafin karfe 10 na safe agogon Turai ta Tsakiya (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu sama da mutane 244,000 da suka kamu da cutar coronavirus, wanda ya yi sanadiyar mutuwar mutane 5,900.
CBC News ta ruwaito, bisa ga bayanan Jami'ar Johns Hopkins, cewa mutane sama da 1,000 sun mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk faɗin duniya, ƙasashe suna ɗaukar takamaiman matakan hana yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin Sharval na Moscow ya tsawaita dokar hana fita ta gari zuwa karfe 1.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa Rashawa za su sami albashi ba tare da yin aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'ar tsawaita dokar ta baci na kwanaki 15 tare da kuri'u 215 a kan, 10 a kan, da kuma kuri'a daya a kan.
Saudiyya ta ba da dokar hana fita a cikin biranen alfarma na Makka da Madina a duk tsawon rana, wanda a baya ya kasance daga karfe 3 na yamma zuwa 6 na safe.
An ba da umarnin cewa Thailand ta aiwatar da dokar hana zirga-zirga tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shagunan Australiya sun rage iyakar sayar da tawul ɗin wanka a kowane ma'amala.
A ranar Lahadi da Asabar da yamma, manyan shagunan Australiya na Walworth da Coles sun rage rabon sayen tawul ɗin takarda zuwa biyu da fakiti ɗaya a kowane sayayya a duk shagunan ƙasar.
ALDI ta sanar da iyakance sayan kaya guda daya a ranar Litinin.
An sanya waɗannan ƙuntatawa a matsayin saƙo a kan akwatin kuɗin shiga da shafukan Facebook na shaguna.
An bayar da rahoton cewa masu siye da siyarwa suna adana soda saboda tsoron COVID-19 da kuma keɓewar kansu.
A ranar Laraba, Woolworths ya ci gaba da iyakance sayen tawul ɗin wanka don isar da ƙofar gida zuwa fakiti ɗaya a kowane tsari.
Waɗannan canje-canjen sun biyo bayan fakitin farko guda huɗu na kowane ƙuntatawa na ma'amala wanda Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
" Coles Supermarkets a cikin wata hira da kafofin watsa labarai a ranar 8 ga Maris ya ba da rahoton cewa duk da iyakancewar fakiti huɗu, ""mabukaci da yawa suna samun ƙarin tallace-tallace a cikin awa ɗaya bayan isar da kaya"" kuma suna kiran buƙata ""ba a taɓa gani ba"" yayin da shagunan sarkar ALDI, a cikin sakon Facebook ɗin su a ranar Talata, sun kira tallace-tallace ""ba zato ba tsammani. """
"A cewar mai magana da yawun Walworth, tallace-tallace sun tashi da ""tsananin karko""".
Shagon Costco a Canberra ya iyakance adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ya ba da umarnin manyan fakiti ga masu samarwa kuma ya ƙara yawan isar da kaya, Wal-Worth ya ba da ƙarin umarni a kan kaya, kuma Aldi ya riga ya shirya don tayin na musamman na Laraba.
Rachel Zimmerman, darektan zartarwa na kungiyar masu sayar da kayayyaki ta Australiya, ta ce masu sayar da kayayyaki suna kokarin kara yawan kaya, amma takunkumin da hukumomin yankin suka sanya kan lokacin zirga-zirgar manyan motoci ya sanya aiki ya zama da wahala.
Ya yi tsammanin farashin samarwa zai yi yawa, yayin da masu samar da kayayyaki ke ƙoƙarin biyan buƙatun kuma suna da ƙananan lokuta na musamman.
A ranar Talata, ALDI (Katin Kasuwanci) ya sanar da cewa wasu shaguna ba za su iya samun tallace-tallace na musamman a ranar Laraba ba saboda fitowar hannun jari da wuri.
A wani rahoto da News.com.au ta bayar, masanin harkokin kasuwanci, Dr. Gary Mortimer na Jami'ar Fasaha ta Queensland ya ce shagunan suna cika kaya a kowane dare.
Ya lura cewa tawul din wanka abu ne mai girma wanda ke ɗaukar ɗan ƙarami a cikin sarari mai yawa. Idan aka sayar da shi, zai share sararin ɗakunan ajiya kuma ya haifar da ƙarancin jin dadi.
Rachel Zimmerman ta shaida wa ABC News cewa, "Coles da Walworth sun yi imanin cewa idan akwai wadataccen kaya a kan ɗakunan ajiya, idan akwai wadataccen kayayyaki kamar tawul ɗin wanka da maganin kashe ƙwayoyin cuta, za ku iya rage wannan tsoro. """
Wani mai kera tawul din wanka mai sake amfani da shi mai suna Who Gives a Crap ya ce sun gama kaya a ranar Laraba da ta gabata.
Kamar yadda News.com.au ta ruwaito, Kimberly-Clark, mai kera tawul din wanka na Clinix da Solaris Paper, mai kera kayan maye, sun jaddada cewa suna aiki awanni 24 a mako don biyan bukatun kasuwa.
Shafin yanar gizo na Domain.com, wanda ke aiki a cikin dukiya, ya ruwaito cewa yayin da masu siye suke hutu saboda hutun ranar aiki mai tsawo kuma ana gudanar da karamin gwanjo, wasu masu siyar da dukiya suna ba da tawul ɗin gidan wanka kyauta ga wanda ya fara siyarwa a gwanjon Melbourne.
Shafin Alhamis na NT News, jaridar da aka buga a Darwin, ya ƙunshi shafi takwas na shafi wanda aka buga don amfani da shi a matsayin tawul na gidan wanka.
A cewar rahoton ABC Australia a ranar 3 ga Maris, shagunan da farko ba su da niyyar sanya takunkumi, suna mai cewa ba su da shirin sanya takunkumin sayayya.
Russell Zimmerman ya kara da cewa: "Sauran kayayyakin kamar masks, disinfectant, bushewa, foda da ruwa na wanke hannu suna da matukar bukata.
Hakanan, a waje da Ostiraliya, an lura cewa ranar Lahadi da yamma babban kanti na Burtaniya na kan layi Okado ya iyakance sayen tawul ɗin wanka zuwa fakiti biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana cutar COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 da ke haifar da coronavirus SARS-CoV-2 a matsayin annoba.
" Kodayake kalmar nan ""annoba"" tana nufin kawai yadda cutar ta yadu kuma ba ta nuna yadda wasu lamuran ke da haɗari ba, Hukumar Lafiya ta Duniya ta lura da buƙatar sa gwamnatoci suyi aiki tare da waɗannan: "
"Duk ƙasashe na iya canza yanayin wannan annoba. ""
Tedros Adhanom, shugaban Hukumar Lafiya ta Duniya, ya yi imanin cewa "" idan kasashe suka dauki mataki don ganowa, gwaji, magani, warewa, bin diddigin mutane da kuma tattara su. "
" ""Muna matukar damuwa game da matakan gargadi game da yaduwar cutar da tsananin cutar da kuma matakan gargadi game da rashin kulawa. """
"A cewar Dokta Tom Friedman, tsohon darektan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, annobar ""ba ta da misali""".
A cikin wata sanarwa da aka buga a CNN a watan Fabrairu, ya ce, "Baya ga mura, ba a gano wasu ƙwayoyin cuta na numfashi ba daga lokacin bayyanar cututtuka zuwa ci gaba da yaduwar duniya".
Ghebreyesus ya yi magana iri ɗaya, yana cewa: "Ba mu taɓa ganin cutar da ke haifar da cutar coronavirus ba".
Ya ci gaba, ""Ba mu taɓa ganin cutar da za a iya sarrafawa a lokaci guda ba"."
Sabon matsayin cutar a matsayin annoba ya biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke a watan Janairu, inda ta ayyana barkewar cutar a matsayin gaggawa ta kiwon lafiyar jama'a a duniya.
" Dokta Anthony Fauci, darektan Cibiyar Kula da Allergy da Cututtuka na Amurka, ya ce game da barkewar cutar, ""Abubuwa suna kara muni". "
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, wanda ya yi sanadiyar mutuwar mutane sama da 4,600.
Cutar annobar coronavirus ta 2020-2019 wata cuta ce mai ci gaba da cutar coronavirus ta 2019 (COVID-19), wanda ke haifar da cutar cututtukan numfashi mai saurin gaske (SARS-COVID-2).
An gano barkewar cutar a watan Disambar 2019 a Wuhan na kasar Sin, an ayyana ta a matsayin gaggawa ta lafiyar jama'a a ranar 30 ga Janairu, 2020 kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar kusan mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mutuwar a China ya kai kashi 4%, duk da haka, a duniya ya bambanta daga 13.4% a Algeria zuwa 0.08% a New Zealand.
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi.
Matsaloli na cutar sun haɗa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Daga lokacin kamuwa da cutar zuwa bayyanar cututtuka, yawanci yakan ɗauki kwanaki 5, amma zai iya bambanta daga kwana biyu zuwa 14.
Babu wani rigakafi ko maganin rigakafin cutar da aka gano don cutar.
Maganin farko shine ainihin maganin alamun bayyanar cututtuka da magani na tallafi. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe baki lokacin da ake tari, nisantar wasu mutane da bincika da keɓe mutanen da ake zargi da kamuwa da cutar.
Hukumomi a duk duniya sun amsa ga takunkumin tafiye-tafiye, keɓewa, ƙuntatawa na motsi, kula da haɗarin wurin aiki da kuma dakatar da wuraren aiki.
Cutar ta haifar da mummunan rikicewar zamantakewar tattalin arziki a duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu da kuma karancin albarkatu da ke haifar da fargaba.
Makarantu da jami'o'i sun rufe a ƙasashe 193, ko a matakin ƙasa ko na gida, wanda ya shafi kusan kashi 99.4 na yawan ɗaliban duniya.
An samu rashin daidaito game da cutar a yanar gizo, kuma an sami wasu lokuta na nuna kyamar baki da nuna wariya ga Sinawa, da sauran mutane masu launin fata da bayyanar gabas da kudu maso gabashin Asiya, da sauran yankuna da ke da yawan kamuwa da cutar.
An rage gurbataccen iska da fitar da carbon saboda rage tafiye-tafiye da kuma dakatar da masana'antun nauyi.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei), sun ba da rahoton wasu cututtukan ciwon huhu da ba a sani ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin marasa lafiya sun kasance suna da alaƙa da kasuwar sayar da kayan abincin teku ta Hunan, don haka ana tsammanin cutar ta samo asali ne daga cutar zainos (cuta ta mutum da dabba).
Kwayar cutar da ta haifar da annobar, wacce aka fi sani da SARS-CoV-2, sabuwar kwayar cuta ce da aka gano tare da halaye masu kama da bat-CoV, pangolin-CoV da SARS-CoV. Daga baya an gano cewa mutum na farko da ya fara nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019 kuma ba shi da wata alaƙa da kasuwar kayan kifin.
Daga rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku na masu kamuwa da cutar suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Morning Post ya nuna cewa abin da aka gano a ranar 17 ga Nuwamba, 2019 a cikin wani mutum mai shekaru 55 a lardin Hubei na iya zama farkon kamuwa da cutar. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, sakamakon raguwar sabbin cututtukan a China, a cikin Italiya, Iran da Koriya ta Kudu, an sami karuwar cututtukan kwatsam, adadin sabbin cututtukan da ke waje da China ya zarce adadin sabbin cututtukan a cikin China a karon farko.
Ana iya ba da rahoton rahotanni masu mahimmanci a matsayin ƙarin, musamman a cikin abubuwan da ke da alamun bayyanar cututtuka.
Har zuwa 26 ga watan Fabrairu, an samu karancin mutane da suka kamu da cutar a tsakanin matasa, inda kashi 2.4% na yawan masu kamuwa da cutar a duniya sun kasance masu shekaru 19 zuwa kasa. Patrick Vallance, babban mai ba da shawara kan kimiyya ga gwamnatin Burtaniya, ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya suna da cutar don samun rigakafin tarin yawa.
Wadannan lamura sun shafi mutanen da aka gwada su don COVID-19 kuma an tabbatar da gwajin su a matsayin tabbatacce bisa ga ƙa'idodin hukuma.
Tun daga ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma manufofin hukuma na ƙasashe da yawa, gami da Italiya, Netherlands, Spain da Switzerland, sun ƙi yin gwaji ga mutanen da ke da alamun rashin lafiya.
Wani bincike da aka buga a ranar 16 ga watan Maris ya nuna cewa a kasar Sin, kusan kashi 86% na cututtukan COVID-19 ba a gano su ba har zuwa ranar 23 ga Janairu, kuma waɗannan cututtukan da ba a gano su ba sune tushen kamuwa da cutar ga kashi 79% na waɗanda aka gano.
Binciken kididdiga da aka fitar a ranar 30 ga Maris ya kiyasta cewa yawan kamuwa da cutar a Italiya ya fi yawan wadanda aka ruwaito.
Tsammani na farko na ƙimar haɓaka tushe (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani binciken da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta wallafa ya bayyana cewa 5.7.
Yawancin mutane da ke fama da COVID-19 suna murmurewa.
Ga waɗanda ba su da cutar, lokacin bayyanar cututtuka zuwa mutuwa ya bambanta tsakanin kwanaki 6 zuwa 41, tare da yawanci kwanaki 14.
Tun daga 10 ga Afrilu, 2020, kusan ƙafa 97,000 aka danganta ga COVID-19.
A China, tun daga ranar 5 ga watan Fabrairu, kusan kashi 80% na mutuwar sun faru ne a cikin mutanen da suka haura shekaru 60, kuma kashi 75% daga cikinsu suna da cututtukan da suka gabata, gami da cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 ya fi haka yawa saboda ba a haɗa da mutanen da suka mutu ba tare da gwaji ba, misali a gida ko asibitoci.
Bayanai na farko daga Italiya sun nuna adadin mutuwar da cutar ta haifar da sau 5 zuwa 4 fiye da adadin mutuwar da aka sanar da hukuma ta COVID.
"Wani mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ya yarda cewa ""mun san cewa [ƙididdigar] ta ƙasa da ainihin adadi". " Rahotanni da aka bayar game da ƙididdigar da ba ta dace ba a Amurka sun tabbatar da waɗannan maganganun. Wannan ƙididdigar ƙasa da gaskiya, galibi yana faruwa a cikin annoba kamar cutar mura ta H1N1. An ba da rahoton mutuwar farko da aka tabbatar a ranar 9 ga Janairu, 2020 a Wuhan. "
Mutuwar farko a waje da kasar Sin ta faru ne a Philippines a ranar 1 ga watan Fabrairu, kuma mutuwar farko a waje da nahiyar Asiya ta faru ne a Faransa a ranar 14 ga watan Fabrairu.
Har zuwa ranar 28 ga watan Fabrairu, an samu sama da mutane da dama da suka kamu da cutar a kasashen Iran, Koriya ta Kudu da Italiya, a wajen kasar Sin.
Zuwa ranar 13 ga watan Maris, an samu mutuwar a kasashe da yankuna sama da 40, a duk nahiyoyi sai dai Antarctica.
Waɗannan lambobi sun bambanta a yankuna da lokuta daban-daban kuma abubuwa kamar yawan gwaje-gwajen da aka yi, ingancin tsarin kula da lafiya, zaɓuɓɓukan magani, tsawon lokacin da ya gabata tun farkon barkewar cutar da kuma yanayin alƙaluma kamar shekaru, jinsi da lafiyar jama'a suna tasiri.
Dangane da ƙididdigar Jami'ar Johns Hopkins, har zuwa 10 ga Afrilu, 2020, yawan mutuwar-zuwa-halittawar cutar a duniya ya kai kashi 6% (mutum 97,039 daga mutane 161,7204).
Adadin ya bambanta dangane da yanki.
A China, ƙididdigar yawan mutuwar cutar ta ragu daga kashi 17.3% (mutanen da ke da alamun bayyanar cututtuka na Janairu 1 zuwa 10, 2020) zuwa kashi 0.7% (mutanen da ke da alamun bayyanar cututtuka bayan Fabrairu 1, 2020). Sauran lissafin sun haɗa da: yawan mutuwar cutar (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar cutar (IFR, wanda ke nuna yawan mutanen da ke da cutar (wanda aka gano da wanda ba a gano ba) wanda ya mutu daga cutar.
Wannan ƙididdigar ba ta da iyakance lokaci kuma yana dogara ne akan al'umma daga kamuwa da cutar zuwa warkewa.
Yawancin masu bincike na jami'a sun yi ƙoƙari su lissafa wannan adadi don wasu mutane.
Cibiyar Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar cutar a duniya gaba ɗaya yana tsakanin 0.1% zuwa 0.39%.
Babban kimantawa na wannan zangon ya dace da sakamakon gwajin COVID-19 na bazuwar a Jamus da nazarin ƙididdigar nazarin tasirin gwajin akan kimantawar CFR.
Hukumar Lafiya ta Duniya ta amince da cewa ana iya sarrafa cutar a duniya.
Ba a san lokacin da cutar ta fara yaduwa ba kuma ba a san lokacin da za ta ƙare ba, kuma zai iya bambanta dangane da wuri.
Maciej Boni na Jami'ar Jihar Penn ya yarda cewa idan ba a kula da cutar ba, yawanci cutar ba ta canzawa ba bayan wani lokaci kuma yana raguwa bayan an gama amfani da masu karɓar baƙi.
"Amma a yanzu, kusan ba zai yiwu a yi wani kyakkyawan hasashen lokacin da cutar za ta ƙare ba"."
Babban mai ba da shawara kan lafiya na gwamnatin kasar Sin, Zhong Nan Shan, ya ce idan dukkan kasashen duniya suka iya karfafa kowa don bin shawarwarin Hukumar Lafiya ta Duniya kan matakan dakile yaduwar cutar, "yana iya karewa a watan Yuni".
A ranar 17 ga Maris, Adam Kucharski na Kwalejin Lafiya da Magungunan Yankin Gashi na London ya ce SARS-CoV-2 "yana yaduwa kuma zai iya wucewa shekara ɗaya ko biyu".
"A cewar wani binciken da kwalejin Imperial ta gudanar karkashin jagorancin Neil Ferguson, za a buƙaci nisantar jiki da sauran matakan"" har sai an samu allurar rigakafi (kimanin watanni 18 ko fiye)".
"William Schaffner na Jami'ar Vanderbilt ya ce, ""Ina ganin ba zai yiwu ba cutar ta ɓace gaba ɗaya - saboda tana da saurin kamuwa da cuta"" kuma ""yana iya zama cuta ta yanayi wanda ke sake tashi kowace shekara. """
Matsayin sake kamuwa da cutar ya dogara da rigakafin garken da kuma yawan maye gurbinsa.
Alamomin COVID-19 na iya zama marasa ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Alamomi biyu na yau da kullun sune zazzabi (88%) da bushewar tari (68%).
Alamomin da ba su da yawa sun haɗa da gajiya, samar da numfashi mai ƙyama (ƙwarewa), asarar ƙanshi, numfashi mai ƙyama, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, rawar jiki, amai, zubar da jini, gudawa ko cyanosis. Hukumar Lafiya ta Duniya ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana fama da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta Amurka ta bayyana alamun gaggawa a matsayin wahalar numfashi, ci gaba da ciwo a kirji ko jin matsi, rikicewa kwatsam, wahalar farkawa daga bacci, da ƙazantar fuska ko lebe. Idan waɗannan alamun sun bayyana, ana ba da shawarar kulawar gaggawa. Ci gaba da cutar na iya haifar da ciwon huhu mai tsanani, cututtukan numfashi mai tsanani, tashin hankali, harin septic da mutuwa.
Wasu mutane da ke dauke da cutar ba za su iya nuna alamun cutar ba, amma sakamakon gwajin ya tabbatar da cutar, don haka masu bincike sun ba da shawarar cewa mutanen da ke da kusanci da su su kula da su sosai don hana yaduwar kamuwa da cutar.
An kiyasta yawan marasa lafiya marasa alamun cutar a China daga ƙananan ƙima zuwa 44%.
Lokacin kamuwa da cutar (lokacin da ke tsakanin kamuwa da cuta da bayyanar cututtuka) yawanci ya bambanta daga kwana ɗaya zuwa goma sha huɗu; a mafi yawan lokuta kwanaki biyar ne. Misali na rashin tabbas, ƙididdigar kashi na mutanen da ke da COVID-19 waɗanda suka rasa ƙanshi ya ragu zuwa 30% da farko kuma daga baya zuwa 15%.
Wasu bayanai game da barkewar cutar sun bayyana kwanan nan.
Ana tsammanin cewa a farkon matakan, yaduwar kwayar cutar ta hanyar kusanci da ƙananan ruwa da ke faruwa yayin tari, hancin ko magana, idan aka yi la'akari da kusanci tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Nazarin ya nuna cewa lokacin da ake tari ba tare da sutura ba, saukad da ruwa zai iya motsawa daga mita 4.5 (ƙafa 15) zuwa mita 8.2 (ƙafa 27).
Wasu sun ba da shawarar cewa ana iya yada kwayar cutar ta hanyar ƙananan ɗigon ruwa, waɗanda ke yawo a cikin iska na dogon lokaci, misali yayin magana.
Wadannan digo na iya shiga bakin ko hanci na mutanen da suke kusa da mu kuma su shiga cikin huhu.
Wasu hanyoyin likita kamar tubing da CPR na iya haifar da yaduwar numfashi a cikin iska, wanda ke haifar da iska.
Idan ka taɓa wani abu mai cutarwa kamar fata sannan ka taɓa idanunka, hancinka ko bakinka, cutar na iya yaduwa.
Duk da cewa akwai damuwa game da yaduwar cutar ta hanyar stool, wannan haɗarin ba shi da tsanani.
Gwamnatin kasar Sin ta musanta yiwuwar yaduwar SARS-CoV-2. Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma tana iya yaduwa ga wasu kafin bayyanar cututtuka da kuma a ƙarshen cutar.
An gwada mutane har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa ana iya samun kamuwa da cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan kawai na ƙwayoyin cuta marasa alamun da aka tabbatar a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun gano watsawa mara alamun a cikin binciken gano lamba.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa, ko da yake ba a san yadda cutar ke yaduwa ba, amma mutum ɗaya da ke da cutar zai iya cutar da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a kan farfajiya daga sa'o'i zuwa kwanaki.
Musamman, an lura cewa kwayar cutar tana iya ganowa sama da kwanaki uku a kan filastik (polypropylene) da bakin karfe 304, kwana ɗaya a kan kwali, da sama da awanni huɗu a kan jan ƙarfe.
Amma wannan ya dogara da zafi da zafin jiki. Gwajin COVID-19 a cikin dabbobin gida da sauran dabbobi sun kasance masu kyau.
Babu wata hujja da ta tabbatar da cewa dabbobi za su iya yada cutar ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan tuntuɓar dabbobi, kamar yadda suke yi idan sun taɓa wasu abubuwa masu cutarwa.
Cutar coronavirus 2 mai saurin kamuwa da cutar numfashi (SARS-CoV-2) wata sabuwar cuta ce da aka fara ganowa a cikin mutane uku da ke fama da cutar sankarar bargo a Wuhan, waɗanda ke fama da raunin iskar oxygen a cikin jini da matsalolin numfashi.
Dukkanin siffofin sabon coronavirus suna bayyana a cikin sauran coronaviruses na halitta. A waje da jikin mutum, ana kashe kwayar cutar tare da sabulu na yau da kullun, saboda an narkar da murfin kariya a cikin sabulu. SARS-CoV-2 yana da alaƙa da SARS-CoV.
Ana zaton cutar ta samo asali ne daga cutar ƙwari ko kuma cutar da ke tsakanin mutane da dabbobi.
Binciken kwayoyin halitta ya nuna cewa kwayoyin halittar cutar coronavirus suna cikin rukuni tare da betacoronavirus da kuma subgenus na sarbecovirus (B-mammara) tare da nau'i biyu na asalin bat.
Wannan kwayar cutar tana da kamanceceniya da kashi 96% a matakin gabaɗaya na kwayoyin halitta tare da sauran samfuran bat-CoVs (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci na amino acid daya kawai tsakanin kwayoyin cutar pangolin da na mutum a wasu sassan tsarin kwayoyin halitta.
Idan aka kwatanta dukkanin kwayoyin halittar mutum har zuwa yau, kashi 92% na abubuwan da ke tattare da kwayoyin halitta tsakanin CAVP da SARS-CoV-2 sun kasance, wanda bai isa ya tabbatar da cewa pangolins ne mai watsa shiri ba.
Ana iya gano kamuwa da kwayar cutar ta ɗan lokaci bisa ga alamun, kodayake ana iya tabbatar da tabbataccen ganewa ta hanyar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuya.
Wani binciken da ya kwatanta halayen polymerase chain reaction (PCR) da CT scan (CT) a Wuhan ya nuna cewa CT ya fi PCR hankali, kodayake ba shi da ƙwarewa sosai kuma yawancin siffofin hoto suna kan gaba tare da sauran nau'ikan nono da hanyoyin cutar.
"A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT don nunawa ko gwajin layin farko na COVID-19"."
Hukumar Lafiya ta Duniya ta buga wasu ka'idojin gwajin RNA don SARS-CoV-2, wanda farkon lamarin ya faru ne a ranar 17 ga Janairu.
Gwajin yana amfani da maganin jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuya.
Ana iya yin gwajin akan samfurori na numfashi ko jini.
Ana bayar da sakamako a cikin sa'o'i da yawa zuwa kwanaki.
Ana yin gwajin ne ta hanyar allurar hanci da hanci, kodayake ana iya amfani da allurar makogwaro. Yawancin dakunan gwaje-gwaje da kamfanoni suna samar da gwaje-gwajen serological waɗanda ke gano ƙwayoyin cuta.
Zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan da ya isa ya zama daidai don amfani da shi ko'ina.
A Amurka, gwajin ƙwayar cuta wanda Cellex ya tsara, wanda aka ba da izinin amfani da gaggawa kawai ta hanyar dakunan gwaje-gwaje masu izini.
Bayanan hoto na musamman a cikin hotunan radiology da CT na mutane tare da alamun sun hada da ƙwayoyin cuta na gilashi kuma ba a lura da fuses na motsi ba.
Radiologicalungiyar Radiology ta Italiya tana tattara bayanan bayanan kan layi na binciken hoto na ƙwayoyin cuta.
Saboda haɗuwa da wasu cututtuka kamar adenoviruses, yin hoto ba tare da tabbatarwar PCR na ƙarshe ba yana da iyakancewa don gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na ƙirjin da PCR, yana nuna cewa yayin da ba a amfani da hoto sosai don wannan kamuwa da cuta ba, yana da saurin gaske kuma ana iya amfani da shi a cikin yankunan annoba a matsayin kayan aikin bincike.
An haɓaka cibiyoyin sadarwa na juyawa na AI don gano siffofin hoto na kwayar cutar a cikin hotunan radiology da CT.
Dabaru don hana yaduwar cutar sun haɗa da kiyaye tsabtace jiki na mutum, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba, tari ko hancin da aka yi a cikin tawul da kuma jefa tawul ɗin da sauri a cikin kwandon shara.
An shawarci waɗanda ke da yiwuwar kamuwa da cutar da su yi amfani da abin rufe fuska a wuraren jama'a.
Hakanan ana ba da shawarar nisantar jiki don hana yaduwar cutar. Yawancin gwamnatoci sun iyakance duk balaguron da ba dole ba zuwa ƙasashe da yankuna da cutar ta shafa.
Koyaya, a yawancin sassan duniya, kwayar cutar ta kai matakin yaduwar al'umma.
Wannan yana nufin cewa cutar tana yaduwa tsakanin al'ummomi kuma wasu membobin al'umma ba su san inda ko ta yaya suka kamu ba. Ana ba da shawarar masu ba da sabis na kulawa waɗanda ke kula da mai cutar su yi amfani da ƙa'idodin kariya, kiyaye kariya ta tuntuɓar mutum da kuma amfani da kayan kariya na ido. Binciken bayanan tuntuɓar mai cutar shine hanya mai mahimmanci da hukumomin kiwon lafiya ke amfani da ita don gano asalin kamuwa da cutar da hana ƙarin kamuwa da cuta.
Amfani da bayanan wurin wayar salula ta gwamnatoci don wannan dalili ya haifar da damuwa game da tsare sirri, wanda Amnesty International tare da wasu kungiyoyi sama da 100 suka ba da sanarwar da ke kira da a takaita irin wannan sa ido.
An yi amfani da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar yin amfani da su da son rai, kuma tun daga 7 ga Afrilu, 2020, sama da ƙungiyoyi 12 na ƙwararru suna aiki kan hanyoyin abokantaka na sirri, kamar amfani da Bluetooth don shiga cikin wayar tare da masu amfani kusa.
Masu amfani za su sami saƙo da ke tambayar su ko sun taɓa saduwa kai tsaye da mutumin da ya gwada tabbatacce ga COVID-19.
Babu riga-kafi ga COVID-19, duk da haka kungiyoyi daban-daban suna aiki don samun shi.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka da Cututtuka ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla dakika 20, musamman bayan sun je gidan wanka ko idan hannayensu sun kasance da datti sosai, kafin cin abinci, bayan feshi, tari ko atishawa.
Domin ana kashe kwayar cutar a waje da jikin mutum ta hanyar sabulu na yau da kullun, saboda sabulu yana lalata murfin kariya.
CDC ta kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke da giya da kashi 60% na giya idan ba a sami sabulu da ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutane su guji taɓa idanu, hanci ko baki ba tare da wanke hannayensu ba.
Za a iya kashe kwayoyin cuta tare da wasu magunguna (minti daya na maganin rigakafi ga matakan stainless steel) wanda ya hada da 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide da 0.2-7.5% poidone iodine.
Sauran mafita kamar Benzalkonium chloride da chloroxydine gluconate ba su da tasiri sosai.
A cewar shawarar CDC, idan an tabbatar da cewa mutum yana da cutar COVID ko kuma yana cikin wani wuri kamar ofishi ko cibiyar kulawa, duk wuraren da marasa lafiya ke amfani da su, kamar ofisoshin, sabis na kiwon lafiya, wuraren da jama'a ke amfani da su, kayan aikin lantarki na yau da kullun kamar su allunan, fuskokin taɓawa, allon mabuɗin, sarrafawa ta nesa da na'urorin ATM, ya kamata a tsabtace su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe hanci da baki da tawul ko gwiwar hannu yayin tari ko hancin, kuma su zubar da tawul ɗin takarda nan da nan.
Ana ba da shawarar sanya abin rufe fuska na tiyata ga mutanen da ke da yiwuwar kamuwa da cutar saboda abin rufe fuska na iya rage girma da nisa na zubar da ruwa yayin magana, hancinsa da tari.
Hukumar Lafiya ta Duniya ta ba da jagororin lokacin da kuma yadda za a yi amfani da masks.
"A cewar Stephen Griffin, masanin kwayar cutar a Jami'ar Leeds, ""saka abin rufe fuska na iya rage sha'awar mutane su taɓa fuskokinsu, wanda shine babban dalilin watsa kamuwa da cuta, ta hanyar zama a hannu. "" Ana kuma ba da shawarar rufe fuska ga mutanen da ke kula da masu cutar da ake zargi. "
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutane masu lafiya su yi amfani da abin rufe fuska ne kawai idan suna cikin haɗarin haɗari, misali suna kula da mutanen da ke fama da COVID-19, kodayake ta tabbatar da cewa yin amfani da abin rufe fuska na iya taimaka wa mutane kada su taɓa fuskarsu.
Kasashe da dama sun fara karfafawa jama'a gwiwa don sanya abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na likitanci wanda ba a yi shi da masana'anta ba. Musamman, China ta ba da shawarar yin amfani da abin rufe fuska na likita sau ɗaya don mutane masu lafiya a cikin al'umma, musamman a kusanci da mita 1 (ƙafa 3 ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska a cikin sufuri na jama'a ko wuraren da jama'a ke yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su samar da abin rufe fuska na masana'anta a gida da wanke wanka na yau da kullun.
Jamhuriyar Czechoslovakia ta ba da izinin shiga wuraren jama'a ba tare da sanya abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin da yake cikin wuraren jama'a don kare kansa da sauran mutane.
Gwamnatin Austria ta tilasta sanya abin rufe fuska ga waɗanda ke shiga kantin kayan abinci.
Isra'ila ta bukaci dukkan 'yan ƙasa da su sanya abin rufe fuska yayin da suke wuraren jama'a.
Taiwan, wanda ya kai ƙarfin samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ya ba da umarnin amfani da abin rufe fuska ga fasinjojin jiragen ƙasa da na bas na tsakanin birni daga 1 ga Afrilu.
A Panama, ana buƙatar sanya abin rufe fuska lokacin fita waje, kuma waɗanda ba za su iya yin abin rufe fuska ba dole ne su yi shi a gida.
Ana amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa tsakanin jama'a (wanda kuma aka sani da nesa ta jiki) ya ƙunshi matakan kula da kamuwa da cuta da aka tsara don rage kamuwa da cuta ta hanyar rage hulɗa tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawa na tafiya; da kuma dakatar da makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane na iya kiyaye nesa ta hanyar kasancewa a gida, takaita tafiya, guje wa wuraren da jama'a ke yawa, amfani da yanayin rashin tuntuɓar mutum da kiyaye nesa da wasu.
Yawancin gwamnatoci a halin yanzu sun tilasta ko kuma suna ba da shawarar nisantar da jama'a a yankunan da ke cikin keɓewa waɗanda ke fama da cutar.
Matsakaicin yawan jama'a da hukumomin gwamnati da kungiyoyin kiwon lafiya a Amurka suka ba da shawarar ya ragu da sauri daga mutane 250 (idan babu wasu cututtukan COVID-19 a yankin) zuwa 50 da 10 a gaba.
" Tun daga 22 ga Maris, 2020, Jamus ta haramta tarurruka na mutane fiye da biyu. Masu yawan ciwon sukari da mutanen da ke fama da cututtukan da ke tattare da su kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini da raunin tsarin garkuwar jiki suna cikin haɗarin kamuwa da cutar da kuma rikitarwa, kuma CDC ta ba da shawarar su zauna a gida idan za su iya a wuraren da ke fama da cutar. A ƙarshen Maris, 2020, WHO da sauran kungiyoyin kiwon lafiya sun maye gurbin kalmar ""nuna nesa"" da ""nuna nesa ta jiki"" don nuna cewa manufar ita ce rage hulɗa ta jiki yayin da ake ci gaba da hulɗa ta hanyar yanar gizo ko ta nesa. "
Amfani da kalmar "nisanci na zamantakewa" ya kawar da ra'ayin cewa mutane su shiga cikin ƙarin keɓewar zamantakewar jama'a maimakon ƙarfafa su su haɗu da wasu ta hanyar madadin. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i a lokacin annobar. "
Wadannan sun hada da shawarar da za a iyakance jima'i ga abokin tarayya wanda ba shi da alamun cutar.
An shawarci mutanen da ke dauke da COVID-19 da kuma wadanda ake zargi da kamuwa da cutar da su keɓe kansu.
Kungiyoyin kiwon lafiya sun ba da cikakkun hanyoyin da za a bi don ware kai. Yawancin gwamnatoci sun ba da shawarar ko kuma sun ba da shawarar keɓe kai ga duk mutanen da ke zaune a yankunan da cutar ta kamu.
An ba da umarnin keɓe kai mafi tsauri ga ƙungiyoyin haɗari.
An shawarci mutanen da suka kasance a cikin hulɗa tare da mutumin da ke da cutar COVID-19 da waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki da ke da yaduwar cutar don keɓe kansu na kwanaki 14 daga lokacin da suka kasance a cikin hulɗa ta ƙarshe.
Dabarun sarrafa yaduwar cuta sun haɗa da iyakancewa ko ragewa da rage yawan yaduwar cuta.
Ana sanya takunkumi a farkon lokacin yaduwar cutar da nufin ganowa da ware mutanen da ke dauke da cutar da kuma gabatar da wasu matakan kula da cutar da allurar rigakafi don dakatar da yaduwar cutar ga wasu mutane.
Lokacin da ba za a iya hana cutar ba, za a iya yin ƙoƙari don ragewa: ana ɗaukar matakan rage saurin yaduwar kwayar cutar da rage tasirinsa a kan tsarin kiwon lafiya da al'umma.
Ana iya amfani da haɗuwa da matakan ƙuntatawa da ragewa a lokaci guda.
Don kawar da cutar, ana buƙatar ƙarin matakan da za a ɗauka don rage yawan adadin cutar zuwa ƙasa da 1. Wani ɓangare na kula da cutar shine rage girman cutar, wanda kuma ake kira daidaitawa da cutar.
Wannan zai rage haɗarin yawan ayyukan kiwon lafiya kuma ya ba da ƙarin lokaci don samar da allurar rigakafi da magani.
Hanyoyin da ba na magani ba waɗanda za su iya sarrafa yaduwar kwayar cutar sun haɗa da matakan rigakafin mutum, kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan jama'a don nisantar da jiki kamar rufe makarantu da soke taron jama'a; haɗin gwiwar jama'a don ƙarfafa karɓar da shiga cikin irin waɗannan ayyukan; da matakan muhalli kamar tsabtace farfajiya.
Sauran ƙasashe ma sun ɗauki matakai daban-daban don iyakance yaduwar cutar.
Koriya ta Kudu ta koma ga tantancewar jama'a da keɓewar gida, tare da gargadi game da motsi da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafi na kuɗi ga masu kamuwa da cutar da suka keɓe kansu kuma ta sanya manyan tarar mutane waɗanda suka yi watsi da keɓewar.
Taiwan ta kara samar da abin rufe fuska kuma ta sanya manyan tarar don hana kayan aikin likita.Gaskiya da aka yi a Burtaniya da Amurka sun nuna cewa rage yaduwar cutar (ragewa amma ba dakatar da saurin yaduwar cutar ba) da kuma raguwa (juyawa saurin yaduwar cutar) suna da manyan kalubale.
Manufofin daidaitawa na iya rage ƙimar buƙatun kiwon lafiya da kashi biyu bisa uku da mutuwar da rabi, amma har yanzu suna haifar da dubunnan dubban mutuwar da wuce ƙarfin tsarin kiwon lafiya.
Ana iya yin amfani da hanawa, amma dole ne a ci gaba da yin hakan har sai cutar ta sake yadawa tsakanin mutane (ko har sai an samar da allurar rigakafi, duk wanda ya zo da wuri), in ba haka ba, cutar za ta sake tashi kuma ta sake yaduwa idan an sauƙaƙe matakan.
Matsayi na dogon lokaci don magance cutar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ana ci gaba da ƙoƙari, gami da gwajin magungunan da ake dasu.
Samun maganin rigakafin cutar ba tare da takardar sayan magani ba, shan ruwa da hutawa na iya zama tasiri wajen rage alamun.
Dangane da tsananin cutar, magani tare da oxygen, ruwan sha na cikin jini da kuma taimakon numfashi na iya zama dole.
Yin amfani da kwayoyin steroid na iya kara tsananta rikitarwa.
Yawancin magungunan da aka riga aka yi amfani da su don magance wasu cututtukan ƙwayoyin cuta ana nazarin su don amfani da su don magance COVID-19.
" WHO ta kuma ce wasu ""magungunan gida da na gargajiya"" na iya rage rikice-rikicen da SARS-COVID-19 ke haifarwa. "
Ƙara ƙarfin aiki da aiwatar da kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 an bayyana su a matsayin muhimmin mataki na WHO don magance cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) da Ofishin Yankin Turai na Hukumar Lafiya ta Duniya (WHO) sun ba da jagororin ga asibitoci da sabis na kiwon lafiya da kulawa ta farko don canza albarkatu a matakai daban-daban, gami da mai da hankali kan sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, soke hanyoyin zaɓi idan ya yiwu, warewa da keɓe marasa lafiya masu cutar COVID-19 da haɓaka ƙwarewar kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka yawan injunan iska da gadaje.
Akwai ra'ayoyi daban-daban game da asalin mutumin da ya fara kamuwa da cutar (wanda ake kira mai haƙuri na sifili).
Ana iya samun labarin farko na sabon coronavirus a Wuhan, Hubei da China a ranar 1 ga Disamba, 2019.
A cikin wata guda, yawan masu kamuwa da cutar coronavirus a Hubei ya karu a hankali.
Yawancin waɗannan sun shafi kasuwar sayar da abincin teku ta Hunan inda ake sayar da dabbobi masu rai, kuma wata ka'idar ita ce cewa kwayar cutar ta samo asali ne daga waɗannan nau'ikan dabbobi; ko kuma, ta zoonotic. An gano tarin huhu tare da sanadin da ba a sani ba a ranar 26 ga Disamba kuma an kula da su a asibitin lardin Hubei na likita Zhang Jian, kuma an sanar da shi ga Cibiyar Kula da Cututtuka ta Wuhan a ranar 27 ga Disamba.
"A ranar 30 ga Disamba, wasu likitoci a babban asibitin Wuhan sun gargadi abokan aikin su game da wani "" SARS-like coronavirus. ""
Likitoci takwas, ciki har da Li Wenliang, sun yi tambayoyi daga 'yan sanda saboda yada jita-jita, kuma wani likita, mai suna Ifen, ya tsawata wa manyan jami'ansa saboda ƙara matakin faɗakarwa.
Daga baya, Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba, kuma ta sanar da Hukumar Lafiya ta Duniya.
An ba da rahoton adadin mutane da yawa da ke fama da cutar nimoniya a farkon watan Janairu ga jami'an lafiya a Wuhan, wanda ya haifar da fara bincike. A farkon farkon barkewar cutar, yawan masu kamuwa da cutar ya ninka kusan kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan kasar Sin saboda bikin sabuwar shekara da kuma cewa Wuhan tana daya daga cikin cibiyoyin sufuri da kuma manyan hanyoyin jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 da suka kamu da cutar, ciki har da mutum biyu a Beijing da mutum daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa a ranar 20 ga Janairu, 2020, mutane 6,174 sun kamu da alamun cutar. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a duniya tare da yawan adadin mutanen da suka kamu da cutar. A ranar 9 ga Afrilu, 2020, an samu rahotanni sama da miliyan 1.61 a duk duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
An bayar da rahoton aƙalla wani kamuwa da cutar a cikin ƙasashe da yankuna kusan 200.
Saboda cutar a Turai, ƙasashe da yawa a cikin yankin Schengen sun iyakance motsi kyauta kuma sun kafa ikon kan iyaka.
Amsoshin ƙasa sun haɗa da matakan ƙuntatawa kamar keɓewa (a ƙarƙashin taken umarnin zama a gida, umarnin mafaka a gida ko keɓewa gaba ɗaya) da ƙuntatawa.Zuwa 2 ga Afrilu, kusan mutane miliyan 300 a Amurka, ko kusan kashi 90% na yawan jama'a suna ƙarƙashin wani nau'in keɓewar gida, fiye da miliyan 50 a cikin Philippines, kusan miliyan 59 a Afirka ta Kudu, da miliyan 1.3 a Indiya suna cikin keɓewar gida.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duk duniya sun shiga cikin wasu nau'ikan keɓewa, bayan kwana biyu, adadin ya kai biliyan 2.6, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An tabbatar da farkon cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an gano farkon cutar a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ya gano tarin marasa lafiya da cutar huhu da ba a san dalilin cutar ba a ranar 26 ga Disamba, kuma nan da nan a ranar 27 ga Disamba, asibitin ya sanar da Cibiyar Kula da Cututtuka ta Jiang Han ta Wuhan.
Gwajin kwayoyin halittar farko na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar SARS-CoV-2.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da Hukumar Lafiya ta Duniya a ranar.
"Da fitar da sanarwar, 'yan sanda sun gargadi likitocin Wuhan game da ""fitar da jita-jita"" game da annobar. "
" Hukumar Lafiya ta Kasa ta kasar Sin ta fara da'awar cewa babu ""tabbacin tabbatacce"" na yaduwar cutar daga mutum zuwa mutum. "
"A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da kamfen mai ƙarfi wanda daga baya Babban Sakataren Jam'iyyar Kwaminis ta China Xi Jinping ya bayyana a matsayin ""yaƙin mutane"" don dakile yaduwar cutar. "
"A lokacin da aka bayyana shi a matsayin ""karkashin kariya mafi girma a tarihin ɗan adam"", an ba da sanarwar belin lafiya a ranar 23 ga Janairu, wanda ya dakatar da shiga da fita daga Wuhan, ya bazu zuwa biranen 15 na Hubei, yana shafar kusan mutane miliyan 57. "
An haramta amfani da motocin mutane a cikin birnin.
An rufe bikin Sabuwar Shekarar Sin (Janairu 25) a yankuna da dama.
Jami'ai sun kuma sanar da gina asibiti na wucin gadi, Huoshenshan Hospital, wanda aka kammala a cikin kwanaki 10.
Daga baya, an gina wani asibiti mai suna Leishenshan don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu cibiyoyi 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta aiwatar da karin matakan dakile yaduwar COVID-19, gami da bayar da takardun kiwon lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu sun rufe a duk faɗin ƙasar.
Yankunan Hong Kong da Macao sun ɗauki matakai da yawa, musamman game da makarantu da jami'o'i.
An aiwatar da matakan nesa a yankuna da dama na kasar Sin.
An sanya takunkumin hana zirga-zirga a ciki da wajen lardin Hubei.
An rufe sufuri na jama'a kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin China.
An sanya dokar hana fita ta gari a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan takunkumin fita daga gida. Bayan barkewar cutar a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar shiga daga wasu kasashe.
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk matafiya na kasa da kasa da ke shigowa birnin. A ranar 23 ga watan Maris, babban yankin kasar Sin yana da mutum daya da ya kamu da cutar a cikin gida, wanda ya kamu da cutar kwanaki biyar da suka gabata ta hanyar matafiyi da ya dawo Guangzhou daga Wuling.
A ranar 24 ga watan Maris, 2020, Li He Chiang, Firayim Ministan kasar Sin, ya ba da rahoton cewa an dakatar da yaduwar cututtukan a cikin gida kuma an sarrafa cutar a kasar Sin.
A wannan ranar, an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan aiwatar da dokar keɓewa.Ma'aikatar Harkokin Wajen ta kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigar da mazauna da masu biza daga kasar daga ranar 28 ga Maris, ba tare da bayyana cikakken bayani game da tsawon lokacin da wannan manufar za ta ci gaba ba.
Wadanda suke son shiga kasar Sin dole ne su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar Sin.
Gwamnatin kasar Sin ta karfafawa masu kasuwanci da masana'antu gwiwa su fara aiki daga ranar 30 ga watan Maris, tare da samar da tallafin kudi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki ta kasa da za a yi na mintuna uku a karfe 10:00 na ranar 4 ga Afrilu, daidai da bikin Qing Ming, kodayake gwamnatin tsakiya ta nemi iyalai su kiyaye tazara ta jiki ta hanyar yanar gizo don hana sabon yaduwar COVID-19.
An tabbatar da cewa COVID-19 ya fara yaduwa daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar Kula da Lafiya da Kula da Lafiya ta kasar ta ba da rahoton karuwar karuwar masu kamuwa da cutar a ranar 20 ga Fabrairu, wanda galibi ya samo asali ne daga taron da aka yi a Daegu don sabon motsi na addini da ake kira Shincheonji Church of Christ.
Masu goyon bayan Shincheonji da suka ziyarci Daegu daga Wuhan suna zargin asalin kwayar cutar.
Tun daga ranar 22 ga watan Fabrairu, a cikin mutane 9,336 na Ikilisiya, an bayar da rahoton alamun cutar a cikin mutane 1,261, ko kusan 13%.
A ranar 28 ga watan Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, wanda ya kai 3,150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka samu rahoton gwajin kwayar cutar coronavirus na sojoji uku.
Hakanan an shafi lokacin jirgin sama, wanda hakan ya canza. Shirin Koriya ta Kudu shine mafi girma kuma mafi kyawun tsari a duniya wanda ya sami nasara wajen tantance yawan jama'a don cutar da ke tattare da keɓaɓɓun mutane da kuma bin diddigin da ke tattare da keɓaɓɓun mutane.
Hanyoyin tantancewa sun haɗa da yin rahoton alamun bayyanar cututtuka na tilas ga sabbin masu zuwa daga jiragen sama na ƙasa da ƙasa ta hanyar aikace-aikacen hannu, gwajin jirgi don cutar wanda sakamakon sa zai bayyana a rana mai zuwa, da haɓaka ƙarfin gwaji zuwa 20,000 a kowace rana.
Shirin Koriya ta Kudu ya kasance mai nasara wajen sarrafa yaduwar cutar duk da cewa ba a kebe biranen gaba daya ba. Da farko, al'ummar Koriya ta Kudu sun kasance masu tsaka tsaki a matsayin martani ga Shugaba Moon Jae-in game da rikicin.
Yawancin 'yan ƙasar Koriya sun sanya hannu kan takarda don yin hukunci a kan Mun saboda abin da suka ga rashin kulawar gwamnati a cikin kula da yaduwar cutar, yayin da wasu suka ba da yabo ga yadda ta amsa.
An bayar da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu kamuwa da cutar a rana ɗaya a cikin makonni huɗu a ranar 23 ga Maris.
A ranar 29 ga watan Maris, an ba da rahoton cewa daga ranar 1 ga Afrilu, duk sabbin masu shigowa daga ƙasashen waje za su shiga keɓewa na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimako daga ƙasashe 121 don gwajin cutar.
Iran ta sanar da farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda mutane biyu suka mutu a ranar, a cewar ma'aikatar lafiya da ilimi.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da sauran abubuwan al'adu, wasanni da sallar Juma'a da kuma dakatar da jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ware Riyal tiriliyan 5 don yaki da cutar.
A ranar 26 ga Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na keɓe wuraren da cutar ta bulla, kuma mutane ne kawai za su keɓe kansu.
An sanar da tsare-tsaren iyakance zirga-zirgar tafiye-tafiye a cikin watan Maris, duk da haka, zirga-zirgar ababen hawa tsakanin biranen kasar sun ci gaba da yawa kafin Sabuwar Shekarar Iran.
Wuraren ibada na Shi'a a Qum sun kasance a bude ga masu ziyara har zuwa 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin wasu da'awar da ake yi na ɓoyewa game da yaduwar cutar a Iran, fiye da ƙasashe goma sun danganta cututtukan da suka kamu da cutar zuwa Iran har zuwa 28 ga Fabrairu, wanda ke nuna cewa cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta ruwaito har zuwa wannan ranar.
An rufe majalisar dokokin Iran, kuma 23 daga cikin mambobi 290 sun ba da rahoton cewa sun gwada cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, mai lura da kare hakkin dan adam ya bukaci hukumomin kurkuku na Iran da su saki masu kare hakkin dan adam da aka tsare saboda rashin jituwa cikin lumana ba tare da wani sharadi ba, tare da sakin dukkan fursunonin da suka cancanci a saki su na dan lokaci.
An bayyana cewa haɗarin yaduwar cutar ya fi girma a cikin wuraren da aka rufe kamar cibiyoyin tsare mutane waɗanda ba su da isasshen sabis na kiwon lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutum 100 a rana ɗaya, wanda shine mafi girma a cikin ƙasar tun barkewar cutar.
An sanar da mutuwar aƙalla 'yan siyasa 12 da tsoffin jami'an gwamnati a Iran har zuwa 17 ga Maris.
Zuwa 23 ga watan Maris, Iran tana da sabbin mutane 50 da ke kamuwa da cutar coronavirus da kuma mutuwar mutum daya a kowace awa.
A cewar wani jami'in Hukumar Lafiya ta Duniya, adadin masu kamuwa da cutar a Iran ya ninka na baya sau biyar.
An kuma ba da shawarar cewa takunkumin da Amurka ta sanya wa Iran na iya yin tasiri ga ikon kuɗin ƙasar don amsawa da kyau ga yaduwar cutar.
Babban Kwamishinan kare hakkin bil'adama na Majalisar Dinkin Duniya ya yi kira da a rage matsin lamba kan tattalin arzikin kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, daidai lokacin da aka bayyana gwajin da aka yi wa wasu 'yan yawon bude ido' yan China biyu da ke Roma don SARS-CoV-2.
Yawan masu kamuwa da cutar ya karu cikin sauri, wanda ya tilasta wa gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama zuwa da daga China da kuma ayyana dokar ta baci.
An gano wasu mutane da ba su da alaƙa da COVID-19 daga baya, wanda ya fara daga 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da amincewa da sabuwar doka don dakile yaduwar cutar, wanda ya haɗa da keɓe mutane sama da 50,000 a yankuna 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "An haramta shiga da fita a yankunan da cutar ta bulla".
"An riga an bayar da umarnin da ya dace don dakatar da ayyukan aiki da abubuwan wasanni a waɗannan yankuna. ""A ranar 4 ga Maris, bayan mutuwar mutane 100 a Italiya, gwamnati ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar. ""
Duk manyan wasannin wasanni, gami da wasan kwallon kafa na Serie A, an gudanar da su a bayan gida har zuwa Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni na wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Kent ya ba da umarnin dakatar da kusan duk ayyukan kasuwanci ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Anesthesiology, Anesthesia, Rehabilitation and Intensive Care (SIAARTI) ta Italiya ta ba da shawarwarin ɗabi'ar likita game da ladabi uku da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin ƙasa mafi yawan masu cutar coronavirus a duniya, tare da rahoton mutuwar 3,405 a rana ɗaya sakamakon cutar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama tara na soja da kayan aikin likita zuwa Italiya.
Tun daga ranar 5 ga Afrilu, an tabbatar da mutane 128,948, mutuwar 15,887, da kuma warkewar mutane 21,815, mafi yawan su a yankin Lombardy.
Wani rahoto daga CNN ya nuna cewa haɗuwa da yanayin rashin lafiyar Italiya da rashin iya gwada duk mutanen da suka kamu da cutar har zuwa yau na iya haifar da yawan mutuwar.
Amsar da Burtaniya ta bayar game da cutar da farko ta kasance ɗayan ƙasashe masu sanyi da cutar ta fi shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'i na nisantar zamantakewa ko matakan keɓewa ga jama'a a kan 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati saboda rashin saurin aiki da kuma tsananin amsawa ga damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson, a cikin jawabinsa, ya hana tafiye-tafiye da keɓaɓɓun zamantakewar jama'a, yana kira ga mutane su yi aiki daga gida idan za su iya kuma su guji zuwa wurare kamar mashaya, gidajen abinci da silima.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa dole ne a rufe duk wuraren nishaɗi kamar mashaya da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan ma'aikatan su kashi 80 cikin ɗari na albashin su har zuwa iyakar dala 2,500 na Australiya a wata don hana rashin aikin yi ya karu a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar cewa za a ƙara tsaurara matakan nisantar zamantakewar jama'a, hana tarurruka sama da mutane biyu, da kuma iyakance tafiya da ayyukan waje zuwa iyakar abin da ya zama dole.
Waɗannan ƙuntatawa za su iya amfani da su ta hanyar 'yan sanda, ta hanyar tara kuɗi da kuma tarwatsa al'ummomi, sabanin matakan da suka gabata.
"An ba da umarnin rufe yawancin kasuwancin, ban da wasu keɓaɓɓu ga kasuwancin da aka ɗauka ""muhimmanci"", gami da manyan kantuna, kantin magani, bankuna, shagunan kayan daki, tashoshin mai da garages. "
A ranar 20 ga Janairu, an tabbatar da cutar COVID-19 ta farko a jihar Arewa maso Yammacin Pacific a Washington a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin aiki na Fadar White House na COVID-19 a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya da kuma sanya takunkumi ga matafiya da ke shigowa daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a a gwamnatin Amurka, ta sanar da cewa ta samar da kayan gwajin ta.
Duk da haka, Amurka ta fara gwajin gwaji a hankali, wanda ya sanya ainihin yaduwar cutar ta cutar ta zama mara tabbas.
Sakamakon gwajin da aka yi a farkon watan Maris (wanda ake buƙatar takardar sayan magani) an yi watsi da shi saboda rashin ingancin kayan gwaji, rashin amincewa da kayan gwaji na gwamnati (ta hanyar jami'o'i, kamfanoni da asibitoci) da ƙarshen Fabrairu da kuma ƙuntatawa ga waɗanda suka cancanci yin gwaji.
A ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje kasa da 4,000 a Amurka.
Atlantic ya ba da rahoton cewa an gudanar da gwaje-gwaje ƙasa da 14,000 har zuwa 13 ga Maris.
A ranar 22 ga Maris, Associated Press ta ruwaito cewa mutane da yawa da ke da alamun rashin lafiya da kuma umarnin likita don yin gwaji sun jira na tsawon sa'o'i da kwanaki don yin gwajin. Bayan rahoton farko na mutuwar a Amurka a ranar 29 ga Fabrairu, Gwamnan jihar, Jay Inslee, ya ayyana dokar ta baci ta jihar, matakin da sauran jihohi suka bi nan da nan.
Makarantu a yankin Seattle sun rufe azuzuwan su a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, ƙungiyar masana ilimin cututtuka a Kwalejin Royal London sun ba da tsinkaya game da tasirin coronavirus a Amurka.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Taimako ta Amincewa da Shirye-shiryen da ke ba da dala biliyan 8.3 don tallafawa ayyukan tarayya da ake buƙata don magance cutar.
Kamfanoni sun sanya takunkumin tafiya ga ma'aikata, sun soke taro kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An rufe abubuwan da suka faru da wasannin motsa jiki. A ranar 11 ga Maris, Trump ya sanya takunkumin hana balaguro na kwanaki 30 ga yawancin ƙasashen Turai, ban da Burtaniya, wanda ya fara aiki a ranar 13 ga Maris.
Kashegari, ya kafa takunkumi musamman ga Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda ya sanya kudaden tarayya su kasance masu ba da amsa ga rikicin.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin Amurka sun rufe ko rage awoyin aiki don rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a duk jihohi 50 da yankin Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa New York City tana da mutane 10,700 da suka kamu da cutar coronavirus, wanda ya fi yawan adadin mutanen da ke Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar zamantakewar jama'a tana da tasiri, saboda ƙididdigar yadda adadin masu kamuwa da cutar ke ninkawa ya ragu daga kwanaki 2 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an samu mutum 32,308 da suka kamu da cutar a birnin New York City, kuma mutane 672 sun mutu sakamakon kamuwa da cutar. A ranar 26 ga watan Maris, an bayar da rahoton cewa Amurka tana da mafi yawan masu kamuwa da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an samu mutane 4,003,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Trump, shugaban Amurka ya yanke shawarar tsawaita jagororin nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan ranar, USNS Comfort, wani jirgin asibiti mai ɗaukar marasa lafiya kusan 1,000 ya tashi a New York.
A ranar 3 ga Afrilu, Amurka ta karya rikodin mutuwar mutum 884 da cutar coronavirus ta kashe a cikin awanni 24.
A ranar 3 ga Afrilu, a jihar New York, yawan masu kamuwa da cutar ya wuce 100,000. An soki Fadar White House saboda watsi da barazanar da kuma takaita umarnin da jami'an kiwon lafiya da masana kimiyya suka bayar don daidaita bayanan jama'a da kuma fitar da bayanai game da cutar tare da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya gamsuwa da kulawar rikici na Trump a cikin jam'iyyun ya zama kashi biyu.
Wasu jami'an Amurka sun soki dogaro da shigo da kayayyaki na asali daga China, gami da kayayyakin kiwon lafiya.
An yi nazarin tsarin tafiye-tafiyen jirgin sama don tsarawa da kuma hango alamun yaduwar kwayar cutar kuma an buga shi a cikin mujallar Medicine Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Transportungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami yawan fasinjoji daga Wuhan.
An ba da rahoton cewa Dubai, Sydney da Melbourne sune wuraren da aka fi so ga matafiya daga Wuhan.
Bali ita ce birni na farko a cikin biranen 20 da aka fi so, yayin da biranen Ostiraliya suka kasance mafi shirye-shirye. Ostiraliya ta sanar da shirin ta na gaggawa don sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Sanarwar ta ce har yanzu ba a gano bayanai da yawa game da COVID-19 ba kuma Ostiraliya za ta jaddada sarrafa kan iyakoki da sadarwa don magance cutar.
A ranar 21 ga Maris, an ayyana dokar ta baci ta kare dan adam a Ostiraliya.
Saboda tsauraran matakan killace zirga-zirgar jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyyarsu daga yankin, musamman ta hanyar jiragen sama na haya daga kasar da aka fara da izinin hukumomin kasar Sin.
Kanada, Amurka, Argentina, Jamus da Thailand na daga cikin kasashen farko da suka fara aiwatar da shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta mayar da wasu 'yan kasar ta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta fitar da 'yan kasar Brazil 34 ko danginsu tare da' yan Poland hudu, da Sinawa daya da kuma dan kasar Indiya daya.
'Yan ƙasar Poland, China da Indiya sun sauka daga jirgin a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan kasar Brazil da suka tafi Wuhan a wani sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan Kanada 215 (mutanen 176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta yi haya) daga Wuhan kuma an kai su CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama tare da mutane 185 na Kanada daga Wuhan ya sauka a CFB Trenton.
Hukumomin Austria sun kai mutane 277 zuwa gidan yarin tsibirin Kirsimeti, wanda aka canza shi zuwa wurin keɓewa, a ranar 3 da 4 ga Fabrairu, inda suka zauna na kwanaki 14.
Jirgin saukar da New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinsa (gami da mutanen da ke daga Ostiraliya da Pacific) an kwashe su a sansanin jiragen ruwa na Whangaparawa a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin da ke dauke da fasinjojin Kanada 129 da aka kwashe daga jirgin ruwan Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta yi kokarin kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman jirgin saman Afirka ta Kudu ya dawo da' yan kasar 122.
An gudanar da gwajin likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke da alamun cutar coronavirus don rage haɗarin.
Sai kawai mutanen Afirka ta Kudu da aka ba da rahoton gwajin su ba shi da kyau sun koma ƙasar.
Sakamakon gwajin duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, ma'aikatan otal,' yan sanda da sojoji da suka hada da aikin jin kai, waɗanda aka sanya su cikin keɓewa na kwanaki 14 a cikin Ranch Resort don taka tsantsan, sun kasance marasa kyau.
A ranar 20 ga watan Maris, Amurka ta janye wasu dakarunta daga Iraqi saboda cutar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen China ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako ga sassan da ke fama da cutar coronavirus a kasar Sin. Wata kungiya a yankin Chicago ta samu nasarar aika da abin rufe fuska N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu. Hukumar Agaji ta Kai tsaye (Direct Relief), tare da hadin gwiwar FedEx, ta aika da abin rufe fuska 20,000 da sauran kayan aikin kulawa da kai, gami da safar hannu da tufafi, zuwa asibitin Union Hospital na Wuhan ta hanyar gaggawa ta hanyar jirgin sama har zuwa ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga Hukumar Lafiya ta Duniya don tallafawa binciken rigakafi da hanyoyin magance su da tallafawa "mutane masu haɗari a Afirka da Kudancin Asiya".
Interaksiyon ta ruwaito cewa gwamnatin China ta ba da gudummawar masks 20,000 ga Philippines a ranar 6 ga Fabrairu, sannan Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayayyakin kiwon lafiya sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu miliyan 18 ga China, Jamus ta aika da kayayyakin kiwon lafiya da dama da suka hada da kayan kwalliya 10,000, kuma Amurka ta aika da tan 17.8 na kayayyakin kiwon lafiya zuwa China tare da alkawarin tallafin kudi na dala miliyan 100 ga kasashen da ke fama da cutar.
A watan Maris, China, Cuba da Rasha sun tura kayan aikin likita da kwararru zuwa Italiya don taimakawa wajen magance barkewar cutar coronavirus.
Shahararren dan kasuwa Jack Ma ya aika da kayan gwaji miliyan 1.1, masks miliyan 6 da rigunan kariya 60,000 don kungiyar tarayyar Afirka ta rarraba su zuwa Addis Ababa, Habasha.
Ya ci gaba da aikawa da kayan gwaji 5,000, masks 100,000 da na'urorin numfashi 5 zuwa Panama.
"Mu"" mun kuma ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun bayyana damuwarsu game da abin rufe fuska da kayan bincike na kasar Sin. "
Misali, Spain ta daina amfani da kayan gwajin da aka yi a China wanda ke da daidaito na kashi 30 cikin ɗari, yayin da Netherlands ta yi nuni da abin rufe fuska na China 600,000 da ke da lahani.
Belgium ta ƙi karɓar abin rufe fuska 100,000 da ba za a iya amfani da su ba, saboda ana tunanin cewa abin rufe fuska daga China ne, amma a zahiri daga Colombia ne.
A gefe guda kuma, an samu tallafi daga kasar Sin a sassan Latin Amurka da Afirka. Tun daga ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan tallafi na gaggawa ga kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi na sarrafawa da kuma dakile annobar.
"WHO ta kwatanta wannan yanayin da barkewar cutar SARS a 2002-2004 lokacin da aka zargi jami'an kasar Sin da yin asirin bayanai, wanda hakan ya shafi kokarin hana yaduwar cutar, kuma a cikin rikicin da ake ciki, gwamnatin tsakiya ta ""yi amfani da sanarwar da aka saba kafin hutun Sabuwar Shekarar Rana don hana yaduwar cutar"."
" A ranar 23 ga watan Janairu, wakilin Hukumar Lafiya ta Duniya, Guden Gally, ya bayyana cewa, "Wannan ba shawarar Hukumar Lafiya ta Duniya ba ce" amma "alamu ne masu mahimmanci na ƙaddamar da ƙudurin dakile annobar a inda ta fi yawa a ko'ina", yana mai cewa, "ba a taɓa yin irinta ba a tarihin lafiyar jama'a. " A ranar 30 ga Janairu, bayan tabbatar da yaduwar cutar daga mutum zuwa mutum a wajen China da kuma karuwar adadin masu cutar a wasu ƙasashe, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin gaggawa ta duniya da kuma shari'ar ta shida tun lokacin da aka fara yin rigakafin cutar ta 2009".
" Tedros Adhanom, Sakatare Janar na Hukumar Lafiya ta Duniya, ya bayyana cewa PHEIC ya zama sanadiyar ""hadarin yaduwar duniya musamman a cikin ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi da ba su da ingantattun tsarin kiwon lafiya. "
Dangane da takunkumin da aka sanya kan tafiye-tafiye, Tedros ya bayyana cewa: ""Babu wani dalili da zai sa a ɗauki matakan da ba dole ba waɗanda za su tsoma baki tare da tafiye-tafiye da kasuwancin duniya"" kuma ya ci gaba da cewa ""WHO ba ta ba da shawarar ƙuntata kasuwanci da motsi ba. """
"A ranar 5 ga watan Fabrairu, Majalisar Dinkin Duniya ta nemi al'ummar duniya da su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabarun ƙasashe masu ƙarancin kuɗi, suna mai nuna buƙatar taimakawa ƙasashe waɗanda ba su da "tsarin gano mutanen da ke da cutar ko ma da alamun cutar". "
Tedros ya ci gaba da cewa ""mu ne masu ƙarfi kamar yadda muke da rauni a cikin haɗin gwiwarmu"" kuma ya yi kira ga al'ummar duniya da su "kasance a yau ko kuma su ninka kuɗin daga baya". A ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta sanar da cutar a wani taron manema labarai da ake kira COVID-19. "
A wannan ranar, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya, Antonio Guterres, ya amince da amfani da "mafi girman ƙarfin tsarin Majalisar Dinkin Duniya don amsa cutar".
" Sakamakon haka, an shigar da ƙungiyar kula da rikicin Majalisar Dinkin Duniya don daidaita aikin Majalisar Dinkin Duniya gaba ɗaya kuma, a cewar Hukumar Lafiya ta Duniya, za a ba su damar ""mayar da hankali kan maganin likita, yayin da sauran hukumomin za su iya amfani da ƙwarewar su kan manyan al'amuran zamantakewa, tattalin arziki da kuma ci gaban ci gaban cutar"". "
" A ranar 14 ga watan Fabrairu, an kaddamar da wani kwamiti na hadin gwiwa tare da jagorancin Hukumar Lafiya ta Duniya don samar da kwararru na kasa da kasa da kuma Hukumar Lafiya ta Duniya a cikin halin da ake ciki a kasar Sin don taimakawa wajen gudanar da aikin gida da kuma kimanta ""tabbatarwa da kuma yaduwar cutar"" ta hanyar gudanar da bita da tarurruka tare da cibiyoyin kasa da kuma gudanar da ziyarar filin don kimanta ""sakamakon ayyukan amsawa a lardin da lardin / gundumar da ke kunshe da birane da yankunan karkara. " A ranar 25 ga Fabrairu, Hukumar Lafiya ta Duniya ta sanar da cewa ""Duniya ta bukaci yin karin aiki don shirya don yiwuwar cutar coronavirus "" kuma ta ce duk da cewa har yanzu ba a fara kiran ta cutar ba, duk da haka, dole ne a "shirya" " " "
"Dangane da karuwar barkewar cutar a Iran, Hukumar Lafiya ta Duniya ta tura wata ƙungiya ta hadin gwiwa don tantance halin da ake ciki a ƙasar. A ranar 28 ga Fabrairu, jami'an Hukumar Lafiya ta Duniya sun ce an ƙara ƙimar barazanar coronavirus a duniya daga ""babba"" zuwa ""mai girma""".
" Mike Ryan, daraktan shirin gaggawa na Hukumar Lafiya ta Duniya, ya yi gargadin a cikin wata sanarwa cewa ""wannan gaskiya ne ga dukkan gwamnatocin duniya: farkawa. ""
"Cutar tana kan hanya kuma dole ne ku kasance cikin shiri, kuna lura cewa amsa mai kyau na iya taimakawa duniya ta guji ""ƙara muni""".
Ryan ya ci gaba da cewa, "Bayanan da muke da su yanzu ba su tabbatar da cewa hukumomin kiwon lafiya na duniya za su ayyana cutar a duniya ba, saboda irin wannan sanarwar na nufin cewa ""muna da tabbacin cewa kowane mutum a duniya zai kamu da cutar""".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana yaduwar cutar coronavirus a matsayin cutar da ta shafi duniya.
Darakta Janar ya ce Hukumar Lafiya ta Duniya ""ta damu matuka game da matakan gargadi game da yaduwar cutar da kuma rashin kulawa da cutar. " " Hukumar Lafiya ta Duniya ta fuskanci suka saboda abin da ake ganin rashin kula da cutar, gami da jinkirin sanar da dokar ta baci ta kiwon lafiya da kuma rarraba kwayar cutar a matsayin annoba. "
Wannan martani na siyasa ya hada da takarda kai ga Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom don neman ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, wasu masana da dama na Majalisar Dinkin Duniya kan kare hakkin dan adam sun jaddada girmama hakkin mutane a lokacin annobar COVID-19.
Kungiyar masana ta ce dole ne a samar da matakan ceto ga kowa kuma gwamnati ce ke da alhakin yin hakan.
Kungiyar ta jaddada cewa rashin samun kudi ko rashin inshorar lafiya bai kamata ya zama hujja ba don nuna bambanci ga wasu rukuni na mutane.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, gami da nakasassu, marasa galihu, marasa galihu, 'yan gudun hijira, marasa gida, wadanda ke rayuwa cikin mawuyacin hali, mutanen da ke tsare da kuma 'yan gudun hijira da sauran mutanen da ke bukatar tallafin gwamnati.
Hukumomin gwamnati na duniya suna gudanar da tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta kafa wani dandamali don samar da cikakken bayani a kan lokaci game da manufofin amsawa a kasashe a duniya da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa nazarin tasirin keɓewa da ƙuntatawa na balaguro, Cibiyar Dijital ta ƙunshi bin tsarin manufofin ƙasa (yadda ƙasashe za su amsa rikicin) da nufin taimaka wa ƙasashe su koya daga kwarewar juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Harkokin Wajen Burtaniya Michael Gove da dan Shugaba Jair Bolsonaro na Brazil Eduardo Bolsonaro, saboda sarrafa cutar da ta fara a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) daga aiki saboda yadda suke gudanar da aikin a kokarin da suke yi na sanya dokar hana fita a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin dadin yadda hukumomin siyasa ke maida martani ga barkewar cutar a yankunan.
Wasu masu sukar sun yi imanin cewa wannan matakin na kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, daga fushin da jama'a ke nuna masa a lokacin annobar coronavirus.
Wasu manyan jami'an kasar Sin, kamar Zhao Lijiang, sun yi watsi da sanarwa game da barkewar cutar coronavirus ta Wuhan, wanda ya haifar da ka'idodin makirci na Amurka da Italiya game da China a matsayin ainihin dalilin barkewar COVID-19.
Gwamnatin Donald Trump a Amurka ta kira coronavirus a matsayin ""Covid-19 na China"" ko ""Covid-19 na Wuhan"" kuma ta ce ""sanarwa, ta haifar da barkewar cutar da ta zama annoba ta duniya"" wanda a sakamakon haka ya fuskanci sukar wasu masu sukar a matsayin wariyar launin fata da kuma ""ƙwarewar rashin tasirin gwamnatin sa wajen dakile cutar. "
"Daily Beast ta sami hanyar sadarwa ta hanyar sadarwa ta hanyar hanyar sadarwa ta hanyar Hukumar Tsaro ta Kasa, ta amfani da dabarun da ake kira ""Dukkan abu a karkashin China""".
" Ana buƙatar mu yi iyakar ƙoƙarinmu don isar da wannan saƙon ga jama'a ta kowace hanya da za mu iya, gami da taron labarai da hirar talabijin. ""Kasuwancin labarai kamar Politico, Foreign Policy da Bloomberg sun yi iƙirarin cewa ƙoƙarin China na aika taimako ga ƙasashen da cutar ta shafa wani ɓangare ne na farfagandar ta don yin tasiri a duniya. "
" Joseph Borel, jami'in harkokin wajen EU, ya yi gargadin cewa ""akwai wani bangare na siyasa wanda ya hada da kokarin yin tasiri ta hanyar karkatar da hankali da kuma 'siyasa ta karimci.'""
Burrell ya kara da cewa, "China tana matukar son nuna wa kowa cewa ita abokiyar hadin gwiwa ce mai dogaro da juna, sabanin Amurka".
China ta kuma bukaci Amurka da ta dage takunkumin da aka sanya wa Syria, Venezuela da Iran domin ta taimaka musu, yayin da ta aika da tallafi mai yawa ga kasashen biyu na karshe.
An toshe bayar da masks 100,000 daga Jack Ma zuwa Cuba saboda takunkumin Amurka a ranar 3 ga Afrilu.
Har ila yau, an zargi jami'an Amurka da karkatar da tallafin da wasu ƙasashe ke bayarwa.
An bayar da rahoton bambance-bambance game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan injunan iska da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin hadin kai da Italiya da cutar coronavirus ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce China ce kawai ta amsa ta hanyar biyu.
"Tabbas, wannan ba alama ce mai kyau ba ga haɗin kan Turai""
A ranar 22 ga Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya, Giuseppe Conte, Shugaban Rasha, Vladimir Putin, ya tura sojojin Rasha zuwa Italiya don aika magungunan soja, kayan kashe ƙwayoyin cuta na musamman da sauran kayan aikin likita.
Jaridar La Stampa ta Italiya ta ce, "kashi 80 cikin dari na taimakon Rasha ga Italiya ba shi da amfani ko kuma ba shi da amfani", a cewar wani "tushen siyasa mai daraja".
" Majiyar ta zargi Rasha da cin zarafin ""yanayin siyasa da diflomasiyya"" ta hanyar yin amfani da ayyukanta na yaudara. "
Attilio Fontana, shugaban Lombardy da Ministan Harkokin Wajen Italiya, Luigi Di Maio, sun yi watsi da rahoton kafofin watsa labarai kuma sun yaba da kokarin.
Rasha ta aika da jirgin sama mai jigilar kayan aikin likita zuwa Amurka.
"Dmitry Pushkov, mai magana da yawun Kremlin ya bayyana cewa "" Lokacin da muka ba da shawarar taimako ga abokan aikinmu a Amurka, mun ɗauka cewa lokacin da masana'antun kayan aikin likita da kayayyakin aiki a Amurka suka ci gaba da aikinsu, za su iya taimaka mana idan ya zama dole. """
"An shirya atisayen yaki na NATO ""Defender 2020"" a Jamus, Poland da Baltic, mafi girman atisayen yaki tun bayan ƙarshen Cold War, za a gudanar da su a cikin ƙaramin sikelin. "
"Sakatare Janar na Kamfen na Kashe Makaman Nukiliya, Kate Hudson, ya soki aikin Defender 2020: ""A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai rayukan sojojin Amurka da na kasashen Turai da ke wurin ba ne ke cikin hatsari, amma har da rayukan mutanen da ke cikin kasashen da ake gudanar da ayyukan. "" Gwamnatin Iran ta kamu da cutar sosai, kuma kusan 'yan majalisa ashirin da hudu da wasu mutane goma sha biyar na siyasa na yanzu ko na baya sun kamu da cutar. "
Shugaban Iran Hassan Rouhani ya aika da wata wasika a bude ga shugabannin duniya a ranar 14 ga Maris, 2020, yana neman taimako, yana mai cewa kasarsa tana kokarin magance barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta sanya wa Iran. Wannan barkewar cutar ta sa Amurka ta aiwatar da manufofin zamantakewar da aka saba da su a wasu kasashe masu arziki, gami da kiwon lafiya na duniya, kula da yara na duniya, izinin iyali tare da biyan kuɗi da kuma karin kudade ga kiwon lafiyar jama'a.
Masu nazarin siyasa sun yi hasashen cewa annobar za ta iya shafar sake zaben Donald Trump a zaben shugaban kasa na 2020 da kuma dangantakar Japan da Koriya ta Kudu.
"Bayan da Japan ta sanar da cewa za ta killace duk matafiya da ke shigowa daga Koriya ta Kudu na tsawon makonni biyu a wuraren da gwamnati ta ayyana, Koriya ta Kudu ta soki Japan da cewa tana da "" rashin fahimta da rashin fahimta game da kokarin killacewa. "" "
Tun farko, mutanen Koriya ta Kudu sun kasance masu nuna rashin amincewa game da yadda Shugaba Moon Jae-in ya amsa rikicin.
Yawancin mutanen Koriya sun sanya hannu kan takardun da ke neman a tsige Moon, ko kuma suna yaba wa yadda gwamnatin ta yi aiki a kan cutar. Cutar ta ba da damar ƙasashe su zartar da dokar ta baci don aiwatar da amsa mai kyau.
Wasu masu sharhi sun nuna damuwa cewa hakan na iya sa gwamnatoci su riƙe iko sosai.
A Hungary, majalisar dokokin kasar ta kada kuri'ar ba Firayim Minista Viktor Orbán damar yin mulki ba tare da wani takunkumi ba, ta dakatar da majalisa da kuma zaben, kuma ta hukunta wadanda ke yada bayanan karya game da kwayar cutar da kuma yadda gwamnati ke kula da rikicin.
Cutar coronavirus ta faru ne saboda wasu misalai na karancin kayan aiki, wanda ya haifar da karuwar amfani da kayan aikin rigakafin cutar, fargabar sayayya da kuma katsewar ayyukan masana'antu da kayan aiki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar buƙatun mabukaci da katsewar masu samarwa.
Yankunan da dama sun ci gaba da fuskantar yawan cin kasuwa, wanda ya haifar da ƙarancin kayayyaki kamar abinci, tawul ɗin wanka da kwalban ruwa.
Musamman masana'antar fasaha ta yi gargadi game da jinkirin aika kayan lantarki.
A cewar Tedros Adhanom, Sakatare Janar na Hukumar Lafiya ta Duniya, bukatar kayan kariya na mutum ya karu sau 100.
Wannan buƙatar ta haifar da farashin da ya ninka sau ashirin na farashin yau da kullun kuma ya haifar da jinkiri na watanni huɗu zuwa shida a cikin samar da kayayyakin kiwon lafiya.
Hakanan ya haifar da karancin kayan aikin kariya na mutum a duniya kuma Hukumar Lafiya ta Duniya ta yi gargadin cewa zai shafi lafiyar ma'aikata.
A Ostiraliya, cutar ta ba wa masu siyar da Diego wata sabuwar dama don sayar da kayayyakin Australiya a China.
Wannan aikin ya haifar da karancin abincin jarirai a wasu manyan kantunan, kuma sakamakon haka gwamnatin Ostiraliya ta hana shi. Duk da yawan masu cutar COVID-19 a arewacin Italiya da yankin Wuhan da kuma yawan bukatar abinci, babu wani yanki da ya sha wahala sosai.
Matakan da China da Italiya suka dauka na hana cin hanci da rashawa da kuma safarar kayayyakin masarufi sun yi nasara, kuma sun hana tsananin karancin abinci da aka yi hasashen zai faru a Turai da kuma Arewacin Amurka.
Ba a sami raguwa mai yawa a cikin samar da kayan gona a yankunan arewacin Italiya waɗanda ke samar da kayan gona, amma farashin na iya tashi, a cewar wakilan yankin.
An samar da kayan abinci marasa amfani a cikin birnin Wuhan na ɗan lokaci, yayin da manyan jami'an kasar Sin suka buɗe shagunan naman alade don tabbatar da wadataccen abinci ga jama'a.
Irin wannan dokar a Italiya ta tilasta masu samar da abinci su adana kayan abinci don irin wannan lokacin.
An ji tasirin tattalin arzikin duniya a China: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020, saboda matakan gwamnati na hana barkewar cutar, tare da rage tallace-tallace da kashi 20.5%.
Tunda babban yankin kasar Sin yana daya daga cikin manyan cibiyoyin tattalin arziki da samar da kayayyaki, barkewar cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agatha Demarais na Economist Information Unit ya yi hasashen cewa kasuwanni za su kasance masu saurin canzawa har sai an bayyana sakamakon da ake iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin cutar a kan ci gaban duniya zai iya zama mafi girma fiye da barkewar SARS a tsakanin 2002 zuwa 2004.
Masanin Jami'ar Washington a St. Louis ya kiyasta cewa sarkar samar da kayayyaki ta duniya za ta shafi dala biliyan 300, wanda zai ci gaba har zuwa shekaru biyu.
"A cewar rahoton kungiyar kasashen da ke fitar da man fetur (OPEC), farashin man fetur ya ""fuskanci mummunan raguwa"" saboda raguwar bukatar China. "
Kasuwancin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, karuwar damuwa game da yaduwar cutar coronavirus ya haifar da raguwar da ba a taɓa gani ba a cikin NASDAQ-100, S&amp;amp;amp;P 500 da Dow Jones Industrial Average, wanda ya zama mafi girma a rana ɗaya tun lokacin rikicin kuɗi na 2007, tare da darajar Dow Jones 1,191.
Dukkanin alamomi uku sun ragu da fiye da 10% a ƙarshen mako.
A ranar 28 ga watan Fabrairu, kamfanin GMBH Scope ya amince da darajar bashi na kasar Sin, amma yana da mummunan hangen nesa.
Hannun jari sun sake faduwa saboda tsoron coronavirus, mafi girman faduwar da aka samu a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa koma bayan tattalin arziki zai yiwu.
Mohammed al-Arian, masanin tattalin arziki, ya yaba da matakan gaggawa na bankunan tsakiya da na ƙasashe.
Babban bankuna sun amsa da sauri fiye da rikicin kuɗi na 2008.
Masana'antar yawon bude ido tana cikin wadanda suka fi fama da matsalar saboda takunkumin tafiye-tafiye, rufe wuraren taruwar jama'a kamar wuraren yawon bude ido da kuma shawarwarin gwamnatoci na guje wa tafiya zuwa wasu kasashe.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke zirga-zirgar jiragen sama saboda karancin buƙata, gami da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin na Burtaniya Flybe ya yi fatarar kuɗi.
Wannan ya shafi masana'antar jirgin ruwa na nishaɗi kamar yadda ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da lokacin babban lokacin tafiye-tafiye wanda ya shafi hutun Sabuwar Shekarar China.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka faru kamar bikin Sabuwar Shekara tare da halartar mutane da yawa, kuma kamfanoni masu zaman kansu sun rufe shagunan su da abubuwan jan hankali na yawon buɗe ido kamar Disneyland Hong Kong da Disneyland Shanghai.
Yawancin abubuwan da ke faruwa na Sabuwar Shekarar Lunar da abubuwan jan hankali na yawon bude ido an rufe su don hana taron jama'a, gami da Garin da aka haramta a Beijing da kuma nunin haikalin gargajiya.
A larduna 24 daga cikin larduna 31 na kasar Sin, hukumomin gundumar da na yanki sun tsawaita hutun sabuwar shekara har zuwa ranar 10 ga watan Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su bude a wannan ranar.
Waɗannan yankuna suna wakiltar kashi 80% na ƙimar cikin gida da kashi 90% na fitarwa.
Hong Kong ta inganta matakin mayar da martani ga cutar zuwa matakin da ya fi girma, ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bukukuwan Sabuwar Shekara. An shafi sashin sayar da kayayyaki a duk duniya, tare da rage lokutan aiki ko kuma hutun wucin gadi.
Ziyarci kantin sayar da kayayyaki ya ragu da kashi 40 cikin ɗari a Turai da Latin Amurka.
Kasuwancin da ke Gabas ta Tsakiya da Arewacin Amurka sun ga kashi 50 zuwa 60 cikin ɗari na tallace-tallace.
Wannan kuma ya haifar da raguwar sayayya a cikin shaguna a watan Maris idan aka kwatanta da Fabrairu.
Masu kula da manyan cibiyoyin cin kasuwa na duniya sun ɗauki ƙarin matakai, kamar ƙara bin ƙa'idodin kiwon lafiya, sanya na'urorin bincike na zafin jiki don bincika zafin jiki na masu siye da soke abubuwan da suka faru.Kamar yadda Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya ta Latin Amurka ta kiyasta, koma bayan da cutar ta haifar zai haifar da talauci mai yawa ga mutane miliyan 14 zuwa 22 a Latin Amurka, wanda ya fi yawan yanayin da babu cutar.
A watan Janairu da Fabrairun 2020, a lokacin da annobar ta fi kamari a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin kusan ma'aikata 'yan gudun hijira miliyan 300 na karkara na kasar Sin sun makale a gida a lardunan da ke nesa da teku ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Bankin Tsaro na Tarayya na St. Louis ya kiyasta cewa barkewar cutar coronavirus na iya shafar ayyuka miliyan 47 a Amurka kuma ya kara yawan rashin aikin yi zuwa kashi 32%. Karin dokar hana fita a Indiya ya haifar da rashin aikin yi ga ma'aikata Indiyawan da suka yi hijira miliyan goma (waɗanda ke aiki a kan albashi). Sakamakon binciken da Cibiyar Angus Reed ta gudanar ya nuna cewa kashi 44% na iyalai na Kanada sun shiga cikin rashin aikin yi.
A cikin rabin rabin watan Maris, ma'aikata Faransa miliyan 4 sun nemi biyan bashin rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi bashi na gama gari (Universal Credit). Kusan rabin miliyan na kamfanoni a Jamus sun aiwatar da shirye-shiryen aiki na ɗan gajeren lokaci na ma'aikata tare da tallafin gwamnati da ake kira Kurzarbit.
Faransa da Burtaniya sun karɓi shirin biyan diyya na ɗan gajeren lokaci na Jamus.
Bangarorin da ke aiki a fannin zane-zane da al'adun gargajiya sun sami mummunan tasiri daga mummunan yanayin cutar, wanda ya shafi ayyukan ƙungiyoyi da mutane, ma'aikata da masu zaman kansu a duk duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari don tallafawa manufa (galibi tare da kudaden jama'a) don samar da damar jama'a ga al'adun al'adu, kiyaye lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha idan ya yiwu.
Har zuwa Maris 2020, a duk duniya, a cikin wasu lokuta, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu tare da baje kolin su, abubuwan da suka faru da kuma wasan kwaikwayon da aka soke ko aka jinkirta, an rufe su har abada.
A sakamakon haka, an yi ƙoƙari da yawa don samar da sabis na madadin ta hanyar dandamali na dijital. Wani sabon abu da ya hanzarta rage cutar shine soke abubuwan addini, manyan abubuwan wasanni da sauran abubuwan zamantakewar jama'a kamar bukukuwa da kide kide da wake-wake, taron fasaha da nunin kayan kwalliya.
Har ila yau, masana'antar fim ta yi rashin jin daɗi.Vatican ta sanar da cewa an soke bikin mako mai tsarki a Roma, wanda ya kamata a yi a lokacin azumin Kirista na makon da ya gabata.
Yawancin bishops sun shawarci Kiristoci tsofaffi su zauna a gida maimakon halartar ayyukan ibada a ranar Lahadi; wasu majami'u sun watsa ayyukan coci ta hanyar rediyo, watsa shirye-shiryen kan layi ko talabijin, yayin da wasu suka ba da shawarar yin ibada ta mutum.
Yayin da bishop na cocin Roman Katolika ya rufe manyan da ƙananan majami'unsu kuma ya kawar da filin St. Peter daga masu bautar Kirista, sauran kungiyoyin addini sun soke ayyukansu kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, masallatai da wuraren ibada.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta bulla, kuma wuraren ibada sun ci gaba da rufewa, yayin da Saudiyya ta hana 'yan kasar shiga wuraren ibada a Makka da Madina, tare da hana masu ziyara daga kasashen waje.
Wannan annoba ta haifar da babbar katsewa a wasanni tun lokacin Yaƙin Duniya na II.
Yawancin manyan abubuwan wasanni an soke su ko an jinkirta su, gami da gasar Zakarun Turai ta 2019-2020, Premier League ta 2019-2020, UEFA Euro 2020, kakar NBA da kakar NHL ta 2019-2020.
" Cutar ta kuma katse shirye-shiryen wasannin Olympics na bazara na 2020 wanda aka shirya fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa taron zai ""zama wani lokaci ban da 2020 amma ba bayan bazara na 2021 ba. " " An rufe gidajen caca da sauran wuraren wasa a duk duniya, kuma an jinkirta ko an soke wasannin karta na rayuwa. "
Wannan ya haifar da yawancin masu caca da yawa zuwa caca ta kan layi, kuma yawancin rukunin caca na kan layi sun ba da rahoton ƙaruwa mai yawa a cikin shigarwa. Masana'antar nishaɗi da nishaɗi ma sun sami matsala, kuma ƙungiyoyi da yawa sun dakatar ko soke rangadin kide kide da wake-wake.
Yawancin manyan gidajen silima, gami da waɗanda ke kan Broadway, sun dakatar da duk nunin su.
"Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da raba aiki ta hanyar Intanet a matsayin madadin wasan kwaikwayon raye-raye na gargajiya kamar su raye-raye na raye-raye ko ƙirƙirar ""bikin yanar gizo"" na yanar gizo don masu fasaha don yin, rarrabawa da tallata ayyukansu. "
Ana amfani da abubuwan da ke cikin intanet don jan hankali da kuma ba'a tsakanin masu ba da labari.
Tun bayan barkewar cutar COVID-19, an lura da mummunan nuna bambanci, wariyar launin fata da wariyar launin fata ga Sinawa da kabilun Gabashin Asiya da kuma mutanen da ke cikin manyan ƙasashen Turai, Amurka da sauran ƙasashe.
An lura da abubuwan da suka faru kamar tsoro, shakka da tashin hankali a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya Pacific.
Rahotanni daga watan Fabrairu (lokacin da yawancin cututtukan suka iyakance ga China) sun nuna cewa akwai wasu ƙungiyoyi a duniya da ke nuna wariyar launin fata da ke nuna cewa mutanen China sun cancanci cutar da abin da ake zargi da azabtarwa.
Wasu kasashen Afirka ma sun ga yadda ake samun tashin hankali a kan kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin su.
An samu tallafi ta yanar gizo da wajen layi daga yankunan da cutar ta shafa a kasar Sin.
Bayan ci gaban cutar a cikin ƙasashe masu yawan sabbin kamuwa da cutar, mutanen Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunan yaduwar COVID-19, na iya ci gaba da fuskantar rashin amincewa da tsoron baƙi daga sauran ƙasashe.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Jama'ar kasar Sin da sauran mutanen Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin mutuncin wariyar launin fata da kuma hare-hare.
" Shugaba Donald Trump ya fuskanci suka saboda kiran coronavirus a matsayin ""Covid-19 na kasar Sin"", kalmar da masu sukar suka ce alama ce ta wariyar launin fata da nuna kyamar kasar Sin. "
Masu zanga-zangar a Ukraine sun kai hari kan bas din da ke dauke da 'yan kasar Ukraine da na kasashen waje da aka fitar daga Wuhan kuma aka kai su sansanin soja.
Dalibai daga yankunan arewa maso gabashin Indiya da ke da iyaka da China da kuma waɗanda ke karatu a manyan biranen Indiya sun ba da rahoton cewa suna cikin tsoro da damuwa saboda barkewar cutar coronavirus.
"Dilip Khosh, shugaban jam'iyyar Bharatiya Janata a Bengal ta Kudu ya ce Sinawa sun lalata yanayi kuma ""saboda haka Allah ya rama musu""".
" Bayan haka, ofishin jakadancin kasar Sin a Calcutta ya yi tir da wannan magana kuma ya kira ta da ""kuskure"". A China, tsoratar da baƙi da wariyar launin fata ga 'yan ƙasar da ba Sinawa ba sun ƙaru bayan annobar, kuma an ɗauki baƙi a matsayin ""sharar waje"" ko kuma an ce su jefa su cikin ""kwandon shara"". "
Yawancin jaridu da ke da sassan kuɗi sun cire waɗannan sassan don ɗaukar labarai game da coronavirus.
Yawancin masu wallafa kimiyya sun ba da labaran kimiyya da suka shafi yaduwar cutar kyauta ga kowa.
Wasu masana kimiyya sun yanke shawarar raba sakamakon su da sauri a kan sabobin da aka riga aka buga kamar bioRxiv.
Cutar da ke tasowa: Cutar da ke tasowa tare da sabon ƙwayar cuta, yawanci sabon abu a cikin yanayin yaduwa ko nau'in watsawa.
Duniya da cuta - nazarin duniya da yaduwar cuta
Jerin cututtuka da cututtuka - jerin yawan mutuwar cututtuka
Cinikin namun daji da cututtukan da ke tattare da mutane da dabbobi, haɗarin kiwon lafiya da ke tattare da cinikin namun daji a cikin namun daji na asali.
Gwajin gwaji na cutar coronavirus na numfashi na 2019 (COVID-19) da kuma SARS-CoV-2 mai alaƙa ya ƙunshi hanyoyi biyu, hanyoyin da ke gano kasancewar kwayar cutar da hanyoyin da ke gano kasancewar ƙwayoyin cuta da aka samar don amsawa ga kamuwa da cuta.
Kasancewar ƙwayoyin cuta a cikin samfuran da RT-PCR ya tabbatar, wanda ke gano RNA na CAV.
Wannan gwaji ne na musamman kuma an tsara shi ne kawai don gano RNA na SARS-CoV-2.
Ana amfani da shi don tabbatar da sabbin cututtuka ko masu aiki.
Ana iya amfani da ganowar ƙwayoyin cuta (serology) don gane cutar da kuma kula da yawan jama'a.
Gwajin rigakafi yana nuna yawan mutanen da ke da cutar, ciki har da waɗanda ke da alamun rashin lafiya da ba su buƙatar bayar da rahoto ko kuma ba su da alamun cutar.
Ana iya ƙayyade ainihin adadin mutuwar da cutar ta haifar da matakin rigakafin garken a cikin jama'a ta amfani da sakamakon gwajin.
Saboda iyakancewar gwaji, har zuwa Maris 2020, babu wata ƙasa da ke da ingantaccen bayani game da yaduwar cutar a cikin mutane.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma akwai bambance-bambance da yawa dangane da yawan gwaje-gwajen da aka yi a ƙasashe daban-daban a duniya.
Hakanan yana iya haifar da canjin canji a cikin yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe ana iya yin hasashen da yawa.
Ta hanyar amfani da maganin polymerase reverse transcription chain reaction (rRT-PCR), ana iya yin gwajin akan samfurori na numfashi da aka samo ta hanyoyi daban-daban, ciki har da samfurin hanci ko samfurin kumburi.
Ana sanar da sakamakon bayan sa'o'i kadan ko kuma kwanaki biyu.
Gwajin RT-PCR da aka yi tare da ɗaukar samfurin daga makogwaro kawai a cikin makon farko na cutar yana da tabbaci.
Daga baya, kwayar cutar na iya ɓacewa a cikin makogwaro, kodayake tana ci gaba da ninkawa a cikin huhu.
Ga masu kamuwa da cutar da aka gwada a mako na biyu, ana iya samun samfurin daga hanyar numfashi ta hanyar katako ta hanyar sutura ko fitar da kumburi (sniffing).
An shirya ɗayan gwajin PCR na farko a cikin Janairu 2020 ta Charité a Berlin, wanda ya yi amfani da hanyar sake fasalin jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun jujjuyawararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwararrun juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju
Birtaniya ta yi gwajin a ranar 23 ga Janairu, 2020. Kogenebiotech a Koriya ta Kudu ta samar da kayan aikin gano SARS-CoV-2 na asibiti, wanda aka kira PowerChek Coronavirus, wanda aka kafa ta PCR a ranar 28 ga Janairu, 2020.
"Ganin ""E"" wanda yake cikin dukkanin nau'ikan beta-CoV da kuma gene RdRp wanda yake cikin SARS-CoV-2 kawai.A China, BGI Group shine kamfani na farko da ya karɓi izinin amfani da gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta China don kayan aikin PCR na asali don gano SARS-CoV-2.A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) na Amurka suna samar da rukunin ganowa na Real-Time RT-PCR na sabon coronavirus 2019 (2019-nCoV) ga dakunan gwaje-gwaje na kiwon lafiya ta hanyar International Reagent Resource. "
Daya daga cikin gwaje-gwaje guda uku na kwayoyin halitta a cikin tsofaffin kayan gwaji ya kasance ba a kammala shi ba saboda kuskuren ganowa, wanda ya haifar da gwaji a CDC Atlanta; wannan ya haifar da ƙarancin adadin samfuran da aka gwada cikin nasara a cikin Fabrairu 2020 ta matsakaita na 100 kowace rana.
Tabbatar da gwajin da ke amfani da abubuwa biyu bai bayyana ba har zuwa 28 ga Fabrairu, 2020, kuma an ba da izinin fara gwaji ga dakunan gwaje-gwaje na jihohi da na gida daga wannan ranar.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Labs na kasuwanci na Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a sami gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics kuma ta samar da kayan gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Ba a sanar da takunkumin keɓewa ba; dole ne a tattara samfurin da kuma bincika shi bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Virology da Biotechnology ta jihar ta tsara da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairun 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ba da rahoton cewa Mayo Clinic ta samar da gwajin da za a iya gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar Hukumar Abinci da Magunguna don gwajin da za a iya yi a cikin awanni 3.5 da yawa, wanda zai ba da damar yin gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna ta ba da izinin Amfani da Gaggawa (EUA) ga Abbott Laboratories don gwajin tsarin Abbott's m2000; Hukumar Abinci da Magunguna ta ba da irin wannan izinin ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, kamfanin Cepheid ya sami EUA daga Hukumar Abinci da Magunguna don gwajin da zai ɗauki minti 45.
Hukumar Abinci da Magunguna ta amince da gwajin da ke amfani da fasahar haɓaka isothermal nucleic acid maimakon PCR.
Ganin cewa wannan ba ya buƙatar jerin zafin jiki na zagaye, wannan hanya tana iya tabbatar da sakamako mai kyau a cikin minti 5 da kuma sakamako mara kyau a cikin minti 13.
Akwai 18,000 na waɗannan injunan a Amurka kuma Abbott yana shirin haɓaka samarwa zuwa 50,000 a kowace rana nan ba da daɗewa ba. A halin yanzu ana yin gwaji a Taiwan wanda ke amfani da ƙwayoyin cuta na monoclonal, wani abu wanda ke ɗaure ƙwayoyin nucleocapsid (protein N) na sabbin coronavirus; ana fatan wannan gwajin zai iya samar da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin saurin mura.
"Zuwa Maris 2020, nazarin bayanan ya kammala cewa ""Radiography na kirji yana da ƙima don gano cutar a farkon matakan cutar yayin da binciken CT na iya kasancewa tun kafin bayyanar cututtuka. """
Daga cikin halayen CT na yau da kullun ana iya komawa zuwa filayen gilashin matte mai girma biyu tare da rarraba gefe, asymmetrical da baya (postiver).
Mamayewa a ƙarƙashin murfin gefe (subpleural dominance), yana faruwa tare da ci gaban cuta, shiga ciki da kuma yanayin rashin fahimta (crazy paving).
Wani bincike a Wuhan, inda cutar ta fara, ya kwatanta PCR da CT kuma ya bayyana cewa CT ya fi dacewa da PCR, kodayake ba shi da ƙwarewa sosai, kuma yawancin siffofin hoton yana haɗuwa da sauran cututtukan huhu da matsalolin numfashi.
"Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "" kada a yi amfani da CT don gano cutar a matsayin layin farko na gwaji don gano COVID-19. " Har zuwa Maris 2020, CDC ta ba da shawarar cewa a yi amfani da PCR don bincike. "
Wani ɓangare na amsawar tsarin garkuwar jiki shine samar da ƙwayoyin cuta kamar IgM da IgG.
Ana iya amfani da waɗannan don gano cutar a cikin mutane, a cikin kwanaki 7 ko fiye bayan bayyanar cututtuka, don ƙayyade rigakafi da kuma sa ido kan yawan jama'a. Ana iya yin gwaje-gwaje a cikin cibiyoyin bincike na tsakiya (CLT) ko ta hanyar gwajin wurin kulawa (PoCT).
Tsarin atomatik mai ƙarfi a yawancin dakunan gwaje-gwaje zai iya yin waɗannan kimantawa, amma samun damar su ya dogara da ƙimar samarwa ga kowane tsarin.
Don CLT yawanci ana amfani da samfurin jini guda ɗaya, duk da haka ana iya amfani da samfurori na ƙwayoyin cuta don bin tsarin rigakafi.
Don PoCT, ana yawan ɗaukar samfurin jini ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar aiwatar da matakan fitarwa kafin gwaji.A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna ta Amurka ta gabatar da kamfanoni 29 waɗanda suka sanar da hukumar bisa ga buƙatun kuma a sakamakon haka za su iya rarraba gwajin rigakafin su.
Tun daga 7 ga Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su; waɗannan kayan aikin na iya gano ƙwayoyin cuta na IgG da IgA akan kwayar cutar a cikin samfuran jini.
Ana iya gwadawa da yawa a cikin sa'a guda, saboda haka yana da sauri fiye da kimantawa na PCR na yau da kullun don RNA na kwayar cuta.
Ana iya gano ƙwayoyin cuta har zuwa kwanaki 14 bayan fara kamuwa da cuta. A farkon watan Afrilu, Burtaniya ta sanar da cewa babu ɗayan kayan gwajin ƙwayoyin cuta da aka saya da suka isa.
"Hong Kong ta kafa wani shiri inda waɗanda ake zargi da cutar za su iya zama a gida, ""sashen gaggawa zai ba da bututun samfurin ga mai haƙuri"", mai haƙuri zai jefa bututun TOF, ya sake aikawa, kuma ya sami sakamakon gwajin.Ma'aikatar Kiwon Lafiya ta Jama'a (NHS) a Burtaniya ta sanar da cewa tana gwaji kan wani shiri inda za a gwada masu cutar a gida don kawar da haɗarin yaduwar cutar a hanyar zuwa asibiti ko buƙatar kashe ƙwayoyin cuta a motar motar asibiti.A cibiyoyin gwajin COVID-19 na jirgin sama don shari'o'in da ake zargi, ƙwararren likita yana ɗaukar samfurin ta hanyar amfani da matakan kariya. "
Cibiyoyin kula da motoci sun taimaka wa Koriya ta Kudu ta aiwatar da ɗayan gwaje-gwaje mafi sauri da kuma cikakke a duk duniya.A Jamus, Kungiyar Likitocin Inshorar Lafiya ta Kasa ta sanar a ranar 2 ga Maris cewa tana da ƙarfin yin gwaje-gwaje kusan 12,000 a kowace rana a cikin motar asibiti, sama da 10,700 a makon da ya gabata.
Lokacin da likita ya rubuta gwajin, inshorar lafiya zai biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwaji 160,000 a mako.
An ba da sabis na gwaji a kan doki a manyan biranen da dama har zuwa 19 ga Maris.
Har zuwa 26 ga Maris, 2020, yawan gwaje-gwajen da aka yi a Jamus ba shi da tabbas, saboda sakamakon tabbatacce ne kawai aka bayar.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla aƙalla
Wanda ya kafa BGI, Wang Jian, da kansa ya kula da aikin na kwanaki 5; samfurin ya nuna cewa idan ba tare da wannan ƙarfin ba, yawan masu kamuwa da cutar a Hubei zai karu da kashi 47% kuma farashin keɓewa zai ninka sau biyu.
Bayan dakin gwaje-gwaje na Wuhan, an fara saurin kafa dakin gwaje-gwaje na Hu-yan a Shenzhen, Tianjin, Beijing da Shanghai, jimlar birane 12 a duk faɗin China.
Zuwa 4 ga Maris, 2020, jimlar fitarwa ta yau da kullun ta kai gwaje-gwaje 50,000. An saki zane-zane masu buɗe ido da haɗin gwiwa waɗanda aka samar ta hanyar Origami Assays, waɗanda za a iya gwada samfura sama da 1,122 don COVID-19, ta amfani da gwaje-gwaje 93. Ana iya aiwatar da waɗannan ƙirar daidaitaccen a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar kayan aikin robotic mai aiki da ruwa ba.
Har zuwa watan Maris, karancin kwayoyin cutar da ƙarancin ƙwayoyin cutar sun kasance ɗaya daga cikin matsalolin samar da gwaje-gwaje da yawa a cikin EU, Burtaniya da Amurka.
Wannan ya sa wasu masu bincike suka fara nazarin hanyoyin shirya samfurin wanda ya hada da dumama samfuran zuwa 98 ° C (208 ° F) na mintuna 5 don sakin kwayoyin RNA don gwaji na gaba.A ranar 31 ga Maris, an ba da sanarwar cewa UAE ta gwada mutane da yawa akan COVID-19 a lokacin, fiye da kowace ƙasa a lokacin, kuma tana kan hanyar kaiwa matakin gwajin yawan jama'arta.
"An yi wannan ne ta hanyar haɗuwa da yiwuwar samar da sabis na hawa da siyan dakin gwaje-gwaje mai yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwaje na gaggawa ""Hu-yan"" a China)".
An gina dakin gwaje-gwaje a cikin kwanaki 14, yana iya yin dubun dubatar gwaje-gwaje na RT-PCR a kowace rana kuma shine farkon wanda aka fara aiki a wannan sikelin a wajen China.
An samar da hanyoyin gwaji daban-daban da ke nufin sassa daban-daban na bayanan halittar kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta yi amfani da umarnin Jamus don samar da kayan aiki don aikawa zuwa ƙasashe masu karamin kuɗi waɗanda ba su da isasshen albarkatu don yin kayan aiki.
An fitar da umarnin Jamus a ranar 17 ga Janairun 2020; yarjejeniyar CDC ba ta kasance ba har zuwa 28 ga Janairu, kuma ta jinkirta gwajin da ke akwai a Amurka.China da Amurka suna da matsaloli game da amincin kayan gwaji a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin don biyan buƙatu da shawarwarin masana kiwon lafiya don yin gwaji ba.
A gefe guda, masana sun ce samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabbin cututtukan coronavirus.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, galibi a cikin ɗakunan gwaje-gwaje na kamfanoni masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta sanar da cewa ya kamata a hanzarta shirye-shiryen gwajin a matsayin mafi kyawun hanyar rage saurin cutar ta COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje a cikin dakunan gwaje-gwaje masu zaman kansu na Amurka kuma samar da kayan aikin da sinadarai yana da wahala.
A watan Maris na 2020, kasar Sin ta ba da rahoton cewa kayan gwajin da aka samar a kasar suna da matsala kuma ba su da daidaito.
"A Amurka, kayan gwajin da CDC ta yi ""rashin inganci"" ne; daga baya gwamnati ta cire shingen gudanarwa wanda ya hana gwaji na masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin kasar Sin Shenzhen Bioeasy Biotechnology Co Ltd amma ta gano cewa sakamakon ba daidai bane. "
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin samun samfurin da ya dace ko kuma amfani da kayan gwajin da ba daidai ba.
Ma'aikatar Tsaro ta Spain ta sanar da cewa za ta tattara kayan aikin da ke dauke da sakamakon da ba daidai ba kuma ta maye gurbin su da wani kayan gwajin daban wanda Shenzhen Bioeasy ya bayar. Kashi 80 cikin dari na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da ba daidai ba. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba ne.
Firayim Minista Matovic ya ba da shawarar a jefa su cikin Tekun Danube. Agha Kara, wani memba na Ma'aikatar Lafiya ta Turkiyya, ya ce kayan gwajin da Turkiyya ta saya daga China suna da "manyan kuskuren kuskure" kuma "ba a yi amfani da su ba".
Gwajin tare da keɓe mutanen da suka sami sakamako mai kyau da kuma bin diddigin mutanen da suka taɓa saduwa da mutanen da ke da cutar SARS-CoV-2 ya haifar da sakamako mai kyau.
Masu bincike da ke aiki a garin Vo, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan mazauna 3,400 na garin, tare da keɓewar kwanaki 10.
Kimanin rabin mutanen da suka sami sakamako mai kyau ba su da wata alama kuma duk waɗanda aka gano an killace su.
Tare da iyakance tafiye-tafiye na birni, sabbin cututtukan sun ragu sosai.
Cutar coronavirus ta ɓarke a cikin 2020 a Singapore saboda tsananin bin diddigin lamba, ƙuntatawa na balaguron cikin gida, gwaji da keɓewa a hankali fiye da sauran ƙasashe masu tasowa, amma ba a sanya takunkumi mai tsanani kamar rufe gidajen abinci da cibiyoyin sayar da kayayyaki ba.
An soke yawancin abubuwan da suka faru kuma Singapore ta shawarci 'yan ƙasa da su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris bayan an dakatar da su.
Wasu ƙasashe da yawa kamar Iceland da Koriya ta Kudu sun gudanar da annobar ta hanyar tsauraran matakan bin diddigin lamba, ƙuntatawa na balaguron cikin gida, gwaji da keɓewa, amma ba su da tsauraran matakan keɓewa.
Wani binciken da aka yi ya nuna cewa ƙasashen da suka yi gwaje-gwaje masu yawa fiye da yawan mutuwar, suna da ƙananan mutuwar, mai yiwuwa saboda waɗannan ƙasashe sun fi dacewa su gano masu cutar da ke da alamun bayyanar cututtuka ko marasa alamun bayyanar cututtuka.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa ƙasashe waɗanda ba su da ƙarfin gwaji kuma suna da dakunan gwaje-gwaje da ke da ƙarancin ƙwarewa game da COVID-19, su aika da farkon lokuta biyar masu kyau da farkon lokuta goma na COVID-19 don tabbatarwa ga ɗaya daga cikin dakunan gwaje-gwaje 16 na Hukumar Lafiya ta Duniya.
A waje da dakunan gwaje-gwaje 16, akwai 7 a Asiya, 5 a Turai, 2 a Asiya, 1 a Arewacin Amurka, da 1 a Ostiraliya.
" A cikin teburin da ke ƙasa, shafi ""Positive a cikin % na gwaje-gwaje"" yana da tasiri ga manufofin gwaji na kowace ƙasa. "
A cikin yanayin daidaito, ƙasa da ke gwada kawai waɗanda aka kwantar a asibiti, tana da ƙarin lokuta masu kyau a cikin kashi, idan aka kwatanta da ƙasa da ke gwada duk 'yan ƙasa, ba tare da la'akari da bayyanar cututtuka ba.
Wanke hannu (ko wanke hannu), wanda ake kira tsabtace hannu, shine aikin da mutum yayi don kawar da datti, mai, ƙwayoyin cuta ko sauran abubuwa marasa kyau akan hannaye.
"Tsabtace hannu da sabulu akai-akai a ""lokacin rikici"" a cikin yini yana hana yaduwar cututtuka da yawa, misali gudawa da annoba, waɗanda ke yaduwa ta hanyar hanyar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Hakanan, mutane na iya kamuwa da cututtukan numfashi kamar mura ko kuma tari idan ba su wanke hannayensu kafin su taɓa idanunsu, hanci, ko bakinsu (misali, mucous membranes).
Akwai lokuta biyar masu mahimmanci a rana don wanke hannuwanku da sabulu don rage yaduwar cututtuka: bayan zuwa gidan wanka (shan ciki da kuma taushi), bayan share kayan shafawa na jariri (canza diapers), kafin ciyar da jariri, kafin cin abinci da kafin da bayan shirya abinci ko lokacin da aka taɓa nama, kifi ko kifi.
Idan babu sabulu da ruwa, zaka iya wanke hannayenka da toka.
Kafin, lokacin da kuma bayan shirya abinci.
Kafin da kuma bayan kula da mai haƙuri.
Bayan canza diaper ko wanke yaro bayan ya yi amfani da bayan gida.
Bayan zubar da hanci, tari ko hancin.
Bayan sun taɓa dabbobi, sun ciyar da su, kuma sun taɓa bayan su.
Lafiya ta hannu tana nufin ayyukan kiwon lafiya da suka shafi hanyoyin likita.
Wanke hannu kafin amfani da magani ko wasu magunguna na iya hana ko rage yaduwar kwayar cutar.
Babban manufar wanke hannu a likitanci shine tsabtace hannaye daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da zasu iya haifar da cuta) da sunadarai waɗanda zasu iya haifar da rauni ko cuta.
Wannan yana da mahimmanci ga mutanen da ke aiki tare da abinci ko aiki a fannin kiwon lafiya, amma yana da mahimmanci ga jama'a.
Wanke hannu yana da fa'idodi da yawa, gami da rage yaduwar mura, coronavirus da sauran cututtukan cututtuka; hana cututtukan da ke haifar da gudawa; da rage kamuwa da cututtukan numfashi;
Kuma rage yawan mutuwar jarirai a haihuwar gida.
Wani bincike da aka yi a 2013 ya nuna cewa ingantaccen aikin wanke hannu na iya haifar da ɗan ci gaba a cikin haɓakar haɓakar yara a ƙasa da shekaru biyar.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da gudawa ta hanyar sauya halayen sauƙaƙe kamar wanke hannu da sabulu.
Wannan aikin mai sauƙi zai iya rage yawan mutuwar a cikin waɗannan cututtuka har zuwa 50%.
Hanyoyin da ke inganta wanke hannu suna iya rage zawo da kusan kashi ɗaya bisa uku, wanda ya yi daidai da samar da ruwa mai tsafta a yankunan da ke da ƙananan kuɗi.
Kashi 48% na raguwar cututtukan gudawa ana iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da arha don hana gudawa da cututtukan numfashi (ARI), wanda ake yi a matsayin aikin yau da kullun a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, babban ARI, shine sanadin mutuwar yara a cikin yara 'yan kasa da shekaru biyar, wanda ke kashe yara miliyan 1.8 a kowace shekara.
Cutar zazzabi da ciwon nono suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, yin wanke hannu kafin cin abinci da bayan bayan bayan gida a matsayin al'ada mai dorewa na iya ceton rayukan mutane fiye da kowane allurar rigakafi ko aikin likita, rage mutuwar da za a iya yi daga zawo da kusan rabin kuma rage mutuwar daga cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Wanke hannu yawanci yana tare da sauran hanyoyin kashe kwayoyin cuta tare da ruwa, maganin kashe kwayoyin cuta da shirye-shiryen kiwon lafiya na mutum (WASH).
Wanke hannu yana hana jaundice (impetigo) wanda ke yaduwa ta hanyar taɓawa ta jiki kai tsaye.
Ƙananan sakamako mai cutarwa na wanke hannu shine cewa wanke hannu akai-akai zai iya haifar da rauni mai tsanani saboda bushewar fata.
Wani binciken Denmark a cikin 2012 ya nuna cewa wanke hannu da yawa na iya haifar da ƙaiƙayi da ɓarna na fata, wanda aka fi sani da eczema ko cutar fata, wanda ya zama ruwan dare musamman tsakanin ma'aikatan kiwon lafiya.
Ana kuma kiran wanke hannu da yawa a matsayin wani alamun bayyanar cututtukan obsessional (OCD).
Akwai lokuta biyar masu mahimmanci a rana don wanke hannuwanku da sabulu don rage yaduwar cututtuka: bayan zuwa gidan wanka (shan ciki da kuma taushi), bayan share kayan shafawa na jariri (canza diapers), kafin ciyar da jariri, kafin cin abinci da kafin / bayan shirya abinci ko lokacin da aka taɓa nama, kifi ko kifi.
Sauran lokutan da ya kamata a yi wanka da hannu don hana yaduwar cutar sun haɗa da kafin da bayan kula da rauni ko rauni, bayan atishawa, tari, ko yin fitsari; bayan taɓa ƙazamar dabba ko sarrafa dabbobi; da kuma bayan taɓa shara.
A ƙasashe da dama, yawan wanke hannu da sabulu yana da ƙarancin.
Wani bincike kan wanke hannu a cikin kasashe 54 a shekarar 2015 ya nuna cewa a matsakaita kashi 38.7% na mutane suna wanke hannayensu da sabulu. A cikin binciken na 2014, Saudi Arabia ta sami mafi girman adadin wanke hannu da kashi 97%, Amurka tana kusa da matsakaici tare da kashi 77% kuma China tana da mafi ƙarancin kashi 23%. Yawancin hanyoyin canza halayyar wanke hannu da sabulu suna aiki. Wanke hannu a cikin rukuni ga yara a makaranta a wani lokaci shine hanya don haifar da canjin halayyar yara.
" "Shirin kula da lafiya mai mahimmanci"" wanda Ma'aikatar Ilimi ta ƙaddamar a Philippines, misali ne na matakan inganta kiwon lafiya da ilimi da renon yara. "
Sau biyu a shekara, wanke hannuwan yau da kullun, gogewa da fluoride, sune manyan abubuwan da ke cikin shirin na ƙasa.
An kuma aiwatar da shi cikin nasara a Indonesia.
Ana ƙara kawar da ƙwayoyin cuta daga fata ta hanyar ƙara sabulu ko kayan tsabtace ruwa.
Babban aikin sabulu da masu tsabtace shine rage shinge na narkewa cikin ruwa, don haka haɓaka solubility.
Ruwa kadai yana da tsabtace fata wanda ba shi da tasiri, saboda kitse da furotin, waɗanda sune abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, tsaftacewa tare da ruwa mai gudana yana taimakawa...
Sabulu mai ƙarfi na iya ƙunsar ƙwayoyin cuta kaɗan fiye da amfani da shi saboda sake amfani da shi.
Wasu ƙananan nazarin da suka yi tunanin cewa ana iya samun kwayar cuta daga sabulu mai laushi mai laushi sun yanke shawarar cewa ba zai yiwu ba, saboda ana wanke kwayoyin cuta da sabulu.
" CDC ta kuma ce: ""Ana son sabulu mai ruwa wanda za'a iya amfani dashi ba tare da buƙatar taɓa hannu ba"."
An yi tallafi sosai don sabulu na antibacterial don inganta lafiyar jama'a.
Har zuwa yau, babu wata hujja da ke nuna cewa amfani da maganin kashe kwayoyin cuta ko maganin kashe kwayoyin cuta da aka ba da shawarar na iya haifar da kwayoyin da ke jure wa maganin rigakafi a cikin yanayi.
Koyaya, sabulu na ƙwayoyin cuta sun ƙunshi magungunan ƙwayoyin cuta na yau da kullun kamar triclosan, wanda ke da jerin nau'ikan ƙwayoyin cuta masu jurewa.
Don haka, koda kuwa sabulu na antibacterial ba zai iya kawar da nau'ikan ƙwayoyin cuta masu jurewa ba, ƙila ba za su yi tasiri kamar yadda aka yi tallafi a baya ba.
Baya ga surfactants da kayan kare fata, wannan ingantaccen tsari na iya haɗawa da acid (acetic acid, ascorbic acid, da lactic acid) a matsayin mai daidaita pH, aiki benzoic acid tare da antimicrobial halaye, da sauran abubuwan danshi na fata (aloe vera, bitamin, menthol, tsantsawar tsire-tsire). Wani bincike mai zurfi daga Faculty of Public Health na Jami'ar Oregon ya nuna cewa sabulu mai sauƙi yana da tasiri kamar sabulu na farko na antibacterial wanda ya ƙunshi triclosan, a cikin rigakafin cututtuka da kuma kawar da kwayoyin cuta.
Ruwan zafi wanda yake da kyau don wanke hannuwanku ba zai iya kashe kwayoyin ba.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 ° C).
Koyaya, ruwan sabulu mai zafi ya fi ruwan sabulu mai sanyi tasiri wajen kawar da ƙwayoyin cuta na halitta waɗanda ke ƙunshe da ƙura da ƙwayoyin cuta.
Duk da haka, akasin yarda da kowa, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri a rage yawan ƙwayoyin cuta.
Mai tsabtace hannu ko mai tsabtace hannu shine kayan aiki mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, kayan tsabtace hannu na ruwa (wanda aka fi sani da tsabtace hannu na barasa, tsabtace hannu na hannu, ko kuma masu tsabtace hannu) sun zama sananne.
Yawancin lokaci suna dogara ne akan isopropyl ko ethanol barasa tare da mai ƙarfafawa kamar carbomers (polymer acrylic acid) wanda aka canza zuwa gel, ko mai laushi kamar glycerin a cikin ruwa, ko kumfa don sauƙaƙe amfani da barasa da rage tasirin bushewar barasa.
Ƙara hydrogen peroxide mai narkewa yana ƙara aikin antimicrobial. Masu kashe ƙwayoyin cuta na hannu, waɗanda suka haɗa da aƙalla kashi 60 zuwa 95% na barasa, suna da tasiri sosai wajen kashe ƙwayoyin cuta.
Magungunan kashe ƙwayoyin cuta na barasa suna kashe kwayoyin cuta, ƙwayoyin cuta masu jurewa da yawa (MRSA da VRE), masu haifar da tarin fuka da ƙwayoyin cuta da yawa (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis) da fungi.
Magungunan kashe ƙwayoyin cuta na 70% na iya kashe ƙwayoyin cuta a hannu a cikin ƙasa da sakan 30 bayan amfani da kashi 99.97% (ragewar logarithmic na 3.5, kwatankwacin ragewar decibel 35) da kuma kashi 99.99% zuwa 99.999% (ragewar logarithmic na 4-5) na ƙwayoyin cuta a cikin minti 1.
Magungunan kashe ƙwayoyin cuta na hannu na barasa kusan ba su da tasiri a matsayin kari ga neuroviruses (ko Norwalk), wanda shine mafi yawan sanadin cututtukan cututtukan gastroenteritis. Ya kamata a yi amfani da maganin kashe ƙwayoyin cuta na hannu ko maganin shafawa na giya a kan fata tare da shafa shi sosai kuma rufe hannaye biyu.
Ana shafa gaban da baya na hannayen biyu da tsakanin yatsunsu da ƙarshen yatsunsu na kimanin 30 seconds don bushe ruwa, farfajiyar ko farfajiyar.
Hakanan ya kamata a wanke yatsun hannu sosai ta hanyar shafawa a ƙarƙashin hannu. Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta ba da shawarar wanke hannu, musamman idan hannaye suna da datti sosai, maimakon amfani da maganin kashe ƙwayoyin cuta.
Ana amfani da waɗannan kayan wanke hannu da yawa saboda sauƙin amfani da saurin aiki don kawar da ƙwayoyin cuta; duk da haka, bai kamata a yi amfani da su azaman madadin wanke hannu ba, sai dai idan sabulu da ruwa suna samuwa.
Amfani da maganin kashe ƙwayoyin cuta na giya sau da yawa yana haifar da bushewar hannu, sai dai idan an ƙara moisturizer da / ko mai laushi a cikin tsari.
Za a iya rage tasirin bushewar barasa ta hanyar ƙara glycerin da / ko sauran abubuwan danshi zuwa dabara.
A cikin gwaji na asibiti, maganin kashe ƙwayoyin cuta na hannu na barasa wanda ke dauke da man shafawa ya haifar da ƙonewa da bushewa ƙasa da sabulu mai dauke da maganin ƙwayoyin cuta.
Allergic contact dermatitis, cututtukan cututtukan cututtuka, ko rashin jin daɗin barasa ko abubuwan da ke cikin gels na giya ba su da yawa.
Saboda ba ta haifar da cututtukan fata mai ƙwanƙwasawa kamar wanke hannu da sabulu da ruwa, yana da kyau.
Duk da babban aiki, kayan aikin da ba na ruwa ba ba su wanke hannayen daga kwayoyin halitta ba, amma suna kashe su.
Wannan shine dalilin da ya sa masu kashe ƙwayoyin cuta na hannu ba su da tasiri kamar sabulu da ruwa don hana yaduwar ƙwayoyin cuta, saboda ƙwayoyin cuta suna ci gaba da kasancewa a hannu.
Ingancin maganin kashe ƙwayoyin cuta na hannu ba tare da barasa ba ya dogara sosai da abubuwan da ke ciki da kuma tsari kuma a tarihi, ya kasance ƙasa da tasiri fiye da barasa da gels na barasa.
Kwanan nan, abubuwan da ke amfani da benzalkonium chloride sun nuna ci gaba da haɓaka aikin antimicrobial bayan amfani, sabanin barasa, wanda bayan amfani da shi sau da yawa, mai yiwuwa saboda tasirin da ke faruwa a baya.
Mutane da yawa a cikin al'ummomin da ke da ƙananan kuɗi ba za su iya sayen sabulu ba kuma suna amfani da toka da toka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa, amma mai yiwuwa ba shi da tasiri fiye da sabulu.
Wani damuwa shine ƙwayoyin cuta na ƙasa ko toka, wanda zai iya taimakawa wajen yada cutar maimakon rage ta.
Ash, kamar sabulu, yana da maganin kashe ƙwayoyin cuta, saboda yana haɗuwa da ruwa, yana samar da bayani mai alkaline.
Hukumar Lafiya ta Duniya ta ba da shawarar sabulu, toka ko yashi a matsayin madadin sabulu lokacin da babu.
Tsarin wanke hannu da aka ba da shawarar Cibiyar Kula da Cututtuka ta Amurka don hana yaduwar cuta ya haɗa da waɗannan matakan:
Ka wanke hannayenka da ruwan zafi ko ruwan sanyi.
Ana ba da shawarar ruwan da ke gudana saboda tafkunan da ke cikin ruwa na iya zama masu cutarwa, kodayake zafin jiki na ruwa bazai bambanta ba.
Yi amfani da sabulu mai yawa a hannayenka, har da bayan hannu, tsakanin yatsun hannu, da ƙarƙashin kusoshi.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma nazarin ya nuna cewa mutane suna wanke hannayensu sosai lokacin da suke amfani da sabulu fiye da lokacin da suke amfani da ruwa kawai.
Yi amfani da hannayenka don aƙalla 20 seconds.
Tausa hannuwan yana haifar da ƙwanƙwasawa wanda ke taimakawa wajen kawar da ƙwayoyin cuta, tausawa na dogon lokaci yana kashe ƙwayoyin cuta da yawa.
Yi ruwa sosai a ƙarƙashin ruwa.
Wankewa a cikin wankin guda ɗaya na iya sake gurɓata hannu.
Ka bushe da tsabta ko kuma ka bar shi ya bushe a cikin iska.
Hannun da ke cikin ruwa da rigar suna da sauƙin sake kamuwa da cuta. Yankunan da ba a wanke su ba sun haɗa da yatsun hannu, wuyan hannu, tsakanin yatsunsu, da ƙarƙashin ƙusa.
Kwayoyin ƙusa da ƙuƙwalwar ƙusa da aka cire suna iya kamuwa da ƙwayoyin cuta.
Ana ba da shawarar man shafawa sau da yawa don hana bushewar hannu; bushewar fata na iya haifar da lalacewar fata, wanda zai iya ƙara haɗarin kamuwa da cuta.
"Za a iya amfani da zaɓuɓɓuka masu rahusa daban-daban idan ana buƙata a ƙasashe masu tasowa don sauƙaƙe wanke hannu inda babu ruwan famfo da / ko sabulu. Misali, zubar da ruwa da / ko sabulu daga gilashin da aka rataye ko gashin bushe tare da ramuka masu dacewa da / ko amfani da toka. A cikin yanayin iyakancewar ruwa (kamar makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai mafita mai amfani da ruwa kamar ""fanfo ba tare da hannu ba"" da sauran zaɓuɓɓuka masu ƙarancin amfani. "
Tickless tap, fasaha ce mai sauƙi ta amfani da zane mai rataye ta hanyar igiya da kuma matattarar da ke aiki tare da ƙafa don zuba ruwa kaɗan a kan hannaye da kuma sabulu.
Drying hannaye daidai yana da muhimmiyar mahimmanci na tsabta, amma akwai muhawara game da yadda za a bushe hannayen hannu a cikin dakunan wanka na jama'a.
Yawan bincike da ke ƙaruwa ya nuna cewa tawul ɗin takarda sun fi bushewa na lantarki da ake amfani da su a yawancin dakunan wanka.
A shekara ta 2008, Jami'ar Westminster a London ta gudanar da wani bincike tare da tallafin masana'antar takarda ta takarda ta Turai, don kwatanta matakan kiwon lafiya da takarda takarda, bushewar hannu mai zafi da bushewar hannu na Airjet suka bayar.
Bayan wankewa da bushe hannuwan hannu tare da bushewar iska mai zafi, an gano cewa matsakaicin adadin kwayoyin cuta a kan yatsunsu ya karu da kashi 194% da 254% a kan hannu.
Drying hannu tare da iska ya haifar da ƙaruwa na ƙwayoyin cuta a kan yatsunsu zuwa 42% da 15% a kan hannu.
Bayan wankewa da bushe hannuwan hannu da tawul ɗin takarda, jimlar ƙwayoyin cuta sun ragu da matsakaita zuwa kashi 76% a kan yatsunsu da kashi 77% a kan hannayen hannu. Masana kimiyya sun ci gaba da gudanar da gwaje-gwaje don gano ko akwai yiwuwar kamuwa da cututtukan da ke tattare da duk wani nau'in bushewa.
Airjet Air Dryer, wanda ke fitar da iska daga motar a saurin mita 180 a kowane dakika (kilomita 650 a kowace awa), yana iya hura ƙwayoyin cuta daga hannu da na'urar, yana iya cutar da masu amfani da gidan wanka da yanayin gidan wanka har zuwa mita 2.
Amfani da na'urar bushewa mai zafi yana yada kwayoyin halitta zuwa mita 0.25 na na'urar bushewa.
Tulle takarda bai nuna alamar yaduwar ƙwayoyin cuta ba. A cikin 2005, wani bincike da TÜV Produkt und Umwelt ya yi ya bincika hanyoyin bushewa na hannu daban-daban.
An lura da canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannu:
Akwai kamfanoni daban-daban da ke samar da na'urar bushewa ta hannu, kuma an kwatanta na'urar bushewa da tawul ɗin takarda.
Wanke hannu da tawul din da ke kashe kwayoyin cuta yayin tafiya zai iya maye gurbin ruwa da sabulu.
Magungunan kashe ƙwayoyin cuta na barasa dole ne su ƙunshi aƙalla kashi 60 cikin ɗari na barasa.
Wanke hannu na likita ya zama tilas ne tun bayan da likitan Hungary, Ignaz Smolovich (1846) ya gano ingancinsa wajen hana kamuwa da cuta a cikin asibiti.
Akwai wasu na'urorin lantarki da ke amfani da bayanan martaba don tunatar da ku game da wanke hannu.
Wani binciken ya nuna rage yawan kamuwa da cuta ta amfani da su.
Wanke hannuwan likita, ta amfani da sabulu da ruwa mai yawa ko kayan shafawa da shafa kowane ɓangaren hannu na akalla dakika 15.
Dole ne a shafa hannayen hannu tare da yatsunsu.
Idan akwai ƙwanƙwasawa da ƙwanƙwasawa a ƙarƙashin kusoshi, yana da kyau a yi amfani da goge gashi don tsabtace shi.
Tun da kwayoyin cuta suna cikin ruwa da hannayen hannu, yana da muhimmanci a yi ruwa da kyau kuma a bushe hannayen hannu tare da tawul mai tsabta.
Bayan bushewa, dole ne a yi amfani da tawul na takarda don rufe bututun ruwa (da kuma buɗe kowane ƙofar fitarwa idan ya cancanta).
Wannan yana hana sake kamuwa da hannu ta hanyar irin waɗannan farfajiyoyi.
"Manufar wanke hannu a cibiyoyin kiwon lafiya shine kawar da kwayoyin cuta (""kwayoyin cuta"") da kuma hana yaduwar kwayar cutar. "
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu a mafi yawan wuraren kiwon lafiya yana da matukar damuwa, tare da yawan likitoci da ma'aikatan jinya da ke mantawa da wanke hannayensu kafin su kusanci marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran ayyuka masu sauki na iya rage yawan kamuwa da cutar ta hanyar jini ta hanyar catheter har zuwa kashi 66%. Hukumar Lafiya ta Duniya ta wallafa wata kasida don nuna daidaitattun hanyoyin wanke hannu da kuma maganin kashe kwayoyin cuta a bangarorin kiwon lafiya.
Za ku iya samun jagorar tsabtace hannu da Hukumar Lafiya ta shirya a shafin yanar gizon ta, wanda ke samuwa ga jama'a.
Wani binciken bita mai dacewa da Whitby da abokan aiki suka yi.
Idan ana buƙatar tabbatar da bin ƙa'idodi, na'urorin kasuwanci na iya auna da tabbatar da tsabtace hannu.
"Kungiyar Lafiya ta Duniya ta gabatar da ""matsayi biyar"" don wanke hannu:
Bayan haɗuwa da jini/ruwan jiki
kafin a yi maganin kashe ƙwayoyin cuta, da
"Bayan kula da mai haƙuri. Ƙara magungunan ƙwayoyin cuta na sinadarai zuwa sabulu ("sabo na likita" ko ""antibacterial"") yana taimakawa wajen maganin ƙwayoyin cuta na kayan wanke hannu. "
"Wadannan matakan kashewa suna iya zama masu dacewa kafin aikin tiyata ko kuma a yanayin da kwayoyin da ke jure wa maganin rigakafi ke da yawa. Don ""tsabtace"" hannun mutum don aikin tiyata, yana buƙatar samun ruwa mai tsabta, wanda ba ya buƙatar taɓa hannu, wanda za'a iya buɗewa da rufewa, mai wanke chlorhexidine ko iodine, tawul ɗin sterile don bushe hannuwan bayan wankewa, da kuma goga sterile don cirewa da kuma sauran kayan aikin sterile don tsabtace ƙarƙashin kusoshi. "
Za a kawar da dukan kayan ado.
Wannan hanya ta hada da wanke hannu da hannu har zuwa gwiwoyi na minti biyu zuwa shida.
Ba lallai ba ne a yi masa tausa na dogon lokaci (minti goma).
Sa'ad da yake wanke hannuwansa, kada ruwan da ya zuba a kan wuyansa ya taɓa hannuwansa.
Bayan an gama wanke hannuwan, a bushe hannuwan da tsabtace hannu da kuma sanya tufafi masu tsabta.
Don rage yaduwar ƙwayoyin cuta, yana da kyau a wanke hannuwanku kafin da bayan kula da mai cutar ko amfani da maganin kashe ƙwayoyin cuta.
Game da kula da cututtukan staph a asibitoci, an tabbatar da cewa babban amfanin wanke hannu yana samuwa ne kawai a 20% na farkon wankewa, yayin da ci gaba da wankewa sama da 35% yana da ƙananan ƙarin fa'idodi.
Wankewa da sabulu mai sauƙi yana haifar da sau uku sau da yawa na watsa cututtukan ƙwayoyin cuta idan aka kwatanta da wankewa da sabulu mai ƙwayoyin cuta. Kwatanta shafa maganin giya da hannu tare da wanke hannu da sabulu mai ƙwayoyin cuta na matsakaicin lokaci na 30 seconds ya nuna cewa shafa barasa a hannu yana rage kamuwa da ƙwayoyin cuta da kashi 26 cikin ɗari fiye da sabulu mai ƙwayoyin cuta.
Amma sabulu da ruwa sun fi maganin kashe ƙwayoyin cuta na hannu na barasa a rage cutar kwayar cutar H1N1 da kuma ƙwayar Clostridium difficile. Matsaloli don inganta tsabtace hannu a cibiyoyin kiwon lafiya na iya haɗawa da horar da ma'aikata kan wankewa, haɓaka samun maganin kashe ƙwayoyin cuta na hannu da kuma tunatarwa ta baki da ta rubutu ga ma'aikata.
Ana buƙatar ƙarin bincike don gano wane daga cikin waɗannan ayyukan ya fi tasiri a cikin wuraren kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu an san shi azaman hanya mai araha da mahimmanci don cimma kyakkyawan kiwon lafiya har ma da abinci mai gina jiki.
Koyaya, rashin wadatar ruwa, sabulu ko kayan wanke hannu a cikin gidajen mutane, makarantu da wuraren aiki yana haifar da ƙalubalen samun halayen wanke hannu na duniya.
Misali, a yankunan karkara na Afirka, wuraren wanke hannu suna da karancin wuraren wanke hannu kusa da dakunan wanka na jama'a ko na masu zaman kansu, kodayake akwai wasu zaɓuɓɓuka masu arha don gina wuraren wanke hannu.
Koyaya, ƙananan yawan wanke hannu na iya zama sakamakon ƙwarewar al'ada fiye da rashin sabulu ko ruwa.
Karfafawa da tallafawa wanke hannu da sabulu na iya tasiri yanke shawara na siyasa, wayar da kan jama'a game da fa'idodin wanke hannu da haifar da sauya halaye na dogon lokaci a cikin jama'a.
Kulawa da kimantawa suna da mahimmanci don aiki mai tasiri.
"Binciken da aka yi na nazarin nazarin 70 ya nuna cewa hanyoyin da ke cikin al'umma sun kasance masu tasiri wajen kara wanke hannu a cikin LMICs, yayin da kamfen ɗin tallan zamantakewar ba su da tasiri sosai. Misali na inganta wanke hannu a makarantu shine "tafiya ta taurari uku" ta UNICEF, wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi da araha, kamar tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu ban da bin duk wasu buƙatun kiwon lafiya. "
Bayan sun cimma mafi ƙarancin ƙa'idodi, makarantu na iya samun ci gaba daga tauraro ɗaya zuwa ƙarshe zuwa taurari uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na ayyukan talla na kamfen na wanke hannu da nufin rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ke kokarin canza dabi'u. A sakamakon cutar coronavirus ta 2019-20, UNICEF ta inganta amfani da emojis na wanke hannu.
Ƙananan nazarin sun yi la'akari da tasirin tasirin tasirin kuɗin wanke hannu a cikin ƙasashe masu tasowa dangane da DALYs.
Koyaya, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi sauran hanyoyin ruwa da tsaftace jiki tsada.
"Mahimmancin wanke hannu ga lafiyar mutum, musamman ma mutanen da ke da rauni kamar mata masu haihuwa ko sojoji da suka ji rauni a asibitoci, an fara gabatar da su ne a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: Likitan Hungary Iniaz Smálweis, wanda ke aiki a Vienna a Austria, da Florence Nightingale, ""mai kafa aikin jinya na zamani"" a Ingila. "
A lokacin, yawancin mutane sun yi imanin cewa cututtuka suna faruwa ne saboda mummunar wariyar da ake kira myasmas.
A cikin shekarun 1980, yaduwar cututtukan da ake samu ta hanyar abinci da cututtukan da ke da alaƙa da kiwon lafiya ya sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su inganta tsabtace hannu a matsayin muhimmiyar hanyar hana fara kamuwa da cuta.
Barkewar cutar mura ta alade a shekarar 2009 da kuma annobar COVID-19 a duniya a shekarar 2020, sun sa yawancin ƙasashe suka ƙara sanin mahimmancin wanke hannu don hana irin waɗannan cututtukan.
" Misali, an sanya allon talla tare da "dabaru masu kyau na wanke hannu"" kusa da wankin bayan gida a cikin dakunan wanka na jama'a da kuma dakunan wanka na gine-ginen ofis da filayen jirgin saman Jamus. "
"Furucin nan ""wanke hannuwan mutum daga"" wani abu, yana nufin sanar da rashin son mutum ya yarda da alhakin ko kuma ya shiga cikinsa".
Ya samo asali ne daga wani sashi na Bisharar Matta inda Pontius Bilatus ya hana yanke shawarar gicciye Yesu Almasihu, amma a wasu tattaunawar Turanci yana da amfani mafi girma.
"A cikin Shakespeare ""Macbeth"", Lady Macbeth tana ta maimaita shafa hannayenta don kawar da lalatar da ke nuna lamirinta game da laifukan da ta aikata da kuma tilasta mijinta ya aikata. """
An kuma nuna cewa mutane suna wanke hannayensu sau da yawa bayan tunatarwa ko tunani game da ayyukan lalata kuma suna kula da wanke hannu.
"Bugu da ƙari, mutanen da aka ba su damar wanke hannayensu bayan irin wannan kulawar ba za su iya shiga cikin sauran matakan "tsabtace"" ba, kamar aikin sa kai. "
Addinai suna ba da umarnin wanke hannu don dalilai na kiwon lafiya da na alama. Wanke hannu na alama, amfani da ruwa ba tare da sabulu ba don wanke hannu, wani ɓangare ne na al'adar wanke hannu da aka nuna a addinai da yawa, gami da addinin Baha'i, Hindu, Toila da Nitlat Yadayim a Yahudanci, Lawab a Kiristanci da Wazo a Musulunci. Addinai suna ba da shawarar wanke hannuwan da tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun umurci wanke hannu bayan wanka.
Addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun umurci wanke hannu kafin da kuma bayan kowane abinci.
Kula da haɗarin COVID-19 a cikin yanayin aiki
Kula da haɗarin aiki don COVID-19 yana nufin amfani da hanyoyin kiwon lafiya da aminci na aiki don sarrafa haɗari da hana barkewar cutar coronavirus 2019 (COVID-19).
Ingantaccen sarrafa haɗarin a wurin aiki ya dogara da yanayin aiki da aikin da aka ba da shi kuma ya bambanta dangane da kimanta haɗarin hanyoyin haɗuwa da cutar, tsananin cutar a cikin al'umma da abubuwan haɗari ga kowane ma'aikaci wanda zai iya zama mai saurin kamuwa da COVID-19.
A cewar sanarwar Hukumar Kiwon Lafiya da Tsaro ta Amurka (OSHA), wuraren aiki masu haɗari suna da mafi ƙarancin haɗarin aiki tare da jama'a da sauran abokan aiki, ana ba da shawarar cewa waɗannan wuraren aiki suyi la'akari da mafi ƙarancin matakan da ake buƙata don hana kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, amfani da abin rufe fuska da tsabtace wuri na yau da kullun.
Ayyukan haɗari na matsakaici sun haɗa da waɗanda ba sa buƙatar haɗuwa da mutane da yawa ko kusanci da mutanen da ake zargi da cutar ko waɗanda ke da cutar COVID-19, amma suna iya zama masu haɗari saboda hulɗa kai tsaye da jama'a ko tafiya ta duniya.
Wannan ya haɗa da ma'aikatan da ke hulɗa da jama'a a wurare kamar makarantu, wuraren aiki masu yawan jama'a da kuma wasu manyan kantunan sayar da kayayyaki.
Kula da haɗari ga wannan rukunin, ban da matakan farko na rigakafin kamuwa da cuta, ya haɗa da iska mai iska tare da amfani da matattarar iska mai inganci, kiyaye hancin, da samun kayan kariya na mutum don saduwa da mutumin da ke da cutar COVID-19.
OSHA ta ɗauki ma'aikatan kiwon lafiya da ke cikin haɗari tare da mutanen da ake zargi da COVID-19 a matsayin masu haɗari, waɗanda ke da haɗari sosai idan aka yi amfani da hanyoyin samar da aerosol ko ɗaukar samfurori daga mutanen da ake zargi ko masu cutar COVID-19.
Ciki har da kula da haɗarin aiki wanda ya dace da waɗannan ma'aikatan, ana iya ambata sarrafa injiniyoyi kamar ɗakunan da ke da iska mai matsin lamba da kayan aikin kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da tasiri da yawa a wuraren aiki.
Ma'aikata na iya kasancewa a wurin aiki saboda rashin lafiya, buƙatar kula da wasu, ko tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa, duka dangane da kayan da ake buƙata da kuma yadda ake karɓar waɗannan kayan (kamar sayayya a waje da lokacin aiki ko ta hanyar sabis na isarwa ko sabis na hawa).
A ƙarshe, jigilar kaya daga yankunan da COVID-19 ya fi shafa na iya zama matsala. Don jagorantar matakan kariya, ana iya amfani da shirin shirye-shirye da amsawa ga cutar.
A cikin tsare-tsaren, ana la'akari da matakan haɗari da ke tattare da wurare daban-daban na aiki da ayyukan aiki, gami da tushen haɗuwa da cutar, abubuwan haɗari a cikin zamantakewar jama'a da gida da abubuwan haɗari ga kowane ma'aikaci daban, gami da rashin lafiya ko kamuwa da cuta mai tsanani.
Hakanan, ana bayyana hanyoyin kula da dacewa da ake buƙata don hana waɗannan haɗarin da kuma wasu tsare-tsaren don yanayin da zai iya haifar da barkewar cutar.
Za a iya aiwatar da shirye-shirye da shirye-shiryen amsawa ga cututtukan cututtuka ta hanyar la'akari da shawarwarin ƙasa ko na gida.
Manufofin magance cutar sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan da ke tattare da su, kiyaye ayyukan kasuwanci da rage tasirin tasirin tasirin tasirin sauran ƙungiyoyi a cikin sarkar samar da su.
Matsayin cutar a cikin al'umma, inda kasuwancin ke, yana shafar amsoshin da aka karɓa.
Tsarin tsarin kula da haɗari shine tsarin da aka yi amfani dashi don kiyaye lafiya da lafiya a wuraren aiki don rarraba matakan haɗari bisa ga tasirin tasirin.
Inda ba za a iya kawar da haɗarin COVID-19 ba, sarrafa injiniya da sarrafawar gudanarwa da kayan kariya na mutum sune mafi ingantattun hanyoyin sarrafawa.
Gudanar da aikin injiniya yana nufin kawar da ma'aikata daga haɗarin aiki ba tare da dogara ga halayyar ma'aikaci ba, wannan zai iya zama mafita mafi mahimmanci.
Gudanar da gudanarwa shine canje-canje da aka ba da manufofi ko hanyoyin aiki waɗanda ma'aikata ko ma'aikata zasu bi.
Kayan aikin kare mutum (PPE) ba su da tasiri sosai fiye da sarrafawar hukuma da aikin injiniya, amma suna iya hana wasu haɗari.
Dukkanin nau'ikan PPE dole ne a zaɓa bisa haɗarin da suke da shi ga ma'aikata, sanya su yadda ya kamata (misali masks na likita), amfani da su akai-akai, bincika su, kula da su, canza su, buɗe su, tsabtace su, sake sanya su idan ya cancanta, ko kuma zubar da su don hana kamuwa da cuta.
A cewar sanarwar Hukumar Kiwon Lafiya da Tsaro ta Amurka (OSHA), ayyukan da ke da ƙananan haɗari sune waɗanda ke da ƙarancin hulɗa da jama'a ko abokan aiki.
Abubuwan da aka ba da shawarar don hana kamuwa da cuta ga mutane a duk wuraren aiki sun haɗa da wanke hannu da yawa, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, amfani da abin rufe fuska na numfashi da rufe baki yayin tari ko hancin, samun takarda da kwandunan shara, shirya don sadarwa ta nesa ko lokutan aiki na yau da kullun idan ya cancanta, ƙarfafa ma'aikata su yi amfani da wasu kayan aiki da kuma tsara jadawalin tsaftacewa da kashe ƙwayoyin cuta a cikin aikin.
Ganowa da kuma ware mutanen da ke da yiwuwar kamuwa da cutar da sauri yana da mahimmanci don kare ma'aikata, abokan ciniki, abokan ciniki da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) na Amurka sun ba da shawarar cewa ma'aikata da ke da alamun ciwon numfashi mai tsanani su kasance a gida har sai zazzabi, zazzabi da duk wani alamun sun tafi, aƙalla awanni 24 bayan an daina amfani da maganin zazzabi ko maganin cutar, kuma manufofin amfani da izinin magani sun zama masu sassauƙa don ba ma'aikata damar kasancewa a gida don kula da dangin da ke rashin lafiya kuma duk ma'aikata sun san sababbin manufofin.
A cewar sanarwar OSHA, ayyukan haɗari masu haɗari sun haɗa da ayyukan da ke buƙatar hulɗa da yawa tare da kusan kusan mita 1.8 daga wasu kuma ba a san ko abokan ciniki suna da cutar COVID-19 ba, amma suna iya kamuwa da SARS-CoV-2 saboda yawan tafiya a cikin al'umma ko tafiya ta duniya zuwa inda cutar ta COVID-19 ta ɓarke.
Waɗannan sun haɗa da ma'aikatan da ke hulɗa da jama'a, kamar waɗanda ke aiki a makarantu, wuraren aiki masu aiki da yawa, da wasu manyan wuraren sayar da kayayyaki. Gudanar da aikin injiniya don waɗannan rukunin da kuma rukunin da ke cikin haɗari sun haɗa da shigar da matattarar iska mai inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar su masu hana fitsari na filastik da shigar da kayan aikin sabis na abokin ciniki. Gudanar da ayyukan don waɗannan rukunin da rukunin da ke cikin haɗari sun haɗa da kayan aiki masu haɗari: ƙarfafa ma'aikata su kasance a gida idan sun kamu da rashin lafiya, ƙarfafa ma'aikata su maye gurbin tarurruka a cikin lokutan hulɗa ta hanyar yanar gizo, ƙirƙirar yanayin aiki mai canzawa, soke tafiye-tafiye marasa mahimmanci yayin da cutar ta ɓarke kamar COVID-19, tsara shirye-shiryen sadarwa na yau da kullun, haɗa da takamaiman shawarwari da shawarwari don abokan ciniki, samar da takamaiman takamaiman kayan aiki, samar da takamaiman kayan aiki, kiyaye takamaiman alamun kariya, da sauran abubuwan da ke da alaƙa da COVID-19, da kuma samar da matakan kariya na yau da kullun, da ke nuna cewa abokan ciniki suna fuskantar iyakancewar haɗari, suna da takamaimanin kayan aiki, da ke nuna alamun kariya, da ke nuna cewa suna da alaƙa da kayan aikin kariya, da ke da ke da alaƙa da COVID-19, da kuma samar da alamun kariya ta musamman ga masu amfani da kayan aikin da ke da kayan aikin kariya.
Ma'aikata a cikin wannan rukunin haɗarin ba sa buƙatar injin numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, ana iya amfani da matakan kula da dacewa don kare ma'aikata da sauran fasinjoji, kamar ware mutum mai cutar daga wasu da kuma samar da tazara ta akalla ƙafa 6, sanya ma'aikatan da aka keɓe don mai cutar, samar da abin rufe fuska ga mai cutar da kuma buƙatar rufe baki da hanci da tawul lokacin yin fitsari ko tari.
Ma'aikatan jirgin za su sa safar hannu na likita na amfani guda ɗaya lokacin da suke kula da matafiya marasa lafiya ko taɓa abubuwan da ke cikin jiki ko kuma abubuwan da ke iya gurɓata su kuma su yi amfani da wasu kayan kariya na mutum idan sun kasance masu zazzabi, tari ko ƙarancin numfashi.
Ya kamata a zubar da safofin hannu da sauran kayan da ake amfani da su sau ɗaya a cikin jakar shara ta asibiti, kuma a tsabtace da kuma kashe ƙwayoyin cuta bayan aiki. Don jigilar kasuwanci, gami da jigilar jiragen ruwa da sauran jiragen ruwa, kula da haɗari ya haɗa da jinkirta tafiya idan ba ku da lafiya, keɓewa da sanar da cibiyar likitancin jirgin nan da nan idan kun sami zazzabi ko wasu alamun yayin tafiya.
A mafi kyawun yanayin, ya kamata a bi magani a cikin ɗakin mutum mai zaman kansa. CDC ta ba da shawarar makarantu da cibiyoyin kula da yara su rufe na ɗan gajeren lokaci don tsaftacewa da kashe ƙwayoyin cuta, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba, saboda mai yiwuwa mutum mai cutar ya kasance a cikin ginin makarantar.
Lokacin da yawan yaduwar zamantakewar ya yi ƙasa ko matsakaici, ana iya amfani da dabarun nisantar zamantakewa kamar soke sansani, tarurruka da sauran tarurruka kamar koyarwar gani da ido ko darussan waƙa ko cin abinci a cikin cafeteria, ƙara tazara tsakanin teburin, canza lokutan farawa da ƙarewa, iyakance halartar abokan ciniki marasa mahimmanci da amfani da ofishin kiwon lafiya na musamman don yara masu alamun cutar mura.
Idan akwai yaduwar yaduwar cutar a cikin al'umma, ban da dabarun nisantar jama'a, dole ne a yi la'akari da rufe makarantu na dogon lokaci. CDC ta yi imanin cewa akwai ƙananan haɗarin kiwon lafiya kai tsaye ga ma'aikatan tilasta yin doka waɗanda ke yin ayyukansu na yau da kullun.
Ana ba da shawarar cewa jami'an tilasta yin doka waɗanda ke hulɗa da mutanen da ke da cutar ko waɗanda ake zargi da cutar COVID-19 su bi irin hanyoyin da masu fasahar gaggawa na likita ke bi, gami da amfani da kayan kariya na mutum.
Idan a lokacin da ake fuskantar kamuwa da cutar, ma'aikata su sanya bel da kayan aiki da kuma tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su da tsabtace su.
OSHA ta yi imanin cewa wasu ma'aikata a cikin kiwon lafiya da kuma ma'aikatan gida suna cikin manyan ayyuka masu haɗari ko masu haɗari.
Ayyukan haɗari kamar masu ba da sabis na kiwon lafiya, tallafi, ma'aikatan dakin gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke fuskantar haɗarin kamuwa da cutar ko waɗanda ake zargi da COVID-19.
Idan ma'aikata suna amfani da hanyoyin samar da aerosol, ko karɓar samfurori daga marasa lafiya ko waɗanda ke da cutar COVID-19, waɗannan suna da haɗarin yaduwa sosai.
Hanyoyin samar da aerosol sun hada da yin amfani da bututu, matakan rage tari, bronchoscopy, wasu gwaje-gwaje da tiyata na hakori ko kuma daukar samfurin mai cin zarafi.
Ayyukan da ke cikin gidan sanyi suna da haɗari sosai, wanda ya haɗa da aikin da mutum zai yi don shirya gawawwakin mutanen da ake zargi da cutar COVID-19 bayan mutuwarsu. Idan an yi autopsy a kan gawa, waɗannan ayyuka suna cikin manyan ayyuka masu haɗari. Don waɗannan rukunin haɗari, ana buƙatar ƙarin sarrafa injiniya, gami da ɗakunan keɓewa don marasa lafiya da ake zargi da COVID-19, musamman lokacin da ake aiwatar da hanyoyin samar da aerosol.
A wasu wuraren kiwon lafiya da na gida, iska mai matsin lamba na iya zama mai dacewa.
Dole ne a ɗauki samfurori tare da kiyaye matakan tsaro na matakin karewa na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa sabbin marasa lafiya su kasance a cikin wuraren jira daban, dangane da ko ana zargin sun kamu da COVID-19. OSHA ta ba da shawarar cewa waɗanda ke aiki a tazarar ƙafa 6 daga marasa lafiya ko waɗanda ake zargin suna da SARS-CoV-2, da waɗanda ke yin hanyoyin samar da aerosol, su yi amfani da abin rufe fuska na likita ban da sauran kayan kariya na mutum.
A Amurka, a cikin tsarin cikakken tsari na kariya na numfashi wanda ya haɗa da gwajin fuska, motsa jiki da bincike na likita, dole ne a yi amfani da masks na N95 masu numfashi waɗanda aka amince da NIOSH ko mafi kyawun samfura.
Sauran nau'ikan kayan numfashi na iya samar da ƙarin kariya da haɓaka jin daɗin ma'aikata. WHO ba ta ba da shawarar yin amfani da ƙarin abin rufe fuska ba, saboda COVID-19 cuta ce ta numfashi kuma ba ta yaduwa ta hanyar ɓoyewar jiki.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa a fara binciken allurar rigakafin likita kawai ga ma'aikatan.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa duk wanda ke karɓar, adana, ko watsa samfuran numfashi da aka tattara daga marasa lafiya na COVID-19 ba tare da aiwatar da wata hanyar samar da aerosol ba, ya kamata ya sanya abin rufe fuska, tabarau, garkuwar fuska, sutura da safar hannu.
Idan ana amfani da hanyar samar da aerosol, ana maye gurbin abin rufe fuska na tiyata da abin rufe fuska na N95 ko FFP2.
Ganin cewa samar da kayan aikin PPE a duniya bai isa ba, Hukumar Lafiya ta Duniya ta ba da shawarar rage buƙatar kayan aikin kare kai ta hanyar waɗannan matakan: telemedicine (likitancin nesa), sanya shingayen jiki kamar su shinge mai haske, ba da izinin shiga ɗakin COVID-19 kawai ga waɗanda ke raba kulawa kai tsaye, amfani da PPE kawai don mahimman ayyuka, amfani da abin rufe fuska na likita da rashin amfani da shi yayin kula da marasa lafiya da yawa waɗanda ke da cutar iri ɗaya, saka idanu da daidaita sarkar samar da PPE, kuma a ƙarshe ƙarfafa marasa alamun su yi amfani da abin rufe fuska na yau da kullun.
Daga: Katherine Maher, Shugaba na Wikimedia Foundation
Ga: Duk ma'aikatan Wikimedia Foundation
Rubutun taken: [Covid-19] Sauƙaƙa kaya da shirya don nan gaba
Ranar da aka buga: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Waɗanne haƙƙoƙi ba a kiyaye su ba
A wannan watan mun sami kanmu cikin yanayi mai ban sha'awa.
Cutar ta COVID-19 wani abu ne da ke nuna alaƙar ɗan adam da duniya da kuma nauyinmu ga juna.
Wannan kalubale ne da ba a taɓa gani ba, amma mun san cewa mafi kyawun amsarmu ta dogara ne da jin daɗin haɗin kai, haɗin kai da kuma alhakin zamantakewar da ke zuciyar ƙungiyar.
Jinƙai da kulawa da muka gani ta hanyar imel, kira ta waya da hira tsakanin dukkan abokan aikinmu ya nuna yadda muke farin cikin yin aiki tare da irin waɗannan mutane masu ban mamaki.
Ina matuƙar godiya da na sami abokan aiki kamarku.
A makon da ya gabata, wani ya raba ni da godiya don aikinmu.
Sun tunatar da ni yadda yake da muhimmanci ga duniya ta koma Wikipedia yanzu da kuma yadda kasancewa a kan layi da kuma samun dama ga kowa shine alamar alama ga wannan mahimman albarkatu.
Ƙoƙarinku zai sa wannan ya yiwu, ko kuna taimakawa ci gaba da shafukan yanar gizo ko abokan aiki su sami albashi ko kiyaye al'ummarmu lafiya.
Yanzu fiye da kowane lokaci, duniya tana buƙatar bayanin da Wikipedia ke bayarwa.
Yanzu lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda mahimmancin wannan aikin da rawar da kuke takawa a ciki, za a sami canje-canje masu yawa a cikin yadda muke aiki tare daga makon da ya gabata.
Canjin aiki da jadawalinmu
Kamar yadda Robin ya ambata a baya, membobin ƙungiyar C sun haɗu a daren jiya don tattaunawa game da tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun yi la'akari da abubuwan da muke tsammanin amsar da ta dace ga matsalar da muke fuskanta ita ce hanya mafi kyau don kiyaye ingancin kamfanin.
Muna so mu rage yawan tashin hankali kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kuna buƙatar sake kira, babu matsala.
Ga dukkan ma'aikata, masu kwangila da ma'aikatan kwangila:
Har sai da za a sanar da mu, aikinmu na yau da kullun zai kasance kusan awanni 4 a rana ko awanni 20 a mako.
Ba za mu sanar da dokar kulle ba - idan za ku iya yin aiki fiye da sa'o'i da yawa, za mu iya amfani da taimakonku.
Koyaya, duniya ba ta da tabbas a yanzu, kuma ko kuna buƙatar kula da ƙaunatattunku ko ku sami abinci ko ku nemi likita, lafiyar ku ita ce fifiko a gare mu.
Ba za mu rubuta lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ba mu bukatar mu ambaci wannan, amma za mu sake ambaci wannan.
Ba a buƙatar izinin magani ko PTO - kawai gaya wa manajan ku kuma taimaka wa ƙungiyar ku don sake nazarin kalandarku da rarraba lokaci don tabbatar da cewa an rufe mahimman wuraren aiki.
(Idan sakamakon gwajin COVID-19 naka ya kasance tabbatacce, da fatan za a sanar da Brian a T&amp;C Ops don T&amp;C ta iya taimaka maka ta hanyar ba da tallafi da tabbatar da cewa gudanarwar ta kula da yanayin ka yadda ya kamata).
Za a biya ƙarin albashi ga waɗanda ke aiki a kan sa'a.
Mun riga mun bayyana kuma mun sake yin alkawarin mutunta alkawuranmu ga masu ba da sabis da abokan aikinmu.
Ya kamata a biya kowa albashi daidai da sa'o'in aiki na yau da kullun a cikin yanayi na yau da kullun.
Idan kana rashin lafiya kuma ba za ka iya yin aiki ba, wannan ya haɗa da kai.
Idan kuna son yin aiki, za mu goyi bayan ku.
Mutane da yawa suna amfani da aiki a matsayin hanyar ƙalubalanci damuwa da ke kewaye da su.
Abin da muke yi na iya zama mai amfani sosai, musamman a lokacin da muke ciki.
Muna sake maimaita cewa wannan batun ya shafi kulawar ku.
Abin da muke nema shi ne ka yi magana da manajanka, don mu san abin da za mu yi tsammani kuma mu daidaita kanmu daidai da haka.
Wasu ayyuka suna da muhimmanci.
Akwai abubuwa da ya kamata mu ci gaba da yi.
Kamfanonin SRE, HR Ops, Trust & Safety da ƙungiyoyin tara kuɗi (da sauransu) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin tallafi.
Za mu fara aiwatar da aiki a duk sassan don tantance manufofin yanzu da kuma mai da hankali kan tallafawa duk abin da ya wajaba don aiwatar da wannan aikin.
Akwai ayyuka da yawa da za a yi, amma za mu mai da hankali ne kawai kan ayyukan da suka fi muhimmanci.
Rage saurin aiki a yanzu ba zai haifar da lahani a nan gaba ba.
"Ba mu da niyyar ""ninka lokaci"" don biyan bashin lokacin da cutar ta ƙare. ""
Ba za a bukaci ka yi aiki fiye da yadda ya kamata ba don ka cika wa'adin da aka ba ka, wanda yanzu ba shi da ma'ana.
Mun yarda cewa yanayi ya canza kuma za mu dauki mataki idan ya cancanta don kafa sabbin manufofi da jadawalin lokaci.
Me zai faru da APP (Tsarin Shekara-shekara)?
Don daidaitawa da gaskiyar yau da kullun da tsammanin aiki, muna shirin canza lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Muna shirin fadada shirinmu na 2019-2020 don ba da ƙarin lokaci don kasafin kuɗi, ba ma'aikata damar ba da fifiko ga ayyuka na asali, kula da kansu da ƙaunatattun su, yayin da waɗanda suke buƙatar aiki ko son yin aiki, suna da jadawalin aiki mai sauƙi a cikin makonni masu zuwa.
Wannan tsawaita jadawalin zai rage matsin lamba na yanzu don tsarawa da matsin lamba a kan dukan ƙungiyar.
Za mu gabatar da shawarwarinmu ga kwamiti a mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi matakai na gaba da zarar an amince da su.
Muna godiya ga ƙungiyar APP don jagorancin da suka bayar.
Yanayi, haɗari da tsabtace wurin aiki
A makon da ya gabata, mun gano cewa wataƙila wani ma'aikacin da ke zaune a SF ya kamu da cutar COVID-19.
Koyaya, don kiyayewa, mun sanya ƙungiyar tsabtace rigakafin ƙwayoyin cuta don kashe ƙwayoyin cuta a duk farfajiyar ofishin San Francisco.
Sun yi amfani da maganin rigakafin cutar cutar asibiti don kashe cututtukan duk farfajiyoyi da kuma harabar da ɗakunan da ke ƙarewa zuwa bene na bene.
Ginin yana aiwatar da ladabi na kulawa ta amfani da kayayyakin da ke kare rigakafin mazaunanta.
Muna jin dadi cewa ofishinmu zai kasance a shirye don lokacin da za mu dawo.
Ofishinmu na DC yana cikin WeWork, wanda ya raba ƙa'idodin COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata, ofishinmu na DC ya koma cikin hanyar da ta dace da jagororin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu da ke zaune a birnin New York suka sani, muna tattaunawa don yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta ta.
Wasu abokan aikinmu suna fuskantar aikin nesa a karon farko.
Abokan aikinmu na dogon lokaci dole ne su san cewa canje-canje na iya faruwa kuma na ga ya zama dole in ba da wasu shawarwari:
Za a iyakance tsawon zaman zuwa awa daya ko biyu.
Idan kuna buƙatar tarurruka masu tsawo, kuyi la'akari da raba taron kuma ku gudanar da shi a cikin kwanaki da yawa.
Bayyana taron a fili, shirya jadawalin taron kuma aika abubuwan da za a karanta a gaba.
Yi kiran bidiyo ta hanyar tsoho tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
A duk tarurruka, akwai jagora, wanda ke kula da tattaunawar da ke da alaƙa da tambayoyi, kuma yana bin jerin mutanen da ke magana, kuma yana da wanda zai yi rubutu (ko kuma aiki tare don yin rubutu).
Idan kana buƙatar lasifikan kai mai dacewa, aika imel zuwa goyon bayan fasaha.
Yi amfani da kuɗin da kuka samu don ku sayi kayan ciye-ciye.
Shiga cikin tashar #remoties a Slack kuma ka yi magana da abokan aikinka game da rarraba aiki
Tawagar ayyukan HR za ta bincika jagororin ergonomics da kuma taron karawa juna sani don tallafawa karuwar rarraba aiki a duk faɗin tushe.
A makon da ya gabata, mun nemi duk masu karɓar tallafi su soke duk abubuwan da Wikimedia ke tallafawa, kamar su shirya abubuwan da ke faruwa, har sai Hukumar Lafiya ta Duniya ta sanar da ƙarshen cutar.
Muna sanar da su cewa mun fahimci cewa buƙatarku don sokewa da sauran ƙuntatawa na iya sa kammala ayyukan ba da izinin ba zai yiwu ba kuma ba za a hukunta kowa ba don jinkirta ko canza waɗannan manufofin.
A cikin mako mai zuwa, za mu ba da ƙarin shawarwari game da Wikimania da sauran taron al'umma na gida da na al'ada.
Ya bayyana cewa jama'a a duniya suna cikin damuwa game da wannan katsewa amma suna jin kwanciyar hankali saboda suna iya mai da hankali kan ayyukan zamantakewar su, Wikimedia da sauran hanyoyin.
CRT yana ci gaba da aiki don ƙirƙirar shafi a Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasirin da kuma bin hanyarmu.
Kasance da masaniya game da COVID-19.
Za mu aika da gayyatar don taron ma'aikata na musamman a ranar Alhamis mai zuwa 14:00 UTC 07:00.
Za mu yi amfani da wannan damar don raba ƙarin bayanai, amsa tambayoyinku da tuntuɓar juna.
Mun shiga cikin wannan halin tare kuma muna shirye mu taimaka a duk hanyar da za mu iya.
A halin yanzu, zaku iya ci gaba da samun bayanai ta hanyar imel ɗin nan kuma ku ziyarci Office Wiki don duk sauran mahimman bayanai game da COVID-19.
CRT yana taimakawa wajen sabunta waɗannan shafuka kuma yana adana duk bayanan tare.
Muna yin iya ƙoƙarinmu don tuntuɓar ma'aikatan da ke cikin ƙasashen da suka fi fama da cutar.
Idan kuna da wata tambaya game da tafiya, abubuwan da suka faru, babban aiki, ko ƙalubalen ɗaukar hoto, ko duk wani batun da kuke buƙatar taimako don warwarewa, da fatan za a sanar da CRT da sauri kuma kuyi aiki tare da shi.
Muna shirye don taimakawa wajen samar da tallafi da sadarwa, idan ya cancanta.
Idan kun san wani abu mai mahimmanci ko sirri, da fatan za a aika da imel zuwa Bryan Judan - Manajan Ayyuka na Duniya na HR.
Duk wani daga cikin waɗannan canje-canjen ba za a iya la'akari da su a matsayin barin aiki da alƙawura ba.
Maimakon haka, a wasu hanyoyi, sun nuna cewa aikinmu da ayyukanmu dole ne su daidaita a cikin sabon hanyar da ba a taɓa gani ba.
Waɗannan matakai ne da muka yi imanin cewa suna da mahimmanci don tallafawa juna don ci gaba da aiki, don ba da goyon baya ga motsi da muke buƙata da kuma tallafawa duniyar da ta dogara da ita.
Ayyukan da muka shirya suna jiran lokacin da ya dace.
Yanzu lokaci yayi da za mu tallafawa juna da kuma samar da sarari don mahimman ayyukan da za mu yi a makonni masu zuwa kuma wataƙila watanni masu zuwa.
Muna buƙatar ku duka don yin wannan, don haka muna son ku duka ku kula da kanku da dangin ku don ku kasance cikin mafi kyawun yanayin da za ku iya kasancewa a lokacin da kuke buƙata.
Yanzu, don Allah - ku wanke hannuwanku kuma kada ku taɓa fuskarku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran mambobin ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Enzyme mai canzawa na Angiotensin-2B (ACE2 ) wani enzyme ne wanda ke haɗuwa da farfajiyar waje (ƙashin ƙwayoyin cuta) na ƙwayoyin huhu, jijiyoyin jini, zuciya, kuraje, da kuma amniotic.
ACE2 yana magance aikin enzyme mai canzawa ta hanyar rage yawan angiotensin 2 da haɓaka angiotensin 1-7, yana mai da shi makasudin magani mai tasiri don magance cututtukan zuciya. ACE2 yana ci gaba da aiki a matsayin hanyar shiga cikin ƙwayoyin don wasu coronaviruses.
Ana kiran nau'in enzyme na mutum da hACE2.
Enzyme mai canzawa na angiotensin-2 ya ƙunshi wani sinadarin zinc-ƙunshe da aka sanya a kan ƙwayoyin intravenous da sauran ƙwayoyin.
Furotin ACE2 ya ƙunshi yankin M2 peptidase N-terminal da yankin jigilar amino acid na polymerase C-terminal.
ACE2 shine nau'in furotin membrane mai nau'in guda ɗaya wanda ke da aikin aiki na enzyme wanda ke zaune a saman kwayoyin a cikin huhu da sauran kyallen takarda.
Wani enzyme mai suna Shadaz ya cire yankin waje na ACE2 daga cikin membrane, kuma furotin da aka samu ya sake shiga cikin jini kuma ya ƙare a cikin fitsari.
ACE2 yana cikin mafi yawan gabobin jiki: ACE2 yana haɗuwa da ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta na huhu, ƙananan ƙwayoyin hanji, ƙwayoyin intravascular da ƙwayoyin tsoka a cikin mafi yawan gabobin.
Ana kuma samun mRNA na ACE2 a cikin ƙwayar kwakwalwa, jikin jiki, hypothalamus da kuma kwakwalwa.
Babban aikin ACE2 shine aiki azaman mai daidaita ACE.
ACE hormone ya raba angiotensin 1 zuwa angiotensin 2, wanda shine mai hana jini.
ACE2 a madadin haka, phenylalanine yana ware amino acid carboxyl-terminal daga angiotensin biyu (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana sarrafa shi zuwa angiotensin mai fadada jijiya (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya haifar da raguwa da yawa daga wasu peptides ciki har da /des-arg9-brededicin, neurotensin, dinorphine A da ghrelin.
ACE2 kuma yana daidaita wucewar masu jigilar amino acid SLC6A19 daga membrane kuma yana da tasiri a cikin cututtukan zuciya.
ACE2 a matsayin furotin mai wucewa ta membrane, yana aiki a matsayin babban wurin shiga kwayar halitta don wasu coronaviruses, gami da HCoV-NL63 (wanda ke haifar da SARS) da SARS-CoV-2 (wanda ke haifar da COVID-19).
Musamman, haɗuwa da furotin na S1 a cikin SARS-CoV da SARS-CoV2 zuwa yankin enzyme na ACE2 a saman ƙwayoyin halitta, yana haifar da endocytosis da watsa duka ƙwayoyin cuta da enzymes zuwa endosomes a cikin ƙwayoyin.
Wannan aikin shigar da kwayoyin yana buƙatar shirya furotin S ta hanyar TMPRSS2 mai karɓar serine protease wanda hana shi ana nazarin shi azaman magani mai yiwuwa. Wannan ya haifar da zato cewa rage matakin ACE2 a cikin sel na iya taimakawa wajen magance kamuwa da cuta.
Koyaya, ƙungiyoyi da yawa na magana da cibiyoyin sa ido sun ba da shawarar ci gaba da daidaitaccen ACE inhibitor da maganin ARB.
"Binciken farko da meta-bincike da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa ""amfani da masu hana ACE yana da alaƙa da raguwar haɗarin ciwon huhu da kashi 34 cikin ɗari idan aka kwatanta da sarrafawa"."
"Bugu da kari, ""hadarin ciwon nono ya ragu a cikin marasa lafiya da aka bi da masu hana enzymes na angiotensin-converting, marasa lafiya da ke da haɗarin ciwon nono, musamman marasa lafiya da ke fama da bugun jini da rashin karfin zuciya".
"Amfani da masu hana ACE yana da alaƙa da rage mutuwar cututtukan huhu, kodayake sakamakon bai da ƙarfi sosai game da haɗarin cutar huhu gaba ɗaya. """
A wani ɓangare, an gano cewa mutum na mutum na ACE2 (rhACE2), sabon magani ne don mummunan raunin huhu, wanda ya haifar da ingantaccen ƙwayar huhu da kuma oxygen saturation a cikin aladu da ke fama da ciwon ciwon huhu mai tsanani wanda ya haifar da lipopolysaccharide.
Rabin rabin rayuwar rhACE2 a cikin mutane yana da kimanin sa'o'i 10 kuma farawa na aiki yana da minti 30 tare da tsawon lokacin tasiri na awa 24.
Bincike daban-daban sun nuna cewa rhACE2 na iya zama magani mai ban sha'awa ga waɗanda ke da tsayayya ga masu hana tsarin rhinine-angiotensin (RAS inhibitors) na gargajiya ko kuma marasa lafiya tare da dogon lokaci na angiotensin II. An bincika allurar rhACE2 a cikin nazarin asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututut
"Aikace-aikacen COVID-19 B sune aikace-aikacen software na wayar hannu waɗanda aka tsara don taimakawa wajen bin diddigin lamba don amsa cutar coronavirus ta 2019-20, ma'ana, aiwatar da gano mutane (""Lambobi") waɗanda zasu iya kasancewa cikin hulɗa da mai kamuwa da cutar".
An samar da aikace-aikace da yawa ko haɓaka su tare da tallafin hukuma a wasu yankuna da yankuna.
An samar da wasu tsarin don ƙirƙirar aikace-aikacen bin hanyar sadarwa.
Akwai damuwa game da tsare sirri, musamman game da tsarin da ke aiki bisa ga bin diddigin yanayin masu amfani da aikace-aikacen wayar hannu.
Zaɓuɓɓuka masu ƙarancin tsangwama sun haɗa da amfani da siginar Bluetooth don yin rajistar kusanci mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su ba da damar tallafawa waɗannan ƙa'idodin tushen Bluetooth kai tsaye a cikin tsarin aiki na Android da iOS.
A China, gwamnatin kasar Sin, tare da haɗin gwiwar Alipay, ta ƙaddamar da wani shiri wanda ke ba da damar 'yan ƙasa su bincika ko sun taɓa yin hulɗa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da software mai suna Tris Togder.
"Kungiyar IT ta gari ta haɓaka wannan aikace-aikacen, an buga shi azaman buɗe rubutu kuma an ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da aikace-aikacen wayar hannu da ake kira "" Dakatar da Korona! "", wanda ke da tushen Bluetooth don bin diddigin tuntuɓar mutanen da ke da yiwuwar kamuwa da cutar, wanda ke ba da damar saurin amsawa ga hukumomin kiwon lafiya".
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da wannan software.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnati ta bayyana cewa shirin bin diddigin lamba yana cikin wani mataki na ci gaba kuma zai kasance a cikin makonni don turawa. An shirya irin wannan shirin a Ireland da Faransa (""StopCovid"")".
Ostiraliya da New Zealand suna tunanin samar da software bisa tushen software na Singapore na WeTreeSignal da kuma yarjejeniyar Bluetooth. Rasha na shirin tsara software na shinge na ƙasa don marasa lafiya da aka bayyana sun sami COVID-19 kuma suna zaune a Moscow don tabbatar da cewa ba sa barin gida.
Ross Anderson, Farfesa a fannin Injiniyan Tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu amfani da tsarin tushen aikace-aikace, gami da lokuta masu kyau da rashin inganci idan ana amfani da aikace-aikacen ga ƙananan ɓangaren jama'a.
"Dangane da damuwa game da yaduwar ɓatarwa ko cutarwa ""Covid-19"" apps, Apple ya sanya ƙuntatawa ga ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi COVID-19 zuwa App Store, yana iyakance wannan ga ƙungiyoyi masu 'hukuma' ko masu izini".
Google da Amazon sun aiwatar da irin wannan ƙuntatawa.
Masu fafutukar kare sirrin mutane sun nuna damuwarsu game da amfani da sa ido na gama gari ta hanyar amfani da aikace-aikacen COVID, musamman game da dakatar da tsarin sa ido da aka kirkira don magance cutar COVID-19 bayan an kawar da barazanar kwayar cutar.
Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kungiyoyi sun sanar da sharudda 8 don ayyukan gwamnati:
"Dole ne sa ido ya zama ""doka, dole, kuma mai dacewa"";"
Za a dakatar da fadada sa ido da kuma sa ido a kan ranar ƙarshe;
Dole ne a iyakance amfani da bayanai ga dalilai na COVID-19.
Dole ne a kiyaye tsaro da rashin sani na bayanai kuma dole ne a tabbatar da wannan kariya ta hanyar shaida.
Kulawa ta dijital ba za ta zama tushen haɓaka nuna bambanci da keɓewa ba;
Duk wani ɓangare na raba bayanai tare da wasu kamfanoni dole ne a bayyana a cikin doka;
Dole ne a sami kariya daga cin zarafi da kuma haƙƙin ɗan ƙasa don amsawa ga masu cin zarafi;
"Za a buƙaci sa hannu mai ma'ana daga dukkan "'yan wasa masu dacewa"", gami da masana kiwon lafiyar jama'a da ƙungiyoyin da aka ware. Kungiyar Kwamfuta ta Haramtattun Jam'iyyun Jamus (CCC) da kuma Masu Ba da Labarai Ba tare da Iyaka (RASF) sun kuma buga jerin abubuwan dubawa".
Shirin da Google/Apple suka gabatar yana nufin kawar da matsalar sa ido ta ci gaba ta hanyar cire tsarin bin diddigin daga tsarin aiki na na'urar su, lokacin da ba a buƙatar su.
Wasu ƙasashe suna amfani da bin hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatar saukar da aikace-aikace da kuma yiwuwar kauce wa bin sawu.
An tabbatar da bin hanyar sadarwa a Isra'ila.
Hanyoyin sadarwa waɗanda ke samun damar bayanan wuri na asali suna haifar da matsalolin sirri.
Duk da haka, ba duk tsarin da ke da sabobin tsakiya ba ne ke buƙatar samun damar yin amfani da bayanan wurin mutum. An kafa wasu tsarin tsare sirri waɗanda ke amfani da sabobin tsakiya kawai don sadarwa ta biyu (duba sashe na ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba a amfani da shi ba don bin diddigin kira.
Maimakon amfani da aikace-aikacen rarrabawa, tsarin yana tattara bayanan sa ido daga tushe daban-daban, gami da bayanan sa ido na wayar hannu da bayanan ma'amala na katin kuɗi, kuma yana haɗa su don samar da faɗakarwa ta hanyar saƙonnin rubutu ga mutanen da ake zargi da kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu sauraro, gwamnati ta ba da damar samun bayanan wurin jama'a, wanda aka ba da izinin saboda canje-canje masu yawa a cikin dokokin sirri bayan barkewar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo. Kasashe kamar Jamus sun yi la'akari da amfani da tsarin tsakiya da tsare sirri.
Har zuwa 6 ga Afrilu, 2020, ba a buga cikakken bayani ba.
Binciken kira don tsare sirri shine kyakkyawan ra'ayi wanda ya haifar da bincike mai yawa tun aƙalla 2013. Tun daga 7 ga Afrilu, 2020, sama da ƙungiyoyin masana da yawa suna aiki akan ingantattun hanyoyin magance sirrin sirri, kamar amfani da Bluetooth low-power (BLE) don yin rajistar kusanci ga mai amfani da wasu wayoyin hannu.
Koyaya, PEPP-PT ƙoƙari ne na daidaitawa wanda ya haɗa da duka hanyoyin da aka rarraba da kuma hanyoyin da ba na yarjejeniya ɗaya ba. Tsarin da ba a rarraba ba ya haɗa da bin diddigin kewayen sirri (DP-PPT / DP-3T), ƙididdigar kiran TCN na ɗan lokaci, ƙididdigar abubuwan da suka faru na kira (FKA, CEN), ladabi masu mahimmanci na sirri da kuma hanyoyin bin diddigin kiran wayar hannu (PACT), da sauransu.
A cikin waɗannan ladabi, bayanan da za a iya ganowa na mutum ba zai taɓa barin injin ba kuma duk bin sawu yana faruwa a cikin injin.
Rukunin tsare sirri a MIT Media Lab yana haɓaka SafePaths, wani dandamali wanda ke amfani da fasahohin tsare sirri yayin tattarawa da amfani da bayanan wuri ko maɓallin kewaye don bin hanyar yaduwar COVID-19.
"Ya dogara ne akan bincike daga farar takarda ""Aikace-aikacen sun tafi ɓarna: Tsare Sirri a Lokacin Cutar"" wanda aka buga a watan Maris na 2020. Wani ƙoƙari makamancin haka shine dandamali na SafeTrace ta Enigma MPC, wani kamfani da ke haɓaka fasahar tsare sirri wanda aka fara ƙirƙira shi a MIT Media Lab".
SafeTrace yana amfani da fasahar kayan aiki mai aminci don bawa masu amfani damar raba bayanan wuri mai mahimmanci tare da sauran masu amfani da hukumomi ba tare da yin barazanar sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi sun kafa TCN Global Coalition a kusa da ainihin tsarin da aka tsara da kuma ladabi masu yawa, tare da nufin rage yawan aiki da haɓaka haɗin gwiwar duniya a cikin bin diddigin da shirye-shiryen faɗakarwa, wanda shine babban mahimmin abu don samun karɓar karɓa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe yarjejeniyar BlueTrace da aka yi amfani da ita a cikin software na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa tsarin aiki na Android da iOS na wayoyin hannu, sun ba da sanarwar sabon abu don bin diddigin lamba, bisa ga haɗin haɗin Bluetooth mai ƙarancin makamashi da ɓoye sirrin sirri, wanda suke da'awar yana kiyaye sirrin sirri.
Sun kuma buga ƙayyadaddun bayanai game da manyan fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin don fadadawa a matakai uku:
An gabatar da sabbin kayan aiki don baiwa gwamnatoci damar kafa shirye-shiryen gano COVID-19 na hukuma tare da kiyaye sirri.
Haɗa kai tsaye cikin iOS da Android; Google da Apple suna shirin rarraba tsarin ta hanyar sanarwar tsarin aiki da farko don magance matsalolin rage sayayya da sa ido na dindindin, sannan kuma cire shi ta wannan hanyar bayan an wuce haɗari.
Sake amfani da magani b (wanda aka fi sani da maganin da aka canza, sake fasalin, sake amfani, ko kuma sake amfani da magani) shine sake amfani da magani da aka amince da shi don magance wata cuta ko yanayin kiwon lafiya daban da abin da aka yi amfani da shi da farko.
Wannan wani bangare ne na binciken kimiyya wanda ake bi yanzu don haɓaka ingantattun magunguna masu lafiya don COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da allurar jini ga mutanen da suka warke. SARS-CoV-2 yana da sunadarai 66 waɗanda za a iya haɓaka magunguna a kansu, kowannensu yana da wurare da yawa na haɗuwa da ligand.
Binciken waɗannan wuraren haɗuwa zai ba da kyakkyawan tsari don samar da maganin rigakafin cutar da ke da tasiri ga sunadarai na COVID-19.
Daga cikin mahimman sunadarai masu mahimmanci na SARS-CoV-2, sun hada da papine-like protease, RNA-dependent RNA polymerase, helicase, protein S, da ribophosphate ADP.
Hussain A.A. da abokan aikinsa sun yi nazarin wasu samfuran samfurin da aka inganta da kuma nazarin su don kamanceceniyar tsarin su da irin wannan magani tare da mafi girman ƙimar amincewa don hanzarta haɓaka maganin anti-SARS-CoV-2 a cikin binciken su na farko, wanda aka ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda ake amfani dashi don magance wasu cututtukan autoimmune.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chloroquine da hydroxychloroquine sun kasance daga cikin magunguna huɗu da ake nazarin su a matsayin ɓangare na binciken asibiti na haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani da gaggawa (EUA).
Ba a amince da wannan magani ta hanyar tsarin gwajin asibiti na FDA ba kuma ana ba da izinin kawai azaman magani na gwaji don maganin gaggawa a cikin marasa lafiya da ke asibiti kuma ba za su iya karɓar magani a cikin gwajin asibiti ba.
"Cibiyar Kula da Cututtuka da Cututtuka ta ce ""amfani, sashi ko sake zagayowar hydroxychloroquine don hana ko magance kamuwa da cutar SARS-CoV-2"" ba a tabbatar da shi ba tukuna.
"Likitoci sun ce suna amfani da wannan magani ne kawai idan ""babu wani zaɓi""".
Wata ƙungiyar bincike ta Turkiyya a Wileypool tana gudanar da bincike kan amfani da chloroquine a hade tare da Rhin, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Jami'ar NYU Langone ta Likita tana gudanar da gwaji kan aminci da ingancin amfani da hydroxychloroquine don rigakafi.
"Binciken asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin cewa Faviprovir ya kasance ""cikakke mai tasiri""".
Tare da matsakaicin kwanaki 4, sakamakon gwajin ga marasa lafiya 35 a Shenzhen ya kasance mara kyau yayin da tsawon lokacin cutar a cikin marasa lafiya 45 waɗanda ba su karɓa ba ya kasance kwanaki 11.
A cikin binciken da aka yi a Wuhan akan marasa lafiya 240 da ke fama da cututtukan huhu, rabin mutanen sun sami favipiravir da rabi na omycinovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke tallafawa wannan magani ba ta da yawa kuma ba ta da tushe.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adanawa kuma za ta sami taimako daga sojoji don jigilar maganin zuwa asibitocin jami'a inda za a yi amfani da shi don kula da marasa lafiya na COVID-19.
"A cewar jaridar ""South China Morning Post"", Shinzo Abe ya ba gwamnatin Trump shawarar sayan maganin. Wannan maganin na iya zama da karancin tasiri a cikin mawuyacin hali inda cutar ta riga ta sakewa".
Ba za a iya amfani da shi ba ga mata masu ciki ko mutanen da ke ƙoƙarin yin haihuwa.
"Wani bincike da aka yi akan lupinavir/ritonavir (KALTRA), wani hadadden maganin cutar kwayar cutar lupinavir da ritonavir, ya kammala cewa ""ba a ga wani amfani ba""".
An tsara waɗannan magungunan don hana yaduwar HIV ta hanyar haɗuwa da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara maganin kuma suna neman cakuda don haɗawa da SARS-CoV-2 protease. Akwai zargi a cikin al'ummar kimiyya game da tura albarkatu zuwa jujjuya amfani da magungunan ƙwaƙwalwa, musamman magungunan da aka samar don cutar kanjamau.
Hukumar Lafiya ta Duniya ta haɗa da maganin lupinavir/ritonavir a cikin gwajin haɗin gwiwar ƙasa da ƙasa.
Gilead Sciences ta samar da kuma haɓaka Remdesivir a matsayin magani don cutar Ebola da kamuwa da cutar Marburg. Daga baya Gilead Sciences ta gano cewa Remdesivir yana da aikin rigakafin ƙwayoyin cuta a cikin yanayin gonar da ke cikin filastik da yawa da suka shafi filastik, nono, paramexo da coronaviruses.
Wata matsala game da maganin rigakafin cutar ita ce samar da juriya ta hanyar maye gurbi wanda zai iya haifar da cutar da kuma watsawa mai tsanani.
Wasu nazarin farko na gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin don juriya. Ana gudanar da bincike na asibiti da yawa, gami da biyu da Asibitocin Jami'ar Cleveland suka gudanar; daya ga mutanen da ke da rauni mai rauni da kuma wani ga masu fama da cutar mai tsanani.
Ana gudanar da gwaji uku na asibiti don allurar bitamin C ga marasa lafiya masu fama da cutar COVID-19 da ke asibiti; gwaji biyu tare da sarrafawar wuribo (China, Kanada) da gwaji ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin maganin Azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana shirin gudanar da gwajin asibiti don alusco-trigine (cicalsonide), wani corticosteroid na numfashi don asma, don kula da marasa lafiya masu alamun cutar coronavirus.
Wani nau'i na enzyme mai canzawa na angiotensin 2 yana gudana a matsayin gwaji na biyu tare da marasa lafiya 200 da aka zaɓa daga cikin masu fama da cutar a Denmark, Jamus da Austria don ƙayyade tasirin magani.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada suna nazarin rawar da calcine ke takawa wajen rage kumburi da matsalolin huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken, wanda ake kira COLCORONA, zai amfana da mutane 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 amma suna fuskantar alamun rashin lafiya waɗanda ba sa buƙatar kwance a cikin gado.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba sa amfani da maganin hana ɗaukar ciki mai tasiri ba su cancanci.
An gwada wasu magungunan hana hana hanawa a Italiya.
Ana amfani da heparin sosai don kula da marasa lafiya saboda ƙarancin nauyin kwayoyin halitta, wanda ya sa Hukumar Magunguna da Kiwon Lafiya ta Italiya ta ba da jagororin amfani da shi.
An sanar da wani bincike mai yawa a kan marasa lafiya 300 da ke nazarin amfani da sodium anoxafarin a cikin allurai na rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cuta ce, an ba da hankali sosai ga amfani da maganin rigakafin cutar da aka amince da shi don cutar da ta gabata kamar MERS, SARS da West Nile.
Ribavirin: Ana ba da shawarar ribavirin bisa ga bugu na bakwai na jagorar kasar Sin don maganin COVID-19.
Omnifenoir: An ba da shawarar Omnifenoir don maganin COVID-19 bisa ga gyara ta bakwai na jagororin kasar Sin.
Wasu magungunan rigakafi da aka sani a matsayin yiwuwar maganin COVID-19 sun haɗa da:
Tosylisomb (mai karɓar IL-6): China ta amince da shi.
An kuma gudanar da gwaji a Italiya da China kuma za ku iya ganin tosylisumab #COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce ta asali da ke da alaƙa da cutar coronavirus ta 2019 (COVID-19).
Kodayake babu wani allurar rigakafi da ta kammala gwajin asibiti, ana yin ƙoƙari da yawa don ƙirƙirar irin wannan allurar.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ba da sanarwar cewa ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 a cikin ƙasa da watanni 18.
A watan Afrilu, an gabatar da alluran rigakafi guda biyar a cikin gwajin rigakafin farko.
An gano COVID-19 a watan Disamba na 2019.
Wani babban barkewar cutar a duk duniya a cikin 2020, wanda ya haifar da babban jari da ayyukan bincike don ƙirƙirar allurar rigakafi.
Yawancin kungiyoyi suna amfani da kwayoyin halittar da aka saki don haɓaka yiwuwar alluran rigakafi don magance SARS-CoV-2.
Kamar yadda aka bayyana a watan Afrilu, jagororin shirin CEPI don haɓaka alluran rigakafi sun haɗa da: saurin, ƙarfin samarwa, faɗaɗa a sikelin da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa an gudanar da bincike da samar da fasahohi daban-daban 10 a farkon 2020 don samar da ingantaccen allurar rigakafin COVID-19.
Babban manufofin dandamali, wanda ya ci gaba a cikin karatun rigakafi na farko, sun haɗa da:
Nucleic acid (DNA da RNA) (mai haɓaka mataki na ɗaya da ɗan takarar allurar rigakafi: Moderna, mRNA-1273)
Mai ɗaukar hoto (lokacin haɓaka na farko da allurar rigakafi: CanSino Biologics, mai ɗaukar hoto adenovirus nau'in 5).
A cikin watan Afrilu, masana kimiyya na Alliance for Epidemic Preparedness Innovations (CEPI) sun ba da rahoton cewa akwai alluran rigakafi 115 a cikin matakan farko na ci gaba, tare da 78 da aka amince da su a matsayin ayyukan aiki (79, a cewar Cibiyar Milken) da sauran alluran rigakafi 37 da aka sanar amma akwai bayanai kaɗan ga jama'a (wanda ake zaton suna cikin tsarin tsarawa ko zane).
Gwajin lokaci na I-II yana gwada rigakafin farko da haɓakar rigakafi kuma galibi ana sarrafa shi ta hanyar bazuwar da sarrafawa ta hanyar placebo kuma ana yin sa a wurare da yawa, yayin da ake ƙayyade mafi inganci da madaidaicin sashi.
Gwaje-gwajen lokaci na 3 galibi suna ɗaukar mahalarta da yawa, gami da ƙungiyar sarrafawa da gwajin ingancin allurar rigakafin don hana cutar da kuma lura da tasirin sakamako a cikin adadin da ya dace.
"Daga cikin alluran rigakafi 79 da aka gabatar waɗanda ke cikin ci gaba (wanda aka amince da su a farkon Afrilu 2020), 74 ba su kai matakin gwaji na ɗan adam ba (har yanzu suna cikin binciken "" preclinical "")".
A ranar 24 ga Janairun 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana nazarin yiwuwar allurar rigakafin kwayar cuta wanda ke canza kwayoyin halittar sunadarai na kwayar cuta don motsa martani na tsarin garkuwar jiki.
A ranar 24 ga Janairun 2020, Cibiyar allurar rigakafin ƙasa da ƙasa (VIDO-InterVac) a Jami'ar Saskatchewan ta Kanada ta sanar da fara aikin kan allurar rigakafi, wanda ke da niyyar fara gwajin ɗan adam a 2021.
An sanar da ayyukan samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanin Johnson Pharmaceutical Company karkashin jagorancin Hank Schweitzer ya sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen yana samar da allurar rigakafin da ake amfani da ita tare da abokin aikinsa na fasahar kere kere, Vaxart.
A ranar 18 ga Maris, 2020, BioSolutions Emergent ta sanar da haɗin gwiwar samarwa tare da Vaxart don samar da allurar.
A ranar 8 ga Fabrairun 2020, Labarin Incogen a Romania ya buga wata takarda game da ƙirar allurar rigakafi tare da fasahar da ta yi kama da allurar rigakafin da aka yi amfani da ita don magance cutar kansa, ta hanyar yin allurar rigakafin sabon antigen.
A ranar 25 ga Maris, shugaban cibiyar ya sanar da cewa sun kammala hada allurar rigakafi kuma sun fara gwaji.
A ranar 27 ga Fabrairun 2020, NuGenerex Immuno-Oncology, wani ɓangare na Generex, ya sanar da cewa sun fara aikin samar da allurar rigakafi don samar da allurar rigakafin peptide Ii-Key akan COVID-19.
"Sun so samar da wani allurar rigakafin da za a iya gwadawa a kan mutane cikin ""kwanaki 90"".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Likita da Kayan Aiki ta Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, dukansu suna yammacin Maryland, sun ba da sanarwar cewa suna aiki kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa za ta yi aiki tare da Novavax.
A cikin ci gaba da samar da allurar rigakafi.
Abokan hulɗa sun sanar da shirye-shiryen ci gaba da gwajin gwaji da kuma gwajin gwaji na farko har zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna kan ayyukan keɓance abubuwa sama da 11, kuma har ma da saurin bin hanyoyin, samar da allurar rigakafi zai ɗauki aƙalla shekara ɗaya da rabi zuwa biyu.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasaha na halittu a Quebec, ya sanar da samar da kwayar cutar coronavirus-kamar ta amfani da kudaden shiga daga Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Wannan samfurin allurar rigakafi yana cikin binciken gwaji na dakin gwaje-gwaje kuma an shirya gwajin mutum a watan Yuli ko Agusta 2020.
"A ƙarshen wannan makon, Jaridar Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba da CureVac "dimbin kuɗi don samun damar allurar rigakafin COVID-19", kuma ya fuskanci ƙin yarda da gwamnatin Jamus".
A ranar 17 ga Maris, 2020, kamfanin Pharmaceutical na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Ana sa ran fara allurar rigakafin mRNA mai son rai, wanda ake kira BNT162, wanda a halin yanzu yana cikin farkon gwajin asibiti, a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar halittu na Italiya ya ba da sanarwar cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020, kuma za a iya gwada samfurin allurar rigakafin ƙarshe a cikin mutum.
A Faransa, a ranar 19 ga Maris, 2020, Ƙungiyar Innovation for Epidemic Preparedness (CEPI) ta ba da dala miliyan 4.9 na Amurka don ƙungiyar bincike kan allurar rigakafin COVID-19, wanda ya haɗa da Cibiyar Pasteur, Themis Bioscience (Wien, Austria) da Jami'ar Pittsburgh, wanda ya kawo saka hannun jari a cikin allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don samar da allurar rigakafin COVID-19 sun haɗa da: Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
Hukumomin kiwon lafiya na Rasha sun sanar a ranar 20 ga Maris, 2020 cewa masana kimiyya sun fara gwaji a kan samfuran allurar rigakafi daban-daban guda shida.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da allurar rigakafin RNA mai haɓaka kanta don COVID-19.
An samar da samfurin rigakafin a cikin kwanaki 14 bayan an karɓi jerin daga China.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da cewa ta ba da tallafin dala miliyan 275 na Kanada don bincike 96 kan matakan rigakafin COVID-19, gami da samfuran allurar rigakafi da yawa a kamfanonin Kanada da jami'o'i kamar Medicare da Jami'ar Saskatchewan.
"A lokaci guda, gwamnatin Kanada ta sanar da kasafin dala miliyan 192 musamman don samar da allurar rigakafin COVID-19 tare da shirye-shiryen ƙirƙirar ""bankin allurar rigakafin ƙasa"" tare da sabbin alluran rigakafi da yawa don amfani da su idan wasu cututtukan COVID-19 suka ɓarke".
"A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Kiwon Lafiya ta Jami'ar Pittsburgh sun sanar da gwajin PittCoVacc, wanda shine yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna cewa ""MNA ta sami alluran rigakafin SARS-CoV-2 S1 subunit, wanda ya haifar da martani na musamman na antigen mai ƙarfi [a cikin beraye] wanda ya bayyana makonni 2 bayan rigakafi. """
A ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Kwalejin Waterloo ta sanar da ƙirar samfurin allurar rigakafin DNA a matsayin yiwuwar fesa hanci.
Ta amfani da bacteriophages, ana tsara DNA don ninkawa a cikin ƙwayoyin cuta na ɗan adam don samar da ƙwayoyin cuta marasa lahani, waɗanda zasu iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta akan kwayar SARS-CoV-2.
A watan Maris na 2020, gwamnati, masana'antu da jami'o'i uku na Amurka sun haɗa albarkatun da ake buƙata don samun damar kwamfutocin IBM, tare da albarkatun girgije daga Holt Packard, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da tasirin da ba daidai ba, wanda ake kira tasirin da ba na musamman ba.
Wannan yana nufin cewa suna iya samun fa'idodi fiye da rigakafin cuta.
Wani gwaji na bazuwar a Ostiraliya yana neman yin rijistar ma'aikatan kiwon lafiya 4,170.
Akwai yiwuwar cewa alluran rigakafin da ake samarwa ba su da lafiya ko tasiri.
Binciken farko don kimanta ingancin allurar rigakafi ta amfani da ƙirar dabbobi na COVID-19, waɗanda suka haɗa da beraye masu canjin jini-ACE2, da sauran dabbobin gwaji da dabbobi masu shayarwa, sun nuna buƙatar matakan tsaro na matakin 3 don sarrafa ƙwayoyin cuta masu rai da kuma daidaitaccen tsarin aminci na duniya.
An gwada alluran rigakafin SARS da MERS a kan samfuran dabbobi.
Har zuwa 2020, babu wani magani ko allurar rigakafi don SARS da aka nuna yana da aminci da tasiri a cikin mutane.
A cewar wasu takardu da aka buga a shekara ta 2005 ko 2006, gabatar da sababbin alluran rigakafi da magunguna don maganin SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duk duniya.
Lokacin da MERS ya zama sananne, an yi imanin cewa binciken da ake yi a kan SARS na iya samar da samfurin da ya dace don samar da allurar rigakafi da maganin MERS-CoV.
Tun daga watan Maris na 2020, akwai allurar rigakafin MERS (wanda aka kafa ta DNA) wanda ya kammala gwajin gwaji na farko, kuma akwai wasu uku da ke gudana, dukansu alluran rigakafin kwayar cutar, biyu adenoviral vector (ChAdOx1-MERS, BVRS-GamVac) da kuma wani hali na MVA vector (MVA-MERS-S).
Sakonnin kafofin watsa labarun sun inganta ka'idar makirci da ke da'awar cewa an san kwayar cutar da ke haifar da COVID-19 kuma riga-kafin ya riga ya wanzu.
Takaddun shaida da aka ambata ta hanyar sakonnin kafofin watsa labarun daban-daban suna nufin takaddun shaida na asali don jerin kwayoyin halitta da alluran rigakafi don sauran nau'ikan COVID-19 kamar SARS.
Cutar coronavirus ta 2019 (COVID-19) cuta ce mai saurin kamuwa da cuta ta hanyar cutar coronavirus mai saurin kamuwa da cuta ta 2 (SARS-CoV-2).
Alamomin da aka saba gani sun hada da zazzabi, tari da kuma numfashi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, asarar ƙanshi da ciwon ciki.
Daga lokacin kamuwa da cutar zuwa bayyanar cututtuka, yawanci yakan ɗauki kwanaki 5, amma zai iya bambanta daga kwana biyu zuwa 14.
Kodayake yawancin mutane suna da alamun bayyanar cututtuka, wasu suna fama da cutar sankarar daji da kuma rashin aiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 a kasashe da yankuna 210, wanda ya yi sanadiyar mutuwar mutane sama da 153,000.
An warkar da mutane sama da 568,000. A farkon, cutar ta yadu tsakanin mutane ta hanyar hulɗa kai tsaye, yawanci ta hanyar saukad da ruwa ta tari, hancin ko magana.
Lokacin da aka samar da waɗannan saukad da a lokacin da ake yin saffir, sukan tsaya a ƙasa ko a saman maimakon su motsa nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓa wani abu mai cutarwa sannan su taɓa idanu, hanci ko baki.
Kwayar cutar na iya rayuwa a saman mutane sama da awanni 72.
Cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya samun yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ake zargi da kamuwa da cutar da kuma masu kula da su.
Shawarwarin game da amfani da abin rufe fuska ga jama'a sun bambanta, wasu hukumomi suna adawa da amfani da abin rufe fuska, wasu suna ba da shawarar, wasu kuma sun sanya shi tilas.
A halin yanzu, babu wani rigakafi ko maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a cikin mafi yawan ƙasashe a duk yankuna shida na Hukumar Lafiya ta Duniya.
Mutanen da suka kamu da cutar bazai iya nuna alamun cutar ba ko kuma suna iya nuna alamun cutar kamar zazzabi, tari, gajiya ko numfashi.
Alamomin gaggawa sun haɗa da wahalar numfashi, ciwo ko ci gaba da matsawa a kirji, rikicewa, wahalar farkawa da launin shuɗi a fuska ko lebe; idan waɗannan alamun sun bayyana, ana ba da shawarar neman kulawar likita nan da nan.
A wasu lokuta, ana iya lura da alamun tsarin numfashi na sama kamar atishawa, ɓacin hanci ko ciwon makogwaro.
An lura da alamun cututtukan narkewa kamar tashin zuciya, amai da gudawa a kashi daban-daban.
Wasu marasa lafiya a China sun nuna kawai tsananin nono da kuma tashin hankali.
A wasu mutane, cutar na iya haifar da ciwon kirji da ƙugu, rashin aiki da yawa da mutuwa.
Wannan lokaci ana kiransa lokacin incubation.
Lokacin ɓoyewa don COVID-19 yawanci kwanaki biyar zuwa shida ne, amma yanayin juyin halitta na iya bambanta tsakanin kwanaki biyu zuwa 14.
Kashi 97.5 cikin dari na mutane suna nuna alamun cutar har zuwa kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba lallai bane duk masu kamuwa da cutar su kasance ba tare da alamun cutar ba.
Ba a san cikakken rawar da waɗannan masu ɗaukar hoto ba a cikin watsa cutar ba, kodayake shaidun farko sun nuna cewa suna iya taka rawa wajen yada kwayar cutar.
A halin yanzu, ba a san adadin masu kamuwa da cutar ba kuma ana nazarin su, a cewar rahoton Cibiyar Kula da Cututtuka da Cututtuka ta Koriya (KCDC), kashi 20 cikin dari na dukkan masu kamuwa da cutar da aka tabbatar ba su da alamun cutar yayin kwantar da su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara hada wadanda ba su da alamun cutar a cikin alkaluman su na yau da kullun daga ranar 1 ga Afrilu. Daga cikin kamuwa da cutar 166 a ranar, mutane 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙura da ƙura na baki suna da yawan adadin kwayoyin cutar.
Yin magana da ƙarfi yana fitar da ƙarin ƙananan ruwa idan aka kwatanta da magana ta al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa tari ba tare da kariya ba zai iya haifar da zubar da ruwa na numfashi daga nesa na mita 4.5 (ƙafa 15).
Kodayake kwayar cutar ba ta yawan zama a cikin iska, Cibiyar Kimiyya ta Kasa ta ce ana iya watsawa ta wannan hanyar kuma samfurin iska na waje na mutane ya nuna tabbataccen RNA na kwayar cutar.
Wasu hanyoyin likita kamar tubing da CPR na iya haifar da yaduwar numfashi a cikin iska, wanda ke haifar da iska.
Ko da yake akwai damuwa cewa cutar za ta iya yadawa ta hanyar kwayoyi, amma yana da wuya. Halin cutar yana da matukar damuwa lokacin da mutum yana da alamun bayyanar cututtuka, ko da yake yana yiwuwa a iya yadawa kafin bayyanar cututtuka.
Cibiyar Kula da Cututtuka ta Turai ta ce yayin da ba a san yadda cutar ke yaduwa ba, mutum ɗaya yana cutar da mutane biyu zuwa uku. Kwayar cutar tana iya zama a saman mutane na tsawon awanni.
Musamman, an gano cewa kwayar cutar tana iya ganowa sama da kwana ɗaya a kan kwali, sama da kwana uku a kan filastik (polypropylene) da ƙarfe mai lalata (AISI 304) da sama da awanni huɗu a kan jan ƙarfe 99%.
Koyaya, wannan ya dogara da yanayin zafi da zafin jiki.
Sabulu da kayan wankewa suna da amfani idan aka yi amfani da su yadda ya kamata: samfurori na sabulu suna kawar da kuma kashe ƙwayar cutar ta hanyar ƙwayar cuta, kuma suna ware kwayar cutar daga fata da sauran farfajiyoyi.
Sauran magungunan kamar Benzalkonium chloride da Chloroxydine glucanate (wani maganin kashe ƙwayoyin cuta na tiyata) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurori na ƙura a matsakaici kwana biyu bayan kwantar da su.
A cikin 5 daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman ƙwayar cutar a rana ta biyu, kuma mai haƙuri na shida ya nuna mafi girman ƙwayar cutar a rana ta biyu.
Cutar coronavirus 2 mai saurin kamuwa da cutar SARS-CoV-2 wani sabon Cutar coronavirus ne wanda aka fara ganowa a cikin mutane uku da ke fama da cutar sankarar bargo a Wuhan, waɗanda ke fama da raunin iskar oxygen a cikin jini da matsalolin numfashi.
Dukkanin halaye na sabon SARS-CoV-2 sun bayyana a cikin yanayin coronavirus.
A waje da jikin mutum, ana kashe kwayar cutar da sabulu na yau da kullun, wanda ke kawar da kumfa mai riƙewa a cikin ƙasa. COVID-19 yana da alaƙa da SARS-CoV-2.
Fuka-fuki sune kwayoyin da suka fi dacewa da COVID-19, saboda kwayar cutar tana shiga cikin ƙwayoyin halitta ta hanyar enzyme mai canzawa na angiotensin 2 (ACE2), mai karɓar mai karɓar mafi yawan ƙwayoyin aloeulaire na huhu biyu.
"Cutar tana amfani da glycoprotein na musamman (peplomer) da ake kira ""spike"" don ɗaure kansa ga ACE2 da shiga cikin tantanin halitta mai masaukin baki".
An gano mummunan rauni na zuciya a cikin kashi 12% na masu jinya a asibiti a Wuhan, China, wanda ya fi yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya da jijiyoyin jini suna da yawa saboda halayen kumburi da rikicewar tsarin garkuwar jiki yayin ci gaban cutar, amma lalacewar jijiyoyin zuciya na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Ana bayyana masu karɓar ACE2 sosai a cikin zuciya kuma suna raba manufar aikin zuciya.
An lura da yawan kamuwa da cutar thrombosis (31%) da thromboembolic veinary (25%) a cikin marasa lafiya na ICU da ke fama da COVID-19 kuma yana iya kasancewa da alaƙa da rashin kyakkyawan hangen nesa.
Kodayake SARS-CoV-2 yana da ƙwarewa ga ƙwayoyin mucous waɗanda ke bayyana ACE2, marasa lafiya da ke fama da cutar COVID-19 mai tsanani suna nuna alamun cutar hyperinflammatory general.
Musamman, an nuna cewa kwayoyin T masu cutarwa waɗanda ke ɓoye GM-CM suna da alaƙa da amfani da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin IL-6 da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton cutar lymphocytic a cikin autopsy.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar gwajin gwaji ita ce juyawa ta juyawa ta juyawa ta juyawa (rRT-PCR).
Ana yin gwajin ne akan samfurori na numfashi da aka samo daga bututun hanci; duk da haka, ana iya amfani da bututun hanci ko samfurin daga ƙuƙwalwa.
Sakamakon zai kasance a cikin sa'o'i kadan zuwa kwanaki biyu.
Ana iya amfani da gwaje-gwajen jini, amma ana buƙatar samfurori biyu na jini da aka ɗauka a cikin makonni biyu, kuma sakamakon yana da ƙananan darajar lokaci.
Masana kimiyya na kasar Sin sun iya ware wani kwayar cutar coronavirus da kuma sakin jerin kwayoyin halittar ta, don haka dakunan gwaje-gwaje a duk duniya zasu iya samar da tsarin polymerase chain reaction (PCR) don gano kamuwa da cutar ta hanyar kwayar cutar.
Har zuwa 4 ga Afrilu, 2020, an ci gaba da gwajin antibody (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar gwajin na kasar Sin ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin dari.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na kulawa a Amurka a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Hanyoyin bincike da asibitin Zongnan na Jami'ar Wuhan ya buga sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halayen asibiti da cututtuka masu yaduwa.
Matte gilashin polygonal bi-directional cortices tare da rarraba yanayi, rashin daidaituwa da kuma baya suna da yawa a farkon kamuwa da cuta.
Cika huhu, tsari mai ban mamaki (ƙarancin ruwan wukake da kuma cikewar jakar iska) da kuma ƙarancin huhu sune alamun ci gaban cutar.
Akwai karancin bayanai game da lalacewar microscopic da pathophysiology na COVID-19.
Babban binciken cututtukan cututtuka daga autopsy sun haɗa da:
Maganin microscopy: chloritis, amnesia na zuciya, daidaitawar huhu da kuma ciwon huhu.
Akwai nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ƙananan ƙwayar kirji: ciwon huhu, hyperplasia na pneumocytes, manyan atypical pneumocytes, ƙwayoyin cuta na ciki tare da lymphocytic artery da kuma girma na giant cell.
Cutar huhu mai tsanani: lalacewar alveolar (DAD) tare da yaduwar alveolar.
DAD yana haifar da ciwon ƙwayar cuta mai tsanani (ARDS) da kuma rage yawan iskar oxygen a cikin jini.
Maganin kirji da na baya: daidaitawar ɓoyewa a cikin rami na jakar iska da fibrosis na ciki na huhu.
Jini: DIC mai zurfi; halayen locurotroplastic
Matakan kariya don rage yiwuwar kamuwa da cuta sun hada da kasancewa a gida, guje wa wuraren da jama'a ke taruwa, wanke hannuwanku akai-akai da sabulu da ruwa na akalla dakika 20, kiyaye tsabtar numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ke zaune.
Cibiyar Kula da Cututtuka ta CDC ta ba da shawarar rufe hanci da baki da tawul lokacin da kake tari ko hancinka, kuma idan ba a sami tawul ba, to ka tari ko hancinka a cikin makogwaro.
Ana ba da shawarar kiyaye tsabtace hannu bayan yin atishawa ko tari.
Don iyakance watsa cutar ta hanyar masu dauke da cutar ba tare da alamomi ba, CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren taruwa. Dabarun nisantar zamantakewar jama'a suna da niyyar rage hulɗar mutane masu kamuwa da cutar da jama'a ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye da soke manyan taron jama'a.
Ka'idojin nisantarwa sun hada da cewa mutane su kasance aƙalla ƙafa 6 (1.8 m) daga juna.
"Babu wani magani da aka sani da zai iya hana kamuwa da COVID-19. Tun da mafi ƙarancin lokacin da zai yiwu don samun allurar rigakafi ba zai kasance ba kafin 2021, babban batun da ke gabanmu a cikin kula da COVID-19 shine ƙoƙarin rage ƙaruwa, ko kuma abin da ake kira "" share lanƙwasawa. """
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu na tsawon dakika 20, musamman bayan sun je gidan wanka ko idan hannayensu sun kasance da datti sosai, kafin cin abinci ko bayan share hanci, bayan atishawa da tari.
Bugu da ƙari, ana ba da shawarar masu amfani da su yi amfani da barasa tare da akalla kashi 60 cikin dari na barasa, amma kawai idan sabulu da ruwa ba su da sauƙi.
A cikin wannan tsari, aikin antimicrobial ya samo asali ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa kashe ƙwayoyin cuta a cikin barasa. "" Ba abu ne mai aiki ba wanda ke kashe hannu""".
An kara glycerol a matsayin mai sha ruwa.
Ana kula da mutane tare da kulawa mai goyan baya wanda zai iya haɗawa da maganin ruwa, taimakon oxygen da kuma tallafawa wasu gabobin rayuwa.
CDC ta ba da shawarar cewa mutanen da ake zargi da kamuwa da cutar su yi amfani da abin rufe fuska mai sauƙi.
An yi amfani da iskar oxygen ta waje da jiki (ECMO) don magance matsalar rashin numfashi, amma har yanzu ana nazarin fa'idodinta.
Ana ba da shawarar kiyaye tsaftacewar mutum da salon rayuwa mai kyau da abinci mai gina jiki don inganta tsarin garkuwar jiki.
Magungunan tallafi na iya zama masu tasiri ga mutanen da ke da alamun cutar mai sauƙi da kuma farkon kamuwa da cutar.Kungiyar Lafiya ta Duniya (WHO) da Hukumar Lafiya ta Kasa ta China (Chinese National Health Commission) sun ba da shawarwari don kula da mutanen da ke asibiti saboda COVID-19.
Kwararrun likitocin kulawa da keɓaɓɓu da likitocin hanta a Amurka sun tattara shawarwarin kula da lafiya daga hukumomi daban-daban a cikin wata hanya ta kyauta, IBCC.
Har zuwa Afrilu 2020, babu wani magani na musamman don COVID-19.
Wasu likitoci sun fi son yin amfani da maganin paracetamol don magance alamun cutar fiye da ibuprofen don maganin farko.
Dole ne a yi taka tsantsan don rage haɗarin watsa kwayar cutar, musamman a cikin yanayin kulawa inda za a iya samar da ƙwayoyin da ke rataye yayin aiwatar da ayyuka, kamar shigar da bututu da amfani da na'urar numfashi ta hannu.
Ga masu aikin kiwon lafiya da ke kula da mutanen da ke da cutar COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakin keɓewa don cututtukan da ke yaduwa ta iska (AIIR) ban da amfani da daidaitattun matakan kariya, kula da tuntuɓar mutum da kuma kula da cututtukan da ke yaduwa ta iska.
Abubuwan da aka ba da shawarar sun haɗa da: PPE, tsarin numfashi ko abin rufe fuska, kariya ta ido da safar hannu. Idan akwai, ana fifita na'urar numfashi (maimakon abin rufe fuska).
An amince da matattarar numfashi na N95 don wuraren masana'antu, amma FDA ta ba da izinin amfani da waɗannan masks kawai don yanayin amfani da gaggawa (EUA).
An tsara su don kare ƙwayoyin da ke cikin iska kamar ƙura, amma ba a tabbatar da ingancinsu ga takamaiman wakili na halitta don amfani da ba a ambata a kan lakabin ba.
CDC ta ba da shawarar amfani da kariya ta fuska, ko kuma a matsayin makomar ƙarshe, rufe fuska a gida lokacin da ba a samun masks.
Yawancin lokuta na COVID-19 ba su da tsanani sosai don buƙatar numfashi na inji ko makamancin haka, amma kashi ɗaya na masu cutar suna buƙatar waɗannan.
Ana nazarin irin taimakon numfashi da marasa lafiya ke buƙata tare da rashin ƙarfi na numfashi na COVID-19 a kan mutane a asibiti, kuma akwai shaidu da ke nuna cewa ana iya hana intubation ko tubing ta hanyar amfani da bututun mai matsin lamba ko kuma iska mai matsin lamba.
Ba a san ko wane daga cikin waɗannan biyu zai haifar da fa'idodi iri ɗaya ga mutanen da ke fama da rashin lafiya mai tsanani ba.
Wasu likitoci sun fi son ci gaba da amfani da na'urar numfashi ta inji a lokacin da ake samun dama, saboda wannan fasaha tana iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da maganin oxygen na hanci mai tsawo. Abubuwan da suka faru a cikin masu fama da cutar sun fi yawa a cikin tsofaffi (mutane a kan shekaru 60, musamman ma mutane a kan shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isasshen gadajen asibiti, wanda ke iyakance ikon tsarin kiwon lafiya don magance hauhawar kwatsam na COVID-19 da ke buƙatar asibiti.
Wani bincike da aka yi a China ya nuna cewa kashi 5% na waɗanda aka karɓa a dakunan kulawa na musamman, kashi 2.3% sun buƙaci taimakon na'urar numfashi ta inji, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da aka kwantar da su a asibiti saboda COVID-19 an kai su ICU.
Aikin iska na inji yana da rikitarwa yayin da cutar ta kamu da cutar ta COVID-19 (ARDS) ta ci gaba kuma samar da iskar oxygen ya zama da wahala.
Ana amfani da na'urorin numfashi, gami da yanayin kula da matsin lamba da PEEP mai ƙarfi, don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da ke tattare da tsarin numfashi da pneumothorax.
Ba za a iya samun ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Bincike kan yiwuwar maganin ya fara a watan Janairun 2020, kuma ana ganin magungunan antiviral da yawa a cikin gwaji na asibiti.
RedSevere shine mafi inganci har zuwa yanzu.
Kodayake samar da sabon magani na iya ɗaukar har zuwa 2021, yawancin magungunan da ake gwadawa sun riga sun tabbatar da wasu amfani ko kuma an riga an amince da su a cikin gwaji na gaba.
Za a iya gwada maganin rigakafin cutar a kan mutanen da ke da mummunan cuta.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa masu sa kai su shiga cikin gwaji don ƙayyade inganci da rigakafin maganin. Hukumar Abinci da Magunguna ta Amurka ta ba da izinin amfani da plasma na masu warkewa a matsayin magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari ko kai tsaye.
Ba a gudanar da nazarin asibiti da ake buƙata don nuna rigakafi da ingancin cutar ba.
A watan Fabrairun 2020, kasar Sin ta gabatar da wata manhajar wayar hannu don magance barkewar cutar.
Ana buƙatar masu amfani don shigar da sunayensu da lambar ganowa.
"Wannan shirin yana iya gano ""kusa da kusanci"" da kuma yiwuwar haɗarin kamuwa da cutar ta amfani da bayanan sa ido".
Kowane mai amfani zai iya duba matsayin wasu masu amfani uku.
Idan aka gano wata barazana, app din ba kawai zai bada shawarar keɓewa ba, amma kuma zai sanar da hukumomin kiwon lafiya na gida game da barazanar. Ana amfani da nazarin manyan bayanai akan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin masu kamuwa da cutar da kuma mutanen da suka sadu da Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta kunna hukumomin tsaro don bin diddigin bayanan wayar hannu na mutanen da ake zargi da kamuwa da cutar coronavirus.
Wannan matakin yana nufin keɓewa da kare mutanen da zasu iya haɗuwa da 'yan ƙasa masu kamuwa da cutar.
Har ila yau, a cikin Maris 2020, Deutsche Telekom ta raba bayanan wuri tare da cibiyar nazarin cutar ta Robert Koch Institute, wata hukumar gwamnatin tarayya ta Jamus, don bincike da hana yaduwar cutar.
Rasha ta aiwatar da fasahar gano fuska don gano masu keta dokar killacewa.
"Julio Galera, memba na Hukumar Kiwon Lafiya ta Yankin Italiya, ya ce an sanar da shi ta hanyar masu amfani da wayoyin hannu cewa ""kashi 40% na mutane suna tafiya a ko'ina"."
Gwamnatin Jamus ta gudanar da wani taron Hackathon na tsawon sa'o'i 48 a makon da ya gabata tare da masu halarta sama da 42,000.
Shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya da ta samar da hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus.
Mutanen da ke keɓewa na iya fuskantar damuwa, ƙuntatawa na tafiya, cututtukan da ke tattare da magani, ko tsoron kamuwa da cuta.
"BBC ta nakalto Rory O'Connor yana cewa:" ""Ƙarin keɓewar zamantakewa, kadaici, damuwa game da lafiya, damuwa da matsalar tattalin arziki suna da hadari a kowane fanni don cutar da lafiyar mutum da lafiyar mutum. """
Cutar na iya kasancewa mai sauƙin bayyanar cututtuka ko ma ba tare da bayyanar cututtuka ba kuma yana kama da cututtuka tare da matsalolin numfashi na sama na yau da kullun kamar faduwa.
Sau da yawa lokuta masu sauƙi suna warkewa cikin makonni biyu, yayin da a cikin mutane masu tsanani, zai iya ɗaukar makonni uku zuwa shida don murmurewa.
Dangane da bayanan da aka samu daga wasu ƙwayoyin cuta masu kama da SARS da MERS, mata masu ciki na iya zama cikin haɗarin kamuwa da COVID-19, amma babu bayanan COVID-19 a halin yanzu. A cikin mutane da yawa, COVID-19 na iya shafar huhu da haifar da hayaki da ƙura.
COVID-19 a cikin mutane masu kamuwa da cutar, na iya ci gaba da sauri zuwa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Matsalolin da ke tattare da COVID-19 sun haɗa da ciwon jini, ƙwayoyin cuta da lalacewar zuciya, koda da hanta.
An lura da rikicewar jini, ko kuma musamman ƙaruwar lokacin prothrombin, a cikin kashi 6% na waɗanda aka kwantar da su a asibiti tare da COVID-19, yayin da aka lura da aikin ƙwayar cuta mara kyau a cikin kashi 4% na wannan rukunin.
A kusan kashi 20 zuwa 30 cikin dari na mutanen da ke fama da COVID-19, ƙwayoyin enzyme na hanta (trans aminases) suna da yawa.
A cewar rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, wanda biyar daga cikinsu ya kasance a asibiti.
Koyaya, matsakaicin lokacin tsakanin lokacin kwantar da marasa lafiya da lokacin mutuwa a cikin ICU ya kasance kwanaki 7.
A cikin binciken da aka yi a kan farkon lokuta, matsakaicin lokacin daga lokacin bayyanar cututtuka na farko zuwa mutuwa ya kasance kwanaki 14, tare da kewayon juyin halitta na kwanaki shida zuwa 41.
A wani binciken da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, maza sun mutu da kashi 2.8 cikin dari, yayin da mata suka mutu da kashi 1.7 cikin dari.
Binciken kwayoyin halitta na ƙwayar cuta bayan mutuwar ƙwayar cuta ya nuna lalacewar alveolar da aka rarraba tare da ƙwayoyin fibromyalgia na ƙwayoyin cuta a cikin ƙwayoyin cuta biyu.
An lura da sauye-sauyen kwayar cutar ta kwayar cuta a cikin pennamocytes.
Hoton hanta yayi kama da ciwon numfashi mai tsanani (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da cutar zuciya saboda yawan matakan troponin ko kuma dakatar da zuciya.
A cikin watan Maris a Amurka, kashi 89% na mutanen da ke asibiti suna da cututtuka masu haɗari. Samun albarkatun magani da tattalin arzikin yankin ba su da tasiri a kan yawan mutuwar.
Ƙididdigar yawan mutuwar da ke faruwa a waɗannan yanayi ya bambanta saboda bambance-bambance na yanki da kuma matsalolin hanyoyin.
Ƙananan ƙididdigar ƙananan lokuta yana haifar da ƙididdigar yawan mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance ne daga abubuwan da aka kamu da su a baya, yana iya nufin cewa an kiyasta yawan mutuwar yanzu.
Masu shan sigari sun fi saurin kamuwa da cututtukan COVID-19 sau 1.4 kuma suna buƙatar kulawa ta musamman kusan sau 2.4 fiye da waɗanda ba masu shan sigari ba.
Jami'in asibitin Hong Kong ya gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin mutane da suka warke daga cutar, kuma hotunan huhu sun nuna lalacewar gabobin.
Hakanan yana iya haifar da ciwo bayan kulawa ta musamman.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar a baya yana haifar da kariya mai tasiri da na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
An yi la'akari da yiwuwar rigakafin rayuwa ta mutane saboda halayen sauran coronaviruses, amma an bayar da rahoton cewa mutanen da suka sami ƙarin rigakafi bayan kamuwa da COVID-19 sun sake kamuwa da cutar.
Ana ganin cewa waɗannan lokuta suna sa kamuwa da cuta mai tsanani ya zama mafi muni maimakon sake kamuwa da cuta.
Ana tsammanin kwayar cutar ta halitta ce kuma ta samo asali ne daga dabbobi ta hanyar kamuwa da cuta.
Ba a san ainihin asalin cutar ba, amma har zuwa Disamba 2019, yaduwar cutar ta kasance ta hanyar ƙarin hanyar watsawa daga mutum zuwa mutum.
Nazarin da aka fara tabbatar da shari'o'in COVID-41 na 19 da aka buga a cikin Lancet a watan Janairun 2020, ya sanar da ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba, 2019.
Rahoton hukuma na Hukumar Lafiya ta Duniya ya ba da rahoton cewa alamun farko na cutar sun bayyana a ranar 8 ga Disamba, 2019.
Yawancin lokaci ana amfani da ma'auni da yawa don lissafin yawan mutuwar.
Waɗannan ƙididdigar sun bambanta dangane da yanki da lokaci kuma suna da bambanci dangane da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin da ya wuce tun farkon barkewar cutar da kuma yanayin alƙaluma kamar shekaru, jinsi da lafiyar gaba ɗaya.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta ba da lambar gaggawa ta ICD-10 cutar U07.1 ga marasa lafiya waɗanda aka tabbatar da cutar SARS-CoV-2 a cikin dakin gwaje-gwaje da lambar U07.2 ga marasa lafiya da suka mutu waɗanda ba su da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje da ke da cutar COVID-19 a asibiti ko a fannin annoba.
A cewar Jami'ar Johns Hopkins, yawan mace-macen duniya ya kai kashi 6.9% a ranar 17 ga Afrilu, 2020 (5,3822/22,40191).
Figures sun bambanta daga yanki zuwa yanki. Sauran ma'auni sun haɗa da yawan mutuwar (CFR), wanda ke nuna mutanen da suka kamu da cutar kuma suka mutu, da kuma yawan kamuwa da cuta (IFR), wanda ke nuna yawan adadin masu kamuwa da cuta (wanda aka gano ko ba a gano ba) waɗanda suka mutu daga cutar.
Wadannan ƙididdigar ba su da iyaka a lokaci kuma suna bin wani yanki na musamman daga kamuwa da cuta zuwa warwarewa.
Kodayake ba duk masu cutar da cutar ba ne ke samar da ƙwayoyin cuta, kasancewar waɗannan ƙwayoyin cuta a cikin mutane yana nuna yawan mutanen da suka kamu da cutar.
A cibiyar barkewar cutar a Italiya, a wani ƙaramin ƙauye mai suna Castel di Adda (Castiglione d'Adda), mutane 80 (1.7%) daga cikin mazauna 4,600 sun mutu.
A Ganglet, cutar ta bazu ta hanyar bukukuwan Carnival kuma ta bazu tsakanin matasa, wanda ya rage yawan mace-mace. Koyaya, ba duk mutuwar COVID-19 bane.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai kasance mai banƙyama ba game da karɓar marasa lafiya da kuma kula da su.
A cikin Netherlands, kimanin kashi 3% na mutane na iya samun ƙwayoyin rigakafi daga kimantawa daga masu ba da jini.
Mutane 69 (0.004% na yawan jama'a) sun mutu sakamakon COVID-19.
Tasirin cutar da kuma yawan mace-macen da ke tattare da ita ya bambanta ga maza da mata.
Yawan mace-mace a cikin maza ya fi girma a cikin nazarin da aka yi a China da Italiya.
Babban haɗarin ga maza a cikin shekarunsu na 50, kuma bambancin tsakanin maza da mata kawai kashi 90 ne.
A kasar Sin, yawan mace-macen ya kai kashi 8.2% a tsakanin maza da kashi 7.1% a tsakanin mata.
Ba a san ainihin dalilin wannan bambancin jinsi ba, amma halayyar mutum da kwayoyin halitta na iya zama sanadi.
Bambance-bambance na rigakafi na jinsi, ƙarancin shan taba a cikin mata, da kuma kamuwa da cututtukan cututtuka na yau da kullun a cikin maza, kamar hawan jini a cikin ƙananan shekaru fiye da mata, na iya taimakawa wajen mutuwar maza.
A Turai, maza sun kai kashi 57% na mutanen da suka kamu da cutar, kuma kashi 72% na mutanen da suka mutu sakamakon COVID-19 maza ne.
Tun daga watan Afrilun 2020, gwamnatin Amurka ba ta sake bin diddigin bayanan kamuwa da COVID-19 ta hanyar jima'i.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta kamar su Ebola, AIDS, mura da SARS suna da tasiri daban-daban akan mata da maza.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma'aikatan jinya, mata ne, waɗanda ke da damar kamuwa da cutar.
"Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan cutar shine ""COVID-19"" (COVID-19)".
Shugaban Hukumar Lafiya ta Duniya Tedros Adhanom Ghebreyesus ya bayyana cewa CO shine farkon kalmar coronavirus, VI shine farkon kalmar cutar, kuma D shine farkon cutar a Turanci, kuma lambar ta nuna shekaru 19 na farkon kamuwa da cutar: 31 ga Disamba, 2019.
An zaɓi sunan cutar ne bisa ga ƙa'idodin sanya suna na duniya don hana ɓata suna, ba tare da yin la'akari da wani yanki na musamman ba (misali China), ko wani nau'in dabba ko rukuni na mutane. An ba da sunan kwayar cutar da ke haifar da cutar COVID-19 coronavirus 2 mai saurin kamuwa da cutar numfashi (SARS-CoV-2).
"Bugu da kari, Hukumar Lafiya ta Duniya ta yi amfani da kalmar ""Covid-19 virus"" ko ""Covid-19 virus"" a cikin bayanan jama'a".
"A yadda aka saba, ""coronavirus"" yana nufin duka kwayar cutar da cutar".
"A lokacin da cutar ta fara bulla a Wuhan na kasar Sin, an san cutar da cutar da sunayen ""coronavirus"" da ""Wuhan coronavirus""".
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta sake sanya wa cutar 2019-nCoV da cutar numfashi mai saurin kamuwa da cutar 2019-nCoV, bisa ga jagororin da aka bayar a shekarar 2015 don sanya wa cututtuka da ƙwayoyin cuta na wucin gadi bisa ga wuri.
An buga sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a cikin sarkar sabis na yau da kullun, wasu masana'antun dijital suna samar da kayayyakin kiwon lafiya kamar su bututun hanci ko sassan iska.
Misali, lokacin da asibiti a Italiya ke buƙatar bawul ɗin iska da sauri kuma mai ba da kaya ba shi da ikon isar da shi, wani farawa na gida ya samar da bawul 100 a cikin dare.
Bayan barkewar cutar COVID-19, ra'ayoyin maƙarƙashiya, da rashin gaskiya da rashin gaskiya game da asali, sikelin, rigakafi, magani da sauran fannoni na cutar sun bayyana kuma sun bazu cikin sauri akan Intanet.
An gano cewa mutane na iya yada kwayar cutar zuwa wasu dabbobi.
Bincike ya gaza don gano shaidar cewa kwayar cutar tana ninkawa a aladu, ducks da beraye.
Babu wani magani ko allurar rigakafi da aka amince da ita don magance cutar.
Ana gudanar da bincike na duniya kan allurar rigakafi da magunguna don COVID-19 ta hukumomin gwamnati, kungiyoyin kimiyya da masu bincike na masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da ""gwadawar hadin gwiwa"" (SOLIDARITY Trial) don tantance tasirin maganin maganin maganin cutar guda huɗu da ke akwai waɗanda ke da begen tasiri".
Babu wani allurar rigakafi da ke akwai, amma kungiyoyi daban-daban suna aiki sosai don samar da samfurori.
Saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam, binciken da aka yi a baya akan SARS-CoV yana da amfani.
An bincika dabarun allurar rigakafi guda uku a wannan batun.
Da farko, burin masu binciken shine samar da allurar rigakafin cutar ta gaba.
Ana amfani da irin wannan kwayar cutar, ko dai a kashe ta ko a kashe ta, don motsa saurin amsawar rigakafin jikin mutum ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, alluran rigakafi, tana da nufin ƙirƙirar allurar rigakafi wanda ke sa tsarin garkuwar jiki ya zama mai saukin kamuwa da wasu ƙananan ƙwayoyin cuta.
A cikin SARS-CoV-2, irin wannan bincike yana mai da hankali ne akan furotin S-spike wanda ke taimaka wa kwayar cutar ta haɗa kanta da mai karɓar enzyme ACE2.
Dabara ta uku ita ce allurar rigakafin nucleic acid (RNA ko DNA allurar rigakafi, sabuwar dabara don ci gaban allurar rigakafi).
Dole ne a gwada alluran rigakafin gwaji na kowane ɗayan waɗannan dabarun don rigakafi da inganci. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar rigakafi tare da masu sa kai huɗu a Seattle.
Allurar rigakafin ta ƙunshi kwafin kwayar halitta mara lahani wanda aka kwafe daga kwayar cutar da ke haifar da cutar. An ba da shawarar ingantawar ƙwayoyin cuta a matsayin ƙalubalen da za a iya yi don samar da allurar rigakafi don SARS-COV-2, amma wannan yana da rikice-rikice.
Sama da nazarin asibiti 300 suna gudana a watan Afrilu 2020.
A halin yanzu, an kimanta gwaji bakwai don maganin zazzabin cizon sauro, gami da bincike huɗu akan hydroxychloroquine ko chloroquine.
Sabbin magungunan rigakafin cutar da ke aiki suna ba da babban ɓangare na binciken Sinawa, kamar yadda aka gudanar da gwaji tara na gwaji na uku na Remdesivir a ƙasashe daban-daban a ƙarshen Afrilu.
Tun daga watan Afrilun 2020, ana ci gaba da aiwatar da gwajin gwaji don samar da allurar rigakafin COVID-19 tare da magungunan da aka ba da izini don yin hakan. Ana nazarin magungunan antiviral da yawa don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lupinavir / ritonavir da lupinavir / ritonavir tare da interferon beta.
Tun daga watan Maris na 2020, akwai shaidar gwaji game da ingancin RedSevere.
An lura da ci gaba a cikin marasa lafiya da ke karɓar magani tare da amfani da remdesivir.
Ana gudanar da gwajin gwaji na uku a Amurka, China da Italiya. An fara nazarin chloroquine a China a watan Fabrairun 2020.
Koyaya, akwai kira don nazarin binciken da wasu masu bincike suka yi.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Nazarin Kwayoyin Cutar Wuhan yayin da take ba da shawarar kashi ɗaya na gram a rana, ta lura cewa ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chloroquine don kula da mutanen da ke fama da COVID-19. Hanyoyin gyare-gyare na bakwai na kasar Sin sun haɗa da interferon, ribavirin ko umifenovir don magance COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban allurai na ribavirin don hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje.
Bayan nuna ƙarancin ƙwayar cuta na SARS-CoV-2, an ba da shawarar nitasoxanide don ƙarin nazarin cikin jiki. Nazarin ya nuna cewa haɗuwa da furotin na farko tare da serine-proteinase 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Babban binciken da aka yi akan chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da iyakoki da yawa waɗanda ke hana ƙungiyar likitoci karɓar da gwada waɗannan hanyoyin ba tare da ƙarin bincike ba. Selthavimir ba ya hana SARS-CoV-2 a cikin yanayin dakin gwaje-gwaje kuma ba shi da wani aiki a cikin maganin COVID-19.
Guguwar cytokine na iya zama matsala a cikin matakan gaba na COVID-19.
Akwai shaidar cewa hydroxychloroquine na iya samun kayan aikin anti-cytocin. An haɗa tuclizumab a cikin umarnin magani bayan kammala wani ɗan gajeren bincike da Hukumar Kiwon Lafiyar Kasa ta China ta yi.
Bayan nuna sakamako mai kyau a cikin mutanen da ke da mummunan cuta, ana gudanar da gwajin gwaji na biyu a Italiya.
Ana amfani da gwajin jini tare da gwajin ferritin na serum don gano lokuta na guguwar cytokine, don magance irin wannan ci gaban bayyanar cututtuka wanda aka ce yana haifar da mutuwar mutane da yawa da ke fama da cutar.
An amince da maganin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Har zuwa yau, babu wata hujja ta hanyar bazuwar ko sarrafawa da ke nuna cewa tosylisumab magani ne mai tasiri don CRS.
Ana nazarin watsawar ƙwayoyin cuta da aka tace da kuma ƙwayoyin cuta da aka tattara daga tsarin rigakafin mutane waɗanda suka warke daga COVID-19 zuwa masu kamuwa da cutar a matsayin hanyar da ba ta allurar rigakafi ba.
An gwada wannan dabarar don SARS ba tare da tabbataccen sakamako ba.
Rushewar kwayar cuta wata hanya ce ta aiki da aka yi hasashen za ta iya haifar da maganin rigakafi mai hanawa SARS-CoV-2.
Duk da haka, wasu hanyoyin kamar cytotoxicity da / ko phagocytosis na ƙwayoyin cuta masu dogara da ƙwayoyin cuta suna yiwuwa.
Ana ci gaba da wasu nau'ikan maganin rigakafin rigakafi, misali, amfani da rigakafin ƙwayoyin cuta na monoclonal.
Samun magani daga mutane masu lafiya, wanda ya ƙunshi ruwa na jini daga marasa lafiya da suka warke kuma ya ƙunshi ƙwayoyin cuta na musamman ga kwayar cutar, za a iya haɓaka don amfani da sauri.
Cutar da ke haifar da CAV, ƙungiyar cututtukan da ke da alaƙa da juna.
Li Wenliang, likita a babban asibitin Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu bayan ya sami labarin yaduwar cutar.
